Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3027475	li-eryt	E6/l (e6/l)	5921	9046	0.00%
3027475	li-eryt	— (—)	2548	3573	100.00%	Distribution not available
3027475	li-eryt	10E6/l (e6/l)	1727	2239	0.80%
3027475	li-eryt-3	E6/l (e6/l)	224	240	0.00%
3027475	li-eryt-1	— (—)	207	220	100.00%	Distribution not available
3027475	li-eryt	E6/L (e6/l)	162	177	0.00%
3027475	li-eryt	E6/l______ (e6/l)	136	147	0.00%
3027475	li-eryt	E06/L (e6/l)	133	149	0.00%
3027475	li-erytrosyytit,likvor	10E6/l (e6/l)	96	107	0.00%
3027475	li-erytrosyytit	10E6/l (e6/l)	86	91	0.00%
3027475	li-erytrosyytit	E6/l______ (e6/l)	48	51	0.00%
3027475	li-eryt-1	E6/l (e6/l)	27	27	0.00%	Distribution not available
3027475	li-erytrosyytit	E6/l (e6/l)	21	21	0.00%
3027475	li-erytrosyytit	— (—)	17	17	100.00%	Distribution not available
3027475	li-eryt-3	— (—)	10	11	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Stroke, including SAH

1660

4139

2.97

322.83

1.9

1.4

7104.78

1265.11

e6/l

1.76

1328

3267

Focal epilepsy, strict definition

795

1813

4.69

322.46

1.7

4242.05

3137.25

e6/l

0.13

649

1397

Polyneuropathies and other disorders of the peripheral nervous system

818

1917

4.55

320.28

1.8

1.4

3222.03

1301.15

e6/l

0.32

650

1512

Cerebral cysts

382

425

10.40

320.01

1.6

1.4

256.13

1622.76

e6/l

1.08

316

331

Anxiety disorders, excluding more controls

2027

4963

2.67

316.85

1.5

3252.31

2215.71

e6/l

0.22

1556

3918

Meningitis

378

424

10.70

316.75

1.9

1.4

1050.80

1064.02

e6/l

0.01

294

332

Implicit bacterial Sepsis, including avohilmo

1254

3216

3.36

310.70

1.6

1.4

1090.96

2136.91

e6/l

0.70

996

2593

Cerebrovascular diseases (FINNGEN)

1314

1968

4.97

307.65

1.9

1.3

7873.97

644.99

e6/l

1.72

1025

1519

Normal-pressure hydrocephalus

704

266

41.49

307.65

1.9

1.3

1360.40

850.96

e6/l

0.22

598

208

Disorders of optic nerve and visual pathways

558

882

7.14

307.65

1.5

1.7

485.94

5702.32

e6/l

0.64

434

682

Neurological diseases

2688

1937

7.25

307.65

1.6

1187.74

3320.96

e6/l

0.53

2123

1474

Implicit Sepsis, including avohilmo

2831

5715

3.69

307.65

1.5

2387.36

1889.78

e6/l

0.13

2157

4563

Any dementia

1194

2015

4.29

307.65

1.3

1.4

369.19

2665.49

e6/l

1.38

926

1613

Other neurological diseases

2973

5022

4.86

307.65

1.7

1.4

1751.58

2431.26

e6/l

0.32

2420

3931

Any dementia, excluding more controls

1177

1659

5.13

307.65

1.3

1.4

349.10

2934.42

e6/l

1.25

912

1337

Any mental disorder

2683

5299

2.59

307.65

1.5

2329.82

2176.22

e6/l

0.04

2087

4189

Episodal and paroxysmal disorders

2826

5441

2.70

307.65

1.5

1565.06

1680.38

e6/l

0.05

2257

4215

MS-disease / Multiple Sclerosis

629

633

12.12

307.65

1.2

1.4

545.82

7613.08

e6/l

0.61

487

489

Symptoms and signs involving the nervous and musculoskeletal systems

2605

5632

4.93

307.65

1.5

1568.22

2343.07

e6/l

0.32

2202

4348

Other symptoms and signs involving the nervous and musculoskeletal systems

1868

3928

5.09

307.65

1.5

747.47

2406.75

e6/l

0.98

1633

3018

Mood disorders, excluding more controls

2428

5208

2.81

307.65

1.4

1.5

2556.72

2172.11

e6/l

0.09

1891

4125

Other degenerative diseases of the nervous system

1809

588

25.10

307.65

1.3

1.2

388.55

464.92

e6/l

0.12

1377

465

Cerebrovascular diseases

2139

4827

3.18

307.65

1.8

1.4

6895.80

734.43

e6/l

2.35

1692

3833

Malaise and fatigue

1628

3014

4.42

307.65

1.5

1.4

2661.80

2821.39

e6/l

0.03

1284

2362

Dementia, including avohilmo

1433

2393

4.28

307.65

1.3

1.4

555.05

2391.51

e6/l

1.24

1117

1905

Viral infections of the central nervous system, including avohilmo

563

713

9.26

307.65

1.5

545.97

1359.25

e6/l

0.96

449

551

Dementia

1325

2071

4.58

307.65

1.3

1.4

488.53

2495.11

e6/l

1.15

1041

1638

Hydrocephalus

1040

462

32.71

307.65

2.4

1.5

2060.17

923.23

e6/l

0.93

861

354

Delirium, not induced by alcohol and other psychoactive substances

490

702

7.50

307.65

1.4

865.51

1075.83

e6/l

0.18

387

549

Focal epilepsy

845

1980

4.55

307.65

1.7

4072.00

3041.53

e6/l

0.13

689

1527

Demyelinating diseases of the central nervous system

764

775

12.08

307.65

1.2

1.4

497.83

6314.30

e6/l

0.61

599

592

Implicit viral Sepsis, including avohilmo

1040

2579

4.23

307.65

1.6

1.4

1072.02

2297.04

e6/l

0.66

817

2070

Other encephalitis

364

221

23.94

307.65

1.8

1.5

690.73

675.74

e6/l

0.01

268

169

Encephalitis

378

235

23.06

307.65

1.8

1.5

660.46

657.08

e6/l

0.00

281

179

Epilepsy

1202

2508

5.06

307.65

1.8

1.6

3068.28

2414.22

e6/l

0.11

972

1928

Intracranial trauma

1436

1403

7.14

307.65

1.6

1.5

2294.91

559.19

e6/l

0.58

1132

1084

Other headache syndromes

1314

3676

3.71

307.65

1.4

4305.80

2069.80

e6/l

0.51

1027

2825

Alzheimer disease, excluding more controls

800

204

27.56

307.65

1.3

1.2

264.51

437.77

e6/l

0.31

598

162

Degenerative diseases of the nervous system

1150

1908

4.54

307.65

1.3

1.4

346.05

2361.92

e6/l

1.10

867

1544

Organic, including symptomatic, mental disorders

1893

2769

5.09

307.65

1.3

1.4

707.42

2372.49

e6/l

1.30

1486

2197

Fever of other and unknown origin

1599

3651

3.92

307.65

1.8

1.4

639.29

2499.87

e6/l

1.08

1325

2834

Neurological diseases, wide definition

993

415

12.56

307.65

1.8

1.6

4868.47

718.06

e6/l

0.56

785

294

Abnormalities of gait and mobility

580

873

7.33

307.65

1.7

1.5

4843.93

991.79

e6/l

0.50

453

656

Visual disturbances and blindness

1648

5611

3.05

307.65

1.5

1179.68

2395.22

e6/l

0.76

1305

4432

Condition for Implicit Sepsis (Organ dysfunction codes)

2975

5654

3.80

307.65

1.4

1.5

2287.54

1922.68

e6/l

0.10

2253

4532

General symptoms and signs

3241

4299

3.90

307.65

1.5

1.4

1219.29

2371.49

e6/l

0.64

2576

3326

Dizziness and giddiness

1951

5140

3.04

307.65

1.4

1.5

934.45

1935.36

e6/l

1.20

1589

4113

Migraine

1588

3782

3.39

307.65

1.4

1.5

1312.76

1980.94

e6/l

0.26

1263

2911

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3095

5853

3.71

307.65

1.4

1.5

2224.75

1890.38

e6/l

0.09

2354

4657

Convulsions, not elsewhere classified

916

1555

6.17

307.65

1.7

1.4

700.97

3799.49

e6/l

0.68

710

1204

Alzheimer’s disease (Early onset), excluding more controls

280

70.57

307.65

1.2

107.45

43.52

e6/l

1.22

214

Alzheimer’s disease (Late onset), excluding more controls

481

159

20.84

307.65

1.3

1.2

385.55

506.79

e6/l

0.15

355

125

Viral infections of the central nervous system

538

665

9.57

307.65

1.5

557.29

1420.62

e6/l

0.94

433

511

Concussion

1202

1389

6.92

307.65

1.5

495.67

516.51

e6/l

0.04

962

1075

STROKE

1722

3684

3.27

307.65

1.8

1.4

6851.78

678.56

e6/l

2.07

1364

2824

Other mental disorders due to brain damage and dysfunction and to physical disease

529

745

7.77

307.65

1.4

768.22

1146.57

e6/l

0.47

416

584

Other symptoms and signs involving cognitive functions and awareness

2419

3052

7.63

307.65

1.3

1.5

2657.79

2164.38

e6/l

0.10

1805

2477

Abnormal findings on diagnostic imaging of central nervous system

396

458

10.37

307.65

1.5

1.7

299.62

1299.17

e6/l

0.89

308

358

Visual disturbances

1577

5234

3.14

307.65

1.5

1227.26

2442.97

e6/l

0.69

1251

4131

Disturbances of skin sensation

1134

2928

4.11

307.65

1.3

1.4

1388.78

2458.65

e6/l

0.34

874

2312

Postprocedural disorders of nervous system

601

578

12.55

307.65

1.4

1.2

1884.49

8320.08

e6/l

0.47

495

446

Inflammatory diseases of the central nervous system

754

731

12.75

307.65

1.9

1.4

876.83

1286.41

e6/l

0.36

577

570

Symptoms and signs involving cognition, perception, emotional state and behaviour

3711

6078

4.27

307.65

1.4

1.5

2047.84

1911.80

e6/l

0.04

2873

4835

Other demyelinating diseases of the central nervous system

406

321

16.77

307.65

1.2

1.6

640.48

1693.30

e6/l

0.53

310

252

Unspecific neurodegenerative disorder

1189

2148

3.95

307.65

1.3

1.4

421.57

2488.84

e6/l

1.29

927

1724

Headache

3001

4004

6.15

307.65

1.5

1.4

1758.97

2455.05

e6/l

0.24

2439

3086

Implicit Sepsis

2470

5490

3.44

307.65

1.5

2583.95

1959.16

e6/l

0.15

1929

4335

Alzheimer disease, including avohilmo

1029

1861

3.98

307.24

1.3

1.4

322.07

2476.65

e6/l

1.17

797

1502

Psychiatric diseases

2248

4447

2.59

306.92

1.5

2604.34

2309.65

e6/l

0.06

1737

3512

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

756

658

5.90

304.47

1.5

5915.13

1647.30

e6/l

0.40

584

489

Focal epilepsy, mode (most common among epilepsy diagnosis)

751

1717

4.68

303.66

1.7

4542.41

3094.31

e6/l

0.16

612

1329

Mood [affective] disorders

2627

7499

2.29

298.34

1.4

1.5

2413.74

1807.27

e6/l

0.16

2040

5932

Mood disorders

2628

7500

2.29

297.27

1.4

1.5

2412.45

1807.34

e6/l

0.16

2041

5934

Traumatic subdural haemorrhage

319

265

11.75

296.65

1.8

1.2

8821.21

141.28

e6/l

0.68

252

212

Benign intracranial hypertension

191

46.97

294.21

1.4

1.5

168.18

60.15

e6/l

0.89

156

Pain, not elsewhere classified

801

1957

4.26

294.17

1.5

1.4

768.54

3513.26

e6/l

0.79

646

1523

Viral Sepsis

730

1682

4.58

291.13

1.6

1.4

1104.21

1300.70

e6/l

0.12

599

1338

Other and unspecified hydrocephalus

227

131

24.88

290.86

3.0

1.3

1188.05

1086.19

e6/l

0.04

192

Depression

2476

7319

2.31

289.74

1.4

1.5

2516.02

1812.72

e6/l

0.18

1923

5780

Alzheimer’s disease, strict definition

748

1343

4.70

289.32

1.2

1.4

300.44

1246.62

e6/l

4.14

556

1091

Implicit viral Sepsis

726

1676

4.57

288.80

1.6

1.4

1105.92

1302.39

e6/l

0.12

595

1333

Alzheimer disease

900

1637

4.09

281.56

1.3

1.4

294.29

1104.95

e6/l

4.35

687

1328

Use of anticholinesterases

945

1961

3.86

281.11

1.3

1.4

456.27

2294.63

e6/l

0.99

732

1586

N06DA Anticholinesterases

945

1961

3.86

281.11

1.3

1.4

456.27

2294.63

e6/l

0.99

732

1586

Infections, IBD-co-morbidities

367

243

11.01

279.32

1.9

1.5

417.89

171.28

e6/l

0.71

290

165

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

231

150

21.19

278.09

1.8

1.5

511.15

879.66

e6/l

0.20

198

115

Alzheimer’s disease (Early onset)

280

247

12.88

275.13

1.2

1.3

107.45

939.12

e6/l

0.97

214

202

Viral encephalitis, not elsewhere classified/unspecified

227

148

21.14

272.77

1.8

1.5

513.75

886.81

e6/l

0.20

197

114

Aneurysms, operations, SAH

604

1274

5.06

269.64

2.5

1.3

11734.39

657.74

e6/l

5.54

494

1012

Other antidepressants

2403

5367

2.33

266.66

1.3

1.4

2648.01

1614.19

e6/l

0.27

1881

4219

Implicit bacterial Sepsis

1100

2979

3.27

264.29

1.7

1.4

680.42

2239.70

e6/l

1.32

888

2400

Communicating hydrocephalus

222

152

19.64

259.28

3.7

1.7

2174.52

913.55

e6/l

0.57

166

110

Depression or dysthymia

1458

2782

2.93

256.68

1.5

1241.22

2088.85

e6/l

0.48

1152

2172

Bacterial Sepsis

1204

3364

3.05

255.33

1.7

1.4

732.47

2076.41

e6/l

1.25

973

2703

Nontraumatic intracranial haemmorrhage

620

1416

4.60

249.63

2.7

1.4

18076.53

928.26

e6/l

2.16

500

1129

Other and unspecified polyneuropathies, also in other diseases

667

1621

4.37

248.85

1.4

3858.17

1279.99

e6/l

0.36

532

1279

Syncope and collapse

1027

2700

3.26

245.34

1.6

1.4

783.95

2787.91

e6/l

0.76

820

2138

Migraine without aura

674

1737

4.06

230.95

1.4

1.6

730.56

3129.05

e6/l

0.54

531

1326

Stroke, excluding SAH

1411

3956

2.64

222.85

1.8

1.4

4751.35

1669.13

e6/l

0.59

1130

3120

Other meningitis

193

137

19.77

222.07

2.1

1.3

1789.63

975.76

e6/l

0.35

155

109

Care involving use of rehabilitation procedures

1654

6436

2.37

218.06

1.6

1.5

1459.07

2239.84

e6/l

0.46

1396

4999

Parkinson's disease, excluding more controls

241

207

11.06

214.67

1.5

1.2

288.58

509.16

e6/l

0.40

208

166

Dorsalgia

2287

5746

2.15

212.25

1.4

1.5

2790.66

1825.19

e6/l

0.25

1850

4429

Migraine with aura

740

2149

3.58

212.15

1.3

1.4

1417.98

2711.37

e6/l

0.29

591

1667

General examination and investigation of persons without complaint and reported diagnosis

1484

3000

2.62

211.17

1.5

1.4

3909.69

1024.00

e6/l

0.63

1252

2271

Anxiety disorders

2206

7284

2.12

210.94

1.5

3004.17

1751.96

e6/l

0.31

1696

5729

Subarachnoid haemorrhage

406

754

5.81

210.24

2.9

1.3

17232.64

607.20

e6/l

5.66

331

596

Neurotic, stress-related and somatoform disorders

2186

7256

2.12

208.63

1.5

2910.80

1718.76

e6/l

0.29

1683

5703

Recurrent or chronic depression

949

2131

3.17

205.73

1.4

1.5

944.78

1455.55

e6/l

0.83

730

1650

Low back pain

1835

5603

2.26

203.92

1.4

1.5

3310.66

1842.04

e6/l

0.32

1482

4328

Obstructive hydrocephalus

162

22.90

203.70

2.6

1.9

1873.00

213.99

e6/l

1.18

129

Diplopia

497

1127

4.72

203.43

1.5

1.4

1996.50

4459.78

e6/l

0.31

398

884

Symptoms and signs involving the skin and subcutaneous tissue

1794

7896

2.19

199.40

1.4

1.5

1091.75

2162.81

e6/l

0.89

1396

6236

Optic neuritis

271

357

8.81

198.59

1.3

1.5

441.80

1798.38

e6/l

0.85

207

285

Persons encountering health services for specific procedures and health care

2509

7589

1.98

194.84

1.6

1.5

1663.86

2065.11

e6/l

0.25

2030

5890

Other dorsopathies, not elsewhere classified

2269

5762

2.08

193.63

1.4

1.5

3024.61

1819.21

e6/l

0.31

1839

4444

Papilloedema, unspecified

202

195

12.96

189.96

1.6

1.4

276.19

671.36

e6/l

0.31

161

154

Parkinson's disease, strict definition, excluding more controls

215

192

10.77

189.70

1.5

1.3

315.80

546.05

e6/l

0.38

186

153

Other soft tissue disorders, not elsewhere classified

2195

6141

2.07

189.16

1.5

1335.45

2201.07

e6/l

0.53

1751

4792

Disorders of thyroid, IBD co-morbidities

312

275

7.96

189.05

1.6

1.3

532.84

156.04

e6/l

1.59

247

199

Anxiety (asthma-related co-morbidities)

1526

5096

2.33

187.28

1.4

1.5

3703.18

1649.47

e6/l

0.36

1148

4029

Autoimmune diseases excluding thyroid diseases

2404

6624

2.00

186.86

1.4

1.5

1472.45

2212.52

e6/l

0.41

1901

5173

Status epilepticus

212

222

10.90

185.42

1.9

1013.08

554.45

e6/l

0.38

191

173

Autoimmune diseases excluding thyroid diseases, strict definition

2320

6395

2.01

182.12

1.4

1.5

1496.16

2239.04

e6/l

0.39

1834

4995

Lower back pain or/and sciatica

2457

7991

1.94

181.96

1.4

1.5

2700.81

1654.89

e6/l

0.30

1994

6245

ILD medications: immunosuppressive drugs

1597

6688

2.21

179.79

2.0

1.4

1373.51

2377.85

e6/l

0.61

1267

5211

Autoimmune diseases related-to ILD

2004

8386

2.03

179.12

1.3

1.5

928.13

2167.49

e6/l

1.24

1596

6598

Viral meningitis, including avohilmo

250

341

8.53

177.99

1.4

341.22

848.16

e6/l

0.46

205

262

Other disorders of optic [2nd] nerve and visual pathways

326

583

6.22

177.44

1.6

1.8

471.84

1563.58

e6/l

1.11

257

453

Motor neuron disease ALS

104

49.51

177.28

1.2

547.46

19.12

e6/l

0.58

Malignant neoplasm of brain, including Hilmo

276

422

7.36

176.00

2.1

1.4

2364.99

1424.01

e6/l

0.48

219

343

Viral meningitis

242

324

8.72

175.21

1.4

1.5

335.82

892.18

e6/l

0.49

199

249

Sequelae of cerebrovascular disease

827

2413

3.01

173.86

2.0

1.4

5199.16

925.05

e6/l

3.18

673

1946

Pain in limb

1931

6006

2.08

173.45

1.6

1.5

1277.68

2203.84

e6/l

0.60

1535

4692

Cerebral palsy and other paralytic syndromes

433

1002

4.63

172.90

1.7

1.6

702.85

1064.54

e6/l

0.42

316

786

Motor neuron disease (with DMD)

105

42.66

172.69

1.2

1.8

545.37

804.74

e6/l

0.11

Anaemias

565

910

4.10

172.20

2.0

1.3

2158.24

719.48

e6/l

0.85

439

717

Bacterial infection, other or unspecified

1276

4608

2.39

170.31

2.0

1.4

1004.45

2742.12

e6/l

1.11

1039

3636

Alzheimer’s disease (Atypical or mixed), excluding more controls

179

15.40

169.55

1.4

1.2

311.84

206.99

e6/l

0.27

159

Nerve, nerve root and plexus disorders

2367

7518

1.92

168.52

1.4

1.5

1937.99

1972.42

e6/l

0.01

1939

5872

Bacterial infection, other or unspecified, including avohilmo

1382

5029

2.30

168.24

1.9

1.4

969.66

2596.40

e6/l

1.14

1126

3964

Ischaemic Stroke, excluding all haemorrhages

1220

3735

2.46

168.04

1.6

1.4

1773.41

1859.09

e6/l

0.04

985

2961

Certain infectious and parasitic diseases

2080

5183

2.04

167.81

1.6

1.4

2812.93

2150.07

e6/l

0.14

1623

4053

ILD medications

2507

7271

1.89

164.82

1.8

1.4

1219.71

2269.09

e6/l

0.82

1995

5675

All anxiety disorders

1563

5698

2.17

163.91

1.4

1.5

3608.25

1554.68

e6/l

0.37

1179

4490

Medical observation and evaluation for suspected diseases and conditions

1379

3000

2.39

162.75

1.5

1.4

3714.42

1024.00

e6/l

0.51

1125

2271

Use of donepezil

509

1303

3.87

162.19

1.3

1.4

485.07

1147.44

e6/l

1.38

407

1050

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

317

601

5.76

161.23

2.0

1.4

2200.73

1274.55

e6/l

0.58

251

481

Subjective visual disturbances

730

2498

3.04

159.89

1.4

1.5

1442.31

2662.05

e6/l

0.31

572

1959

Malignant neoplasm of brain

217

286

8.73

158.77

2.0

1.4

2697.48

1652.11

e6/l

0.39

172

231

Bleeding

1823

6393

2.04

158.12

2.0

1.4

8107.45

644.92

e6/l

2.49

1446

5037

Primary_lymphoid and hematopoietic malignant neoplasms

653

2148

3.16

153.37

3.1

1.4

3939.00

1280.87

e6/l

0.37

520

1700

Other anxiety disorders

1214

4537

2.33

153.20

1.4

4200.16

1315.49

e6/l

0.42

915

3560

Dementia in Alzheimer disease

392

732

4.63

152.58

1.3

1.4

279.01

1304.77

e6/l

2.51

346

581

Provisional assignment of new diseases of uncertain etiology

1296

5884

2.24

152.39

1.6

1.5

1171.16

2298.06

e6/l

0.66

1006

4665

Covid-19 confirmed case

937

3729

2.58

152.02

1.7

1.5

1494.88

2860.09

e6/l

0.49

720

2960

Codes for special purposes

1296

5891

2.23

151.90

1.6

1.5

1171.16

2295.11

e6/l

0.66

1006

4671

Depression medications

673

991

3.50

151.72

1.5

1.2

7309.17

578.89

e6/l

0.61

515

785

Selective serotonin reuptake inhibitors

2025

5413

1.97

150.68

1.4

1.5

1655.81

1603.62

e6/l

0.03

1608

4249

Dorsopathies

2181

5814

1.93

150.67

1.4

1.5

2888.85

1805.40

e6/l

0.27

1757

4482

Pain (limb, back, neck, head abdominally)

1431

3217

2.26

149.18

1.6

1.5

3653.14

1309.52

e6/l

0.43

1141

2487

Alzheimer’s disease (Late onset)

516

1190

3.68

147.68

1.3

1.4

384.67

1249.30

e6/l

2.92

384

970

Examination and observation for other reasons

1230

2987

2.37

146.08

1.5

1.4

1251.79

1024.63

e6/l

0.15

959

2262

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

676

2296

2.99

145.48

1.3

1.4

6557.33

1676.62

e6/l

0.41

522

1834

Use of rivastigmine

402

996

4.20

144.78

1.2

1.4

372.91

1161.01

e6/l

2.22

308

803

Sciatica+with lumbago

1182

4690

2.28

143.13

1.4

1.5

1488.81

2054.44

e6/l

0.32

972

3590

Malignant neoplasm of eye, brain and central nervous system

234

374

7.01

142.94

2.1

1.5

2553.44

1314.30

e6/l

0.57

183

299

Substance abuse, excluding more controls

1116

4061

2.34

142.49

1.4

4299.93

2425.36

e6/l

0.23

880

3242

Used for control exclusion in common control thyroid runs

2237

6101

1.88

142.35

1.4

1.6

1308.84

2305.94

e6/l

0.64

1765

4757

Guillain-Barre syndrome

142

125

14.44

142.25

1.4

1.3

427.53

994.05

e6/l

0.27

112

100

Other special examinations and investigations of persons without complaint or reported diagnosis

1327

3000

2.28

140.61

1.5

1.4

3729.76

1024.00

e6/l

0.49

1085

2271

Other bacterial diseases

2036

7260

1.89

140.49

1.9

1.4

1304.81

2293.17

e6/l

0.76

1637

5680

Benzodiazepine use

2202

8215

1.84

140.32

1.4

1.5

2599.20

1729.66

e6/l

0.21

1735

6474

Intracranial injury

1359

6074

2.13

140.00

1.6

1.5

2419.04

1315.24

e6/l

0.30

1066

4805

Abnormal involuntary movements

411

1069

4.04

139.65

1.6

1.4

514.04

4969.97

e6/l

0.66

321

819

Opioids

2076

5723

1.90

138.39

1.4

986.28

2091.19

e6/l

0.86

1633

4514

Pain in joint

1169

3137

2.33

137.51

1.3

1.5

1984.66

1303.24

e6/l

0.32

900

2424

Extrapyramidal and movement disorders

906

3739

2.49

136.40

1.4

1.5

484.85

3105.17

e6/l

1.56

697

2981

Cardiovascular diseases (excluding rheumatic etc)

1492

4125

2.11

135.23

1.7

1.5

4384.69

521.11

e6/l

0.86

1168

3166

Migraine without aura and triptan purchases

540

1715

3.29

135.02

1.4

727.88

1528.09

e6/l

0.80

431

1334

Nausea and vomiting

695

2470

2.83

134.16

1.9

1.6

1625.57

1322.46

e6/l

0.12

552

1928

Bell's palsy

394

1030

4.04

133.24

1.5

1.4

434.15

1207.05

e6/l

1.20

308

799

Metabolic disorders

2013

6550

1.87

132.78

1.5

1921.74

2265.27

e6/l

0.16

1540

5213

Other disorders of urethra and urinary system

1535

5356

2.03

131.99

1.5

1400.23

1911.78

e6/l

0.36

1200

4255

Secondary parkinsonism, excluding more controls

29.28

131.86

1.4

78.52

34.48

e6/l

0.46

Tramadol

1670

5139

1.98

130.99

1.4

1445.78

2240.62

e6/l

0.45

1291

4067

Viral hepatitis, IBD co-morbidity

126

100

13.15

130.49

1.8

1.3

31373.80

116.82

e6/l

0.51

Parasetamol

1514

3724

2.09

129.93

1.5

1.4

3401.32

920.59

e6/l

0.50

1200

2863

Memory loss

283

585

5.15

129.61

1.4

584.43

1207.42

e6/l

1.01

174

462

Cardiovascular diseases

1412

3581

2.13

129.05

1.6

1.5

4451.83

548.76

e6/l

0.79

1091

2756

Spirochaetal infections, other/unspecified

344

838

4.42

128.96

1.3

1.5

368.17

1159.31

e6/l

1.12

242

662

Liquid cancers

740

2703

2.67

127.03

2.9

1.4

3611.28

1551.99

e6/l

0.31

583

2191

Autoimmune diseases

2313

6658

1.79

126.72

1.4

1.6

1508.86

2205.85

e6/l

0.40

1830

5197

Use of other anti-dementia drugs

578

1541

3.10

126.32

1.3

1.4

229.32

1095.03

e6/l

4.59

475

1250

Use of memantine

578

1541

3.10

126.32

1.3

1.4

229.32

1095.03

e6/l

4.59

475

1250

Other intervertebral disc disorders

1666

5158

1.95

125.06

1.4

1.5

1632.38

1965.79

e6/l

0.18

1395

3982

Codeine

1925

5647

1.87

123.47

1.3

1.4

1194.33

2117.99

e6/l

0.60

1503

4452

Circumscribed brain atrophy

135

134

11.79

123.26

1.2

1.4

760.49

1008.50

e6/l

0.10

105

Explicit Sepsis, including avohilmo

930

3651

2.36

122.65

2.2

1.5

1585.26

1948.63

e6/l

0.16

772

2924

GASTRO-related operations

1635

4193

1.98

122.60

1.8

1.3

903.10

2085.00

e6/l

0.67

1277

3300

Any gastric operation

1635

4193

1.98

122.60

1.8

1.3

903.10

2085.00

e6/l

0.67

1277

3300

Nonorganic sleeping disorders, excluding more controls

516

1689

3.15

121.87

1.4

1.5

283.22

1431.02

e6/l

1.94

383

1365

Personality disorders, excluding more controls

603

2150

2.88

121.38

1.4

611.60

1720.11

e6/l

1.64

460

1719

Injuries to the head

2363

8191

1.73

121.27

1.5

3915.66

1313.41

e6/l

0.78

1866

6447

Pain in throat and chest

1821

5830

1.88

120.87

1.4

1.5

1373.74

2182.25

e6/l

0.48

1441

4533

First line medication for Crohn's disease

2312

7194

1.75

120.21

1.8

1.4

1399.44

2207.11

e6/l

0.55

1834

5615

Schizophrenia or delusion, excluding more controls

655

2431

2.73

119.21

1.3

1.4

6289.53

2013.85

e6/l

0.33

505

1948

Other bacterial diseases, including avohilmo

2127

7600

1.77

118.68

1.9

1.4

1652.72

2125.32

e6/l

0.28

1696

5927

Other disorders of fluid, electrolyte and acid-base balance

709

2605

2.63

118.67

1.6

1.5

620.20

2217.34

e6/l

1.17

599

2111

Diseases of the eye and adnexa

1685

4415

1.94

118.60

1.6

1.5

3306.56

1702.84

e6/l

0.31

1329

3465

Explicit Sepsis

906

3587

2.35

118.60

2.2

1.5

1621.74

1978.41

e6/l

0.15

753

2876

Migraine with aura and triptan purchases

500

1645

3.17

117.77

1.4

1.5

461.84

1565.35

e6/l

1.51

398

1273

Non-invasive ventilation

583

1762

2.93

117.71

1.6

1.4

2455.06

755.68

e6/l

0.89

516

1366

Any reimbursement code in KELA

1267

3012

2.14

116.03

1.7

1.3

694.42

3257.17

e6/l

1.20

981

2303

Unspecified dementia

251

444

5.25

115.98

1.4

1.3

334.56

903.06

e6/l

1.03

217

358

ILD medications: prednisolone, methylprednisolone, prednisone

2218

7137

1.75

115.87

1.6

1.4

1287.86

2292.10

e6/l

0.73

1770

5572

Other reaction to severe stress, and adjustment disorders

900

3998

2.31

114.26

1.6

1.4

591.43

1367.06

e6/l

2.15

711

3140

Hypothyroidism (congenital or acquired)

530

933

3.25

112.19

1.4

1.2

1836.73

583.67

e6/l

0.52

424

744

Paralytic strabismus

263

580

4.88

111.99

1.6

1.5

1192.81

789.68

e6/l

0.28

215

459

Influenza and pneumonia

2219

8070

1.72

111.37

1.6

1.5

1339.92

2106.91

e6/l

0.60

1787

6279

Spondylopathies

1524

4721

1.94

111.34

1.4

1.5

1531.24

2007.79

e6/l

0.29

1267

3631

Non-follicular lymphoma

306

762

4.27

110.98

2.0

1.4

7224.55

753.34

e6/l

0.48

262

595

Non-Hodgkin lymphoma, all, including Hilmo

389

1150

3.55

109.50

1.8

1.4

6047.41

1062.54

e6/l

0.44

320

921

Abnormalities of breathing

1860

5961

1.81

109.41

1.4

1.5

1906.13

2157.99

e6/l

0.07

1516

4631

Hypothyroidism, levothyroxine purchases

524

933

3.22

109.21

1.4

1.2

1858.73

583.67

e6/l

0.52

419

744

Hypothyroidism and >3 levothyroxin purchases

524

933

3.22

109.21

1.4

1.2

1858.73

583.67

e6/l

0.52

419

744

Diffuse large B-cell lymphoma, including Hilmo

208

387

5.89

108.31

1.7

1.3

1004.81

758.23

e6/l

0.17

180

320

Diffuse large B-cell lymphoma

208

387

5.89

108.31

1.7

1.3

1004.81

758.23

e6/l

0.17

180

320

Diffuse large B-cell lymphoma, helper endpoint

208

387

5.89

108.31

1.7

1.3

1004.81

758.23

e6/l

0.17

180

320

Speech disturbances, not elsewhere classified

299

747

4.24

107.90

1.4

171.65

888.89

e6/l

2.32

226

586

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1806

5910

1.81

107.05

1.6

1.4

1470.92

2344.16

e6/l

0.49

1450

4563

1806

5910

1.81

107.05

1.6

1.4

1470.92

2344.16

e6/l

0.49

1450

4563

Lumbar disc prolapse

1296

4950

1.97

104.47

1.4

1.5

1216.26

1895.82

e6/l

0.46

1083

3812

Disorders of ocular muscles, binocular movement, accommodation and refraction

1130

5634

2.03

103.80

1.6

1.5

4737.11

1283.03

e6/l

0.53

908

4401

Persons encountering health services in other circumstances, wide

2286

7057

1.68

102.71

1.5

1383.55

2204.12

e6/l

0.58

1796

5580

Tick-borne viral encephalitis, including avohilmo

25.17

102.20

1.1

1.3

69.05

2479.87

e6/l

0.54

Neuromuscular dysfunction of bladder

287

725

4.18

101.92

1.6

1.4

1612.83

1301.24

e6/l

0.16

229

569

Cerebral aneurysm, nonruptured

278

690

4.27

101.25

1.8

1.3

4787.29

777.50

e6/l

1.32

234

540

Benign neoplasm: Cerebral meninges

303

806

3.99

100.30

1.6

1.4

1344.76

1183.19

e6/l

0.12

221

627

Hard cardiovascular diseases

1685

5580

1.81

100.05

1.6

1.5

4415.87

1709.35

e6/l

0.63

1381

4285

Benign neoplasm of meninges

319

882

3.82

99.72

1.6

1.4

1318.18

1229.32

e6/l

0.07

234

685

Asthma (mode)

1506

4264

1.88

98.16

1.4

917.48

2376.78

e6/l

0.87

1187

3288

Complications of surgical and medical care, not elsewhere classified

2021

8076

1.69

97.25

1.7

1.4

2777.61

1754.87

e6/l

0.38

1605

6360

Other and unspecified degenerative diseases of nervous system

131

169

8.67

97.14

1.4

1.3

220.35

839.75

e6/l

0.45

132

Asthma, excluding more controls

1483

4092

1.89

96.95

1.4

878.10

2451.13

e6/l

0.92

1169

3151

Other diseases of urinary system

1959

6475

1.72

96.74

1.5

3274.82

1744.56

e6/l

0.35

1536

5141

Symptoms and signs involving the digestive system and abdomen

1947

5698

1.73

96.28

1.6

1.5

2961.84

1404.59

e6/l

0.38

1549

4447

Oedema, not elsewhere classified

573

2187

2.61

96.02

1.4

1883.32

3499.19

e6/l

0.36

459

1719

Hypo-osmolality and hyponatraemia

414

1360

3.12

95.90

1.6

1.5

761.88

1426.51

e6/l

1.16

357

1096

Traumatic subarachnoid haemorrhage

14.52

95.19

1.7

1.4

3708.53

135.38

e6/l

1.28

Spondylosis

1056

4113

2.04

94.91

1.4

1.5

1034.94

2201.26

e6/l

1.07

879

3178

Asthma

1508

4236

1.86

94.74

1.4

868.83

2385.65

e6/l

0.91

1188

3268

Liquid cancers, including Hilmo

804

3220

2.25

94.67

2.8

1.4

3442.55

1474.92

e6/l

0.33

640

2596

Bacterial meningitis

167

290

6.43

94.02

2.0

1.4

718.83

806.65

e6/l

0.06

132

223

Other/unspecified dorsalgia

781

3505

2.24

93.63

1.3

1.5

812.42

2246.40

e6/l

1.24

615

2701

Symptoms and signs involving the circulatory and respiratory systems

2008

5984

1.70

93.09

1.5

1230.21

2151.12

e6/l

0.61

1609

4646

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2174

7051

1.66

92.60

1.5

1485.98

2204.68

e6/l

0.47

1693

5575

Strabismus

663

2836

2.40

91.98

1.6

1161.41

2479.18

e6/l

0.46

535

2213

Systemic atrophies primarily affecting the central nervous system

173

317

5.96

91.57

1.6

531.45

836.65

e6/l

0.25

137

249

All pneumoniae

2069

8219

1.65

91.49

1.6

1.5

1324.82

2104.79

e6/l

0.61

1663

6400

Enlarged lymph nodes

337

1016

3.42

91.26

1.6

1.4

984.15

5221.78

e6/l

0.58

266

790

Soft tissue disorders

2015

6192

1.69

90.86

1.5

1711.38

2183.67

e6/l

0.23

1593

4831

Tick-borne viral encephalitis

27.26

90.85

1.1

1.3

75.89

3115.97

e6/l

0.54

Pneumonias (Asthma/COPD co-morbidities)

2053

8205

1.65

90.59

1.6

1.5

1331.13

2109.14

e6/l

0.61

1650

6387

Codeine or tramadol medication

2226

7479

1.63

90.49

1.3

1.4

1181.02

2186.36

e6/l

0.83

1742

5921

Persons encountering health services for examination and investigation

1179

3000

2.00

90.45

1.5

1.4

4368.12

1024.00

e6/l

0.53

930

2271

Inflammatory bowel disease treatment related agents

2285

7911

1.62

89.98

1.7

1.4

1077.04

2190.34

e6/l

1.00

1845

6156

Oral corticosteroids

2118

7640

1.64

89.46

1.5

1.4

1093.05

2240.51

e6/l

0.99

1731

5948

Hypertension, essential

1551

4946

1.80

89.21

1.5

1.4

2539.72

1899.85

e6/l

0.26

1204

3894

Undefined dementia

251

571

4.18

89.15

1.4

1.3

334.56

711.94

e6/l

0.78

217

466

Hypertensive diseases (excluding secondary)

1078

3151

2.02

88.73

1.5

1.4

2819.78

577.32

e6/l

1.57

829

2421

Intracerebral haemorrhage

295

833

3.67

88.66

2.5

1.4

17183.43

953.60

e6/l

0.69

233

656

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1961

8087

1.65

87.17

1.9

1.4

1160.06

2178.73

e6/l

0.94

1563

6346

Septicaemia

854

3748

2.12

87.10

2.3

1.4

1680.54

2931.75

e6/l

0.44

714

2975

Other septicaemia, including avohilmo

785

3460

2.17

85.92

2.4

1.4

1791.05

3057.29

e6/l

0.40

660

2749

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1998

8210

1.64

85.66

1.6

1.5

1366.57

2108.26

e6/l

0.57

1608

6395

Other and unspecified visual disturbances

316

958

3.46

85.65

1.3

1.5

694.15

1394.71

e6/l

0.69

239

747

Other extrapyramidal and movement disorders in other diseases

571

2372

2.48

85.19

1.3

1.4

555.95

2936.92

e6/l

0.86

425

1877

Asthma, unspecified (mode), excluding more controls

1041

3821

1.98

84.70

1.5

1.4

1059.15

2597.10

e6/l

0.79

814

2944

Dysphagia

552

2265

2.50

84.38

1.5

4742.03

1475.05

e6/l

0.38

435

1777

Small fibre neuropathy

144

241

6.68

84.24

1.4

58.44

591.57

e6/l

0.56

120

181

Cervicobrachial syndrome

503

1978

2.61

84.23

1.4

8470.89

1490.29

e6/l

0.50

426

1515

Certain infectious and parasitic diseases, including avohilmo

1333

3624

1.87

84.09

1.6

1.4

3502.86

1847.51

e6/l

0.25

1036

2863

Pneumonia, organism unspecified

1821

7575

1.67

84.02

1.6

1.5

1351.90

2204.46

e6/l

0.62

1476

5896

Transient ischemic attack

943

3763

2.03

83.98

1.4

1886.72

1837.55

e6/l

0.02

777

2977

Other septicaemia

765

3391

2.17

83.60

2.4

1.4

1833.41

3102.49

e6/l

0.39

644

2695

Other disorders of central nervous system

12.42

83.15

1.8

1.4

4990.67

219.37

e6/l

0.89

Asthma, unspecified (mode)

1055

3952

1.95

83.09

1.5

1.4

1045.13

2528.21

e6/l

0.79

825

3053

Implicit fungal Sepsis, including avohilmo

216

515

4.43

82.95

1.5

1.4

260.16

1172.74

e6/l

1.99

170

415

Symptoms and signs involving speech and voice

727

3384

2.20

82.70

1.4

469.07

2515.20

e6/l

1.14

556

2678

Meningitis, viral

24.46

81.24

1.5

1.4

20.02

238.28

e6/l

0.81

Complications of medical and surgical care

1465

7728

1.73

80.40

1.7

1.4

3587.72

1720.24

e6/l

0.56

1142

6108

Abdominal and pelvic pain

1868

5697

1.66

80.11

1.5

4714.14

1385.29

e6/l

0.81

1501

4446

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1288

6346

1.79

79.91

1.4

1.5

2643.19

2144.72

e6/l

0.10

1014

5027

Use of teriflunomide

11.99

79.31

1.2

1.3

61.68

176.44

e6/l

0.57

Antihypertensive medication - note that there are other indications

1301

3749

1.84

79.14

1.5

1641.78

2016.01

e6/l

0.12

1002

2916

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

190

425

4.69

78.79

1.5

1.4

1270.54

545.63

e6/l

0.63

136

334

Disorders of lipoprotein metabolism and other lipidaemias

1528

5452

1.72

77.91

1.4

1.5

2469.01

2567.79

e6/l

0.03

1116

4350

Symptoms and signs involving the urinary system

1479

6578

1.72

77.46

1.5

2658.38

2071.57

e6/l

0.14

1185

5173

Cystitis

1602

5671

1.70

77.22

1.5

3597.55

1885.49

e6/l

0.32

1257

4506

Asthma (only as main-diagnosis), excluding more controls

1320

4092

1.81

77.05

1.4

887.84

2451.13

e6/l

0.90

1068

3151

Triptan medication for migraine, single purchase ok

1568

6342

1.70

76.91

1.4

1.5

3283.97

1580.26

e6/l

0.32

1235

4944

Migraine, single triptan purchase ok & required. ICD-code if available is included

1568

6342

1.70

76.91

1.4

1.5

3283.97

1580.26

e6/l

0.32

1235

4944

Other disorders of eye and adnexa

394

1442

2.84

76.68

1.5

1.6

2389.89

3760.32

e6/l

0.18

293

1113

Other general symptoms and signs

153

289

5.52

76.53

1.8

935.58

15595.03

e6/l

0.55

110

218

L04AX Other immunosuppressants

1173

6595

1.81

76.38

2.1

1.4

1230.63

2415.48

e6/l

0.71

931

5171

Asthma (only as main-diagnosis)

1340

4236

1.79

76.22

1.4

872.59

2385.65

e6/l

0.91

1087

3268

Second line medication for Crohn's disease

1205

6836

1.79

75.94

2.2

1.4

1215.35

2439.30

e6/l

0.78

959

5361

COPD/asthma/ILD related infections

1903

5910

1.63

75.33

1.5

1.4

1437.86

2344.16

e6/l

0.52

1519

4563

COPD/asthma related infections

1903

5910

1.63

75.33

1.5

1.4

1437.86

2344.16

e6/l

0.52

1519

4563

Somatoform disorder

406

1523

2.75

75.11

1.3

1.5

1055.14

1625.56

e6/l

0.39

325

1207

Hemiplegia

177

392

4.83

74.98

1.6

1.5

502.57

617.32

e6/l

0.10

137

308

L04AA Selective immunosuppressants

544

2360

2.37

73.82

1.7

1.5

1349.08

2994.95

e6/l

0.43

435

1827

Pure hypercholesterolaemia

1368

5044

1.74

73.18

1.4

2264.64

2719.50

e6/l

0.16

1003

4026

Hypertension

1523

5125

1.70

72.01

1.5

2539.12

1850.30

e6/l

0.29

1188

4024

Invasive ventilation

232

648

3.79

71.69

2.1

1.8

3413.18

1520.24

e6/l

1.27

190

507

Hypertensive diseases

1523

5132

1.69

71.69

1.5

2511.34

1848.46

e6/l

0.28

1188

4028

Other lack of coordination

107

9.58

71.62

1.4

1.5

1346.97

1237.31

e6/l

0.03

Bipolar affective disorders

446

1799

2.55

71.02

1.3

1.4

595.47

1224.08

e6/l

0.71

350

1435

Fall on same level

2218

7744

1.54

70.53

1.5

856.28

2282.27

e6/l

1.57

1715

6118

Dental caries

558

2349

2.29

69.71

2.2

1.4

848.97

3615.72

e6/l

0.86

440

1861

Symptoms and signs concerning food and fluid intake

227

631

3.71

69.64

1.7

1.4

1099.73

7391.25

e6/l

0.51

194

485

Diseases of the musculoskeletal system and connective tissue

1054

2829

1.89

69.57

1.7

1.6

4664.86

1892.62

e6/l

0.34

823

2158

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

132

145

6.50

69.02

1.3

1.6

591.07

329.71

e6/l

0.24

108

Cervicalgia

441

1794

2.52

68.82

1.3

1.4

491.18

1053.63

e6/l

1.39

356

1374

Endovascular or surgical operations to intracerebral aneurysms

186

462

4.27

67.87

2.1

1.2

11058.57

667.83

e6/l

2.28

161

359

2110

6972

1.55

67.78

1.5

1.4

1350.31

2108.90

e6/l

0.51

1715

5428

Unspecified mental disorder

855

4550

1.91

66.82

1.3

1.4

629.35

2368.04

e6/l

1.29

671

3573

Exclusions for E4_PCOS_BROAD

447

1861

2.48

66.60

1.5

1.8

771.27

3365.12

e6/l

0.67

361

1450

Diarrhoea and gastroenteritis of presumed infectious origin

1394

7595

1.66

66.01

1.5

602.42

2249.44

e6/l

2.05

1114

5963

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

676

3341

2.07

65.82

1.3

1.4

6557.33

1249.32

e6/l

0.46

522

2634

Acute lymphocytic leukaemia

13.52

65.50

12.6

1.4

52.46

347.97

e6/l

0.60

Acute lymphocytic leukaemia, helper endpoint

13.52

65.50

12.6

1.4

52.46

347.97

e6/l

0.60

Acute lymphocytic leukaemia, including Hilmo

13.52

65.50

12.6

1.4

52.46

347.97

e6/l

0.60

365

1393

2.71

65.38

1.7

1.4

1043.45

4160.67

e6/l

0.58

265

1094

Somnolence, stupor and coma

134

264

5.39

65.08

1.9

1.6

548.07

797.41

e6/l

0.18

114

208

Intestinal infectious diseases

1826

8806

1.56

64.81

1.5

835.88

2137.57

e6/l

1.55

1464

6902

All kidney diseases

1891

8249

1.55

64.75

1.5

4463.28

1357.58

e6/l

0.75

1508

6457

Bronchitis

2067

8198

1.53

64.51

1.6

1.4

1188.49

2071.56

e6/l

0.80

1678

6406

Acute upper respiratory infections of multiple and unspecified sites

1492

6739

1.63

64.42

1.6

1.4

1242.07

2163.20

e6/l

0.63

1216

5219

Caries of dentine

493

2088

2.33

64.27

1.9

1.4

709.94

3955.64

e6/l

0.91

395

1647

Other diseases of spinal cord

112

190

6.39

64.21

2.5

1.2

1309.59

1269.69

e6/l

0.01

144

COPD differential diagnosis

1420

4265

1.69

64.16

1.5

1.4

1475.55

2376.05

e6/l

0.40

1127

3289

Use of hypnotics and sedatives

2008

7538

1.54

64.07

1.4

1.5

1626.13

2126.29

e6/l

0.29

1601

5927

Other pulmonary diagnosis

1424

4282

1.68

64.04

1.5

1.4

1464.75

2358.36

e6/l

0.39

1133

3307

ILD differential diagnosis

1418

4264

1.68

63.77

1.5

1.4

1478.17

2376.78

e6/l

0.39

1125

3288

Excluding asthma or asthma-COPD overlap

1421

4282

1.68

63.41

1.5

1.4

1486.59

2358.36

e6/l

0.38

1131

3307

Endocrine, nutritional and metabolic diseases

1521

4705

1.65

63.35

1.5

1435.20

2160.61

e6/l

0.34

1181

3699

Non-selective monoamine reuptake inhibitors

641

3012

2.08

63.14

1.4

1414.37

2139.32

e6/l

0.40

502

2372

Radiculopathy

327

1201

2.80

62.91

1.4

1163.81

1251.65

e6/l

0.07

274

929

Viral infections characterized by skin and mucous membrane lesions

879

4817

1.86

62.49

1.8

1.5

515.81

2095.26

e6/l

1.27

710

3775

Other functional intestinal disorders

925

4655

1.83

62.48

1.5

1.6

1856.53

2299.82

e6/l

0.13

731

3663

Speech and linguistic disorders, excluding more controls

220

602

3.56

62.18

2.0

2.1

1010.98

958.92

e6/l

0.02

172

471

Other specific joint derangements/joint disorders

1469

5668

1.63

61.64

1.3

1.5

1683.25

2178.74

e6/l

0.19

1156

4413

Retention of urine

635

2506

2.09

61.23

1.6

1.4

3802.34

2947.07

e6/l

0.09

522

2017

Other sleep disorders

250

807

3.20

60.86

1.3

1.4

2689.61

5474.67

e6/l

0.22

213

625

Acute upper respiratory infections

1929

7631

1.53

60.73

1.5

1.4

1594.31

2026.22

e6/l

0.25

1571

5942

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1924

8164

1.53

60.72

1.4

1.5

796.90

2207.24

e6/l

1.74

1517

6410

Complications of procedures, not elsewhere classified

1524

7796

1.59

60.30

1.6

1.4

2931.68

1705.31

e6/l

0.36

1194

6137

Behavioural syndromes associated with physiological disturbances and physical factors

1807

8018

1.54

60.10

1.4

1.5

1019.34

2182.48

e6/l

1.02

1399

6312

Spinal stenosis

848

3385

1.87

59.18

1.5

1184.41

2502.60

e6/l

0.96

705

2620

All influenza

542

2566

2.16

59.12

1.6

849.80

2923.11

e6/l

0.75

448

2006

Non-Hodgkin lymphoma, all

139

307

4.81

59.09

1.7

1.4

141.12

614.32

e6/l

0.76

110

260

Focal brain injury

137

6.89

59.00

2.0

1.2

4752.76

110.04

e6/l

2.29

103

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1151

6781

1.69

58.92

1.7

1.4

4365.90

1846.61

e6/l

0.62

905

5372

Exposure to unspecified factor

1938

8819

1.51

58.66

1.5

2352.98

1792.23

e6/l

0.18

1451

7016

Intestinal infectious diseases, including avohilmo, including avohilmo

2139

8068

1.49

58.64

1.5

1000.99

2207.94

e6/l

1.25

1684

6346

Third [oculomotor] nerve palsy

145

7.24

58.51

1.4

1064.61

885.89

e6/l

0.07

112

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1743

8931

1.53

58.42

1.6

1.5

2087.55

1862.48

e6/l

0.06

1392

7006

Cluster headache, strict

116

222

5.56

58.28

1.4

1.3

246.24

1382.22

e6/l

0.77

174

Diagnoses used for exclusion with ILD

504

2337

2.20

58.06

1.6

1.4

532.32

1255.88

e6/l

2.41

408

1871

Poisoning by medicine

513

2400

2.19

58.00

1.3

1.4

331.11

1208.52

e6/l

2.05

384

1889

Progressive vascular leukoencephalopathy

113

212

5.65

57.97

1.2

1.4

82.56

559.47

e6/l

0.76

172

Myalgia

512

2397

2.18

57.57

1.3

1.4

2187.27

2936.12

e6/l

0.14

408

1889

Shoulder lesions

1356

5012

1.64

57.30

1.5

1269.52

2510.30

e6/l

0.72

1106

3935

Ocular pain

250

840

3.11

57.27

1.5

1.6

3537.03

5783.42

e6/l

0.17

189

658

Sleep disorders

1735

7856

1.54

57.26

1.3

1.5

1105.32

2207.31

e6/l

0.91

1342

6188

Follow-up examination after treatment for conditions other than malignant neoplasms

741

2567

1.95

57.17

1.4

1206.34

1128.71

e6/l

0.07

540

1950

Asthma-related infections

1148

6772

1.67

57.15

1.5

769.70

2375.64

e6/l

1.64

928

5325

Asthma, hospital admission 2, infections

1148

6772

1.67

57.15

1.5

769.70

2375.64

e6/l

1.64

928

5325

Renal tubulo-interstitial diseases

1623

7734

1.55

56.91

1.5

3328.30

1666.94

e6/l

0.32

1298

6052

Acute sinusitis

1045

5615

1.71

56.31

1.5

1.4

2860.19

1866.14

e6/l

0.38

842

4338

Substance abuse

1116

6244

1.68

56.21

1.4

4299.93

1700.53

e6/l

0.35

880

4942

Mental and behavioural disorders due to psychoactive substance use

1145

6355

1.67

56.18

1.4

4199.83

1712.63

e6/l

0.34

901

5030

Nonorganic sleeping disorders

516

2451

2.16

56.11

1.4

1.5

283.22

2748.32

e6/l

0.94

383

1932

Kela-code for severe mental illness

745

4018

1.89

56.04

1.3

1.4

590.88

2387.31

e6/l

1.14

586

3150

Poisoning by drugs, medicaments and biological substances

547

2657

2.11

56.01

1.4

7530.66

1143.69

e6/l

0.43

413

2091

Constipation

1642

7274

1.54

55.43

1.5

2769.25

1952.09

e6/l

0.23

1290

5742

Fibromyalgia

239

796

3.12

55.38

1.3

1.4

575.90

5701.46

e6/l

0.55

189

624

Brain meningioma, including Hilmo

167

447

3.97

55.13

1.9

1.4

1849.53

791.30

e6/l

0.97

133

359

Disorders of adult personality and behaviour

639

3309

1.97

54.58

1.4

437.78

2392.90

e6/l

1.02

488

2612

Hypothyroidism, drug reimbursement

253

578

3.12

54.41

1.4

1.2

898.56

812.14

e6/l

0.07

201

467

Post-traumatic stress disorder

240

810

3.08

54.37

1.4

1.5

443.45

1413.22

e6/l

1.21

182

638

Benign neoplasm of brain and other parts of central nervous system

191

564

3.57

54.34

2.0

1.6

1149.15

1421.42

e6/l

0.14

148

434

Brain meningioma

163

435

3.98

54.06

1.9

1.4

1906.54

773.31

e6/l

1.02

129

347

Cluster headache, wide

118

245

5.10

53.99

1.4

1.3

243.50

1514.93

e6/l

0.97

191

severe traumatic brain injury, does not include concussion

430

1927

2.28

53.92

1.8

1.4

7090.71

1088.64

e6/l

0.59

329

1537

Disorders of other endocrine glands

871

4908

1.77

53.47

1.6

735.75

2037.08

e6/l

0.95

695

3850

Persons encountering health services in other circumstances

799

4414

1.82

53.44

1.5

1692.18

2568.11

e6/l

0.30

654

3482

Herpesviral [herpes simplex] infections

294

1118

2.72

53.25

1.7

1.5

424.72

4725.33

e6/l

0.68

241

868

Sixth [abducent] nerve palsy

124

275

4.87

52.81

1.5

1.7

396.94

610.75

e6/l

0.18

101

212

Factors influencing health status and contact with health services

484

1073

2.29

52.78

1.5

1.3

805.32

1114.98

e6/l

0.19

375

804

Triptan medication for migraine, min. 3 purchases

1155

5290

1.65

52.56

1.4

3896.88

1456.68

e6/l

0.34

904

4125

895

5159

1.75

52.20

1.5

672.19

2027.07

e6/l

1.09

730

4039

Other disorders of lacrimal gland

727

3980

1.86

52.17

1.5

1.4

1350.29

2742.68

e6/l

0.53

589

3122

Personality disorders

603

3110

1.98

52.17

1.4

611.60

2438.25

e6/l

0.83

460

2455

Sleep disorders (combined)

1978

7037

1.48

52.12

1.4

1.5

1081.51

2249.27

e6/l

1.04

1565

5543

Schizophrenia, schizotypal and delusional disorders

658

3494

1.92

52.05

1.3

1.4

6264.81

1292.86

e6/l

0.40

507

2740

Rare circulating lymphoid malignancy, including Hilmo

114

239

5.17

51.98

9.8

1.4

591.15

820.53

e6/l

0.13

201

Other diseases of intestines

1989

7580

1.47

51.97

1.4

1.5

912.41

1872.55

e6/l

1.09

1553

5976

Visual field defects

212

685

3.22

51.88

1.8

1.4

1199.41

1313.85

e6/l

0.06

180

548

Falls/tendency to fall

1949

6629

1.49

51.70

1.5

1085.13

2373.51

e6/l

1.06

1516

5234

Acute tubulo-interstitial nephritis

1169

6121

1.63

51.58

1.6

1.5

4420.77

1741.13

e6/l

0.40

945

4826

Schizophrenia or delusion

655

3486

1.91

51.46

1.3

1.4

6289.53

1297.09

e6/l

0.40

505

2730

Psychotic depression

134

319

4.36

51.42

1.4

1.6

277.00

566.01

e6/l

0.54

261

Urinary track infection

1112

3324

1.70

51.40

1.4

1.5

4380.95

1510.69

e6/l

0.39

868

2619

Certain disorders involving the immune mechanism

415

1879

2.27

51.04

2.5

1.5

189.63

1216.78

e6/l

4.89

331

1471

Other CVD (FINNGEN)

247

648

2.99

50.37

1.7

1.3

9787.20

768.78

e6/l

0.52

201

502

Cervical disc disorders

626

3307

1.92

50.14

1.5

1209.32

2459.96

e6/l

0.81

519

2539

Other and unspecified nonorganic psychotic disorders

448

2106

2.18

50.12

1.3

1.4

8795.97

1255.90

e6/l

0.42

348

1660

Hyperkinetic disorders, excluding more controls

294

1066

2.64

49.95

1.4

1.8

302.39

1823.03

e6/l

1.27

219

851

Dyspnoea

1643

7951

1.51

49.88

1.4

1.5

1920.28

1892.39

e6/l

0.01

1357

6190

Systemic connective tissue disorders

657

3535

1.89

49.84

1.4

1114.63

2441.85

e6/l

0.58

521

2795

Cervicocranial syndrome

244

871

2.89

49.82

1.3

1.5

3113.79

929.71

e6/l

1.29

200

668

Other medical care

857

4149

1.76

49.82

1.7

1.5

1148.82

2829.16

e6/l

0.88

672

3250

Asthma (diagnoses ohter than nonallergic)

1623

8808

1.50

49.68

1.5

1080.79

2009.92

e6/l

0.96

1284

6928

Alcohol abuse, main dg, excluding more controls

285

1102

2.65

49.63

1.3

1.5

716.01

1492.77

e6/l

1.17

226

896

Dissociative [conversion] disorders

130

314

4.40

49.42

1.3

1.7

523.98

733.86

e6/l

0.18

109

240

Disorders of eyelid, lacrimal system and orbit

1579

7718

1.51

49.29

1.5

1506.98

2175.35

e6/l

0.39

1245

6082

Complications of other internal prosthetic devices, implants and grafts

133

328

4.31

49.19

2.9

1.5

799.11

796.59

e6/l

0.00

112

261

Other viral diseases, including avohilmo

801

4549

1.77

49.06

1.7

1.5

530.43

2003.46

e6/l

1.03

625

3546

Pain in thoracic spine

317

1299

2.50

48.92

1.3

1.5

1379.13

943.07

e6/l

0.29

267

997

Mental and behavioural disorders due to alcohol

954

5456

1.69

48.91

1.3

1.4

4581.43

1698.23

e6/l

0.34

760

4325

Dementia in other diseases classified elsewhere

117

262

4.69

48.78

1.4

1.3

138.53

615.60

e6/l

0.56

204

Neoplasms

1487

5082

1.55

48.59

2.1

1.4

1515.60

2112.63

e6/l

0.27

1147

4032

Other heart diseases

864

3229

1.76

48.43

1.5

1186.55

571.89

e6/l

1.37

697

2488

Specific personality disorders

524

2646

2.02

48.28

1.4

401.72

2575.41

e6/l

0.87

407

2081

Brain glioblastoma and astrocytoma

140

6.57

48.22

1.9

1.2

3256.13

1502.28

e6/l

0.35

112

Other acute disseminated demyelination

8.59

47.76

1.3

604.15

169.81

e6/l

0.44

Oxycodone

698

3289

1.84

47.60

1.6

1.4

898.73

1647.73

e6/l

1.24

570

2627

Paraplegia, diplegia of upper limbs

167

5.90

47.24

1.9

1.6

961.58

1206.83

e6/l

0.10

129

Diseases of the myoneural junction and muscle

277

1087

2.63

47.09

1.7

1.5

1343.87

1095.94

e6/l

0.14

230

857

Mental and behavioural disorders due to alcohol, excluding acute intoxication

825

4784

1.73

47.01

1.3

1.4

5225.67

1885.70

e6/l

0.34

659

3775

Alcohol use disorder, Swedish definition

1002

5587

1.65

46.91

1.4

4493.27

1785.33

e6/l

0.33

793

4423

Other diseases of blood and blood-forming organs, wide

449

2169

2.12

46.76

2.3

1.5

642.13

1271.40

e6/l

1.39

379

1689

Alzheimer’s disease (Atypical or mixed)

182

563

3.27

46.37

1.4

309.91

847.23

e6/l

1.20

160

460

Other complications of surgical and medical care, not elsewhere classified

244

911

2.77

45.93

1.6

1.4

4216.33

1449.73

e6/l

0.53

204

712

Insomnia

1653

7852

1.48

45.64

1.3

1.5

1148.17

2201.05

e6/l

0.83

1272

6192

1105

6080

1.60

45.27

1.4

4119.36

1683.27

e6/l

0.32

873

4823

Other viral diseases

619

3368

1.87

44.92

1.8

1.6

635.62

2119.49

e6/l

0.69

489

2625

Unspecified fall

947

5702

1.65

44.90

1.5

1508.39

2344.41

e6/l

0.36

719

4510

Benign neoplasm: Pituitary gland, craniopharyngeal duct

160

479

3.53

44.70

1.5

1229.34

1091.58

e6/l

0.08

125

374

1054

5915

1.61

44.60

1.3

1.4

4200.17

1728.70

e6/l

0.31

831

4695

Unknown and unspecified causes of morbidity

139

378

3.79

44.41

1.5

5279.23

1407.37

e6/l

0.45

123

297

Disorders of vestibular function (Vertigo)

828

4805

1.70

43.99

1.4

1313.44

2960.63

e6/l

0.96

668

3783

Encephalopathy

9.49

43.96

1.9

1.6

307.12

1820.09

e6/l

0.43

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1027

6454

1.61

43.77

1.7

1.4

4754.55

1916.90

e6/l

0.63

810

5118

Suicide or other Intentional self-harm

516

2682

1.96

43.74

1.3

1.4

8764.78

1264.20

e6/l

0.49

389

2115

Gastrointestinal diseases

1110

3465

1.62

43.55

1.7

1.4

735.92

2504.82

e6/l

0.93

871

2725

Any death

1078

4748

1.61

43.49

1.7

1.4

4916.82

1699.95

e6/l

0.46

881

3716

Disorders of lacrimal system

817

4795

1.70

43.29

1.5

1870.92

2475.66

e6/l

0.19

666

3770

Brachial plexus disorders

231

865

2.76

43.27

1.3

1.4

409.27

5524.77

e6/l

0.60

199

665

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

592

3189

1.87

43.19

2.4

1.4

7066.77

1224.56

e6/l

0.43

455

2506

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

658

3707

1.81

43.10

1.5

1.6

981.97

2339.93

e6/l

0.67

518

2904

Frontotemporal dementia, wide, incl. Pick's disease

12.88

43.02

1.1

1.3

140.39

94.61

e6/l

0.21

Zoster [herpes zoster]

364

1681

2.21

42.61

1.8

1.5

323.37

1269.34

e6/l

2.94

289

1328

Alcohol use disorder, ICD-based

757

4457

1.72

42.32

1.3

1.4

5671.30

1983.05

e6/l

0.34

601

3508

Other joint disorders

1618

5772

1.47

41.89

1.4

1.5

985.00

2149.34

e6/l

0.79

1297

4493

Finngen Rheumatological endpoints

1751

6932

1.45

41.67

1.4

1.5

1698.63

2221.30

e6/l

0.26

1381

5433

Diseases of oesophagus, stomach and duodenum

1895

7934

1.42

41.44

1.4

1.5

1966.96

2007.43

e6/l

0.01

1510

6230

Rotator cuff syndrome

1048

4561

1.60

41.43

1.4

1.5

1475.30

2707.10

e6/l

0.61

853

3595

Superficial injury of head

460

2341

2.00

41.23

1.6

1026.85

880.48

e6/l

0.17

349

1849

Herpesviral [herpes simplex] infections, including avohilmo

539

2902

1.89

41.04

1.5

1.4

777.85

2524.90

e6/l

0.71

435

2280

Generalized anxiety disorder

361

1685

2.19

41.00

1.3

1.5

608.35

1539.89

e6/l

0.91

280

1339

Secondary parkinsonism+Parkinsonism in other disease

189

5.09

40.87

1.4

1.3

77.46

846.45

e6/l

0.71

150

Asthma, including avohilmo

2112

8417

1.39

40.46

1.4

1.5

856.86

2124.97

e6/l

1.52

1669

6617

Frontotemporal dementia

13.24

40.42

1.1

1.3

143.57

97.77

e6/l

0.20

Accidents

1403

4700

1.51

40.31

1.4

1.5

3876.43

1563.77

e6/l

0.39

1077

3735

Secondary parkinsonism

189

5.04

39.91

1.4

1.3

78.52

860.88

e6/l

0.71

148

Other intracranial haemorrhages

185

5.03

39.77

2.4

1.4

25510.34

308.08

e6/l

0.57

142

Diseases of the ear and mastoid process

2046

7383

1.40

39.67

1.5

1.4

1068.95

2280.67

e6/l

1.16

1630

5764

Other external causes of accidental injury

1399

4700

1.50

39.66

1.4

1.5

3864.48

1563.77

e6/l

0.39

1076

3735

Hypopituitarism

203

747

2.83

39.53

1.6

2.1

596.38

623.87

e6/l

0.03

176

571

Other acute lower respiratory infections

961

5806

1.59

39.51

1.6

1.5

1530.01

2310.44

e6/l

0.35

770

4578

Osteopathies and chondropathies

1000

5853

1.58

39.26

1.6

1.5

1440.13

2623.52

e6/l

0.60

794

4612

Other spirochaetal diseases, including avohilmo

641

3685

1.77

39.21

1.3

1.5

414.58

2582.36

e6/l

1.37

466

2903

Other spirochaetal diseases

635

3641

1.77

39.20

1.3

1.5

254.86

2609.96

e6/l

1.56

461

2870

Injuries to the abdomen, lower back, lumbar spine and pelvis

736

4325

1.70

39.16

1.5

798.52

2558.08

e6/l

1.03

570

3435

Other disorders of binocular movement

197

4.95

39.10

1.6

1868.11

677.27

e6/l

0.29

150

Use of levodopa decarboxylase inhibitor

259

1075

2.47

39.05

1.4

604.52

1068.44

e6/l

0.54

218

846

Diseases of inner ear

928

5605

1.60

39.03

1.4

1230.81

2722.69

e6/l

1.03

744

4415

Spirochaetal infections, other/unspecified, including avohilmo

632

3625

1.77

38.97

1.3

1.5

255.25

2574.23

e6/l

1.51

459

2856

Lyme disease, including avohilmo

629

3607

1.77

38.82

1.3

1.5

256.05

2583.94

e6/l

1.51

456

2843

Lyme disease

629

3607

1.77

38.82

1.3

1.5

256.05

2583.94

e6/l

1.51

456

2843

Use of galantamine

155

495

3.23

38.65

1.2

1.4

415.13

856.27

e6/l

0.73

113

403

Lymphoid leukaemia

144

443

3.41

38.47

8.2

1.4

824.27

638.78

e6/l

0.10

116

348

Use of peginterferon beta-1a

13.99

38.35

1.1

1.2

84.07

34.59

e6/l

0.32

Diseases of the respiratory system

1090

3494

1.58

38.34

1.5

1.4

1156.91

2347.58

e6/l

0.51

861

2679

Hypotension

299

1330

2.29

38.33

1.7

1.4

7922.45

1127.91

e6/l

0.48

249

1056

Postviral fatigue syndrome

8.88

38.03

1.3

1.8

13.51

75.20

e6/l

0.90

Other symptoms and signs involving general sensations and perceptions

104

259

4.20

37.86

1.2

1.6

1070.97

1259.59

e6/l

0.08

199

Asthma-related pneumonia or sepsis

634

3668

1.75

37.31

1.6

894.36

2871.25

e6/l

0.96

509

2912

Asthma, hospital admissions 3, pneumonia

634

3668

1.75

37.31

1.6

894.36

2871.25

e6/l

0.96

509

2912

Panic disorder

319

1476

2.21

37.27

1.3

1.5

761.15

1423.50

e6/l

0.59

241

1175

Asthma-related pneumonia

632

3660

1.74

37.08

1.6

896.12

2878.12

e6/l

0.96

508

2905

Polyuria

404

2045

2.01

37.03

1.4

424.90

3264.93

e6/l

0.90

318

1627

Fungal Sepsis

111

296

3.93

36.83

1.7

1.3

40.47

911.78

e6/l

1.29

240

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

214

839

2.64

36.65

1.4

420.74

1195.68

e6/l

1.21

168

669

Panhypopituitarism

132

5.80

36.16

1.9

1.6

786.97

1002.24

e6/l

0.09

101

External causes of morbidity and mortality

1125

3684

1.54

36.07

1.5

4612.77

1340.15

e6/l

0.45

847

2909

Vascular dementia

140

420

3.28

35.95

1.5

1.4

870.38

875.87

e6/l

0.00

107

342

Sequelae of external causes of morbidity and mortality

474

2566

1.88

35.53

1.7

1.4

1381.14

2737.05

e6/l

0.40

359

2016

Phobic anxiety disorders

291

1325

2.24

35.19

1.5

905.27

1480.79

e6/l

0.32

223

1049

Persistent mood disorders

352

1728

2.08

35.17

1.4

1.5

1215.98

1566.84

e6/l

0.19

262

1384

Genitourinary diseases

994

3189

1.58

35.05

1.6

4513.78

1279.77

e6/l

0.41

790

2511

Other systemic involvement of connective tissue (FG)

460

2428

1.89

35.04

1.4

1306.73

2924.83

e6/l

0.47

361

1925

Other viral diseases, not elsewhere classified, including avohilmo

548

3097

1.79

34.86

1.8

1.6

519.80

2266.40

e6/l

0.78

426

2422

Agranulocytosis

243

1036

2.42

34.73

2.6

1.5

509.28

1424.18

e6/l

1.42

212

804

Undetermined asthma, excluding more controls

253

1094

2.36

34.70

1.5

1.4

289.61

4505.55

e6/l

0.65

200

852

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

360

1798

2.05

34.48

1.3

1.4

11488.60

1355.86

e6/l

0.44

266

1418

Open wound of head

918

5587

1.56

34.38

1.5

1019.51

1202.46

e6/l

0.23

729

4438

Sarcoidosis

276

1248

2.27

34.32

1.7

1.4

229.72

1291.10

e6/l

3.06

220

980

Injuries to the thorax

783

4906

1.61

34.23

1.4

1139.31

2592.61

e6/l

0.87

617

3884

Undetermined asthma

253

1101

2.35

34.20

1.5

1.4

289.61

4432.23

e6/l

0.64

200

860

ILD medications: azathioprine

298

1390

2.19

34.18

1.6

1.4

463.37

3574.34

e6/l

0.59

241

1078

Implicit fungal Sepsis

104

280

3.90

34.09

1.7

1.3

42.22

879.76

e6/l

1.15

230

Dental pulpitis, including avohilmo

1669

7706

1.40

33.88

1.4

1366.16

2151.70

e6/l

0.53

1274

6070

Other CVD

330

1604

2.09

33.83

1.6

1.5

7493.68

1227.92

e6/l

0.48

270

1283

Other strabismus

441

2364

1.89

33.74

1.6

1.7

1101.67

1194.34

e6/l

0.06

355

1840

Sleep apnoea

1620

7329

1.40

33.65

1.4

1.5

1787.50

2167.57

e6/l

0.20

1300

5723

Abnormal findings on examination of blood, without diagnosis

788

4483

1.61

33.59

1.4

1.5

3276.82

2276.73

e6/l

0.13

621

3568

Chronic lower respiratory diseases

2123

8338

1.35

33.50

1.4

1.5

905.62

2136.14

e6/l

1.42

1681

6545

Abnormalities of heart beat

620

3572

1.70

33.42

1.4

1.5

572.62

2779.47

e6/l

1.27

503

2784

Hypokalaemia

230

972

2.42

33.39

1.8

1.4

482.40

1183.42

e6/l

1.17

188

779

Brain glioblastoma

106

6.23

33.28

1.8

1.3

4049.54

1782.07

e6/l

0.34

Other and unspecified mood [affective] disorders

168

612

2.83

33.26

1.5

180.81

1095.46

e6/l

1.10

118

489

Speech and linguistic disorders

229

928

2.44

33.13

2.0

2.1

988.02

5007.53

e6/l

0.46

176

699

Other degenerative diseases of the basal ganglia

143

5.35

33.11

1.3

1.4

266.39

1043.42

e6/l

0.47

113

Injuries to the neck

461

2535

1.85

32.94

1.4

1.5

1252.10

2610.88

e6/l

0.41

374

1993

Hypothyroidism, strict autoimmune

1158

5159

1.48

32.75

1.4

1.5

1338.63

2610.08

e6/l

0.66

930

4029

Emotionally unstable personality disorder

284

1325

2.20

32.69

1.3

1.4

444.88

4393.41

e6/l

0.75

214

1032

Benign neoplasm of other and unspecified endocrine glands

272

1248

2.24

32.64

1.4

1.5

1739.21

1121.65

e6/l

0.45

205

971

Other disorders of bladder

219

916

2.45

32.56

1.5

1.4

704.66

1232.29

e6/l

0.64

190

726

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

730

2816

1.65

32.50

1.5

1.3

1557.15

601.96

e6/l

1.12

594

2167

Persons encountering health services for specific procedures, not carried out

197

789

2.57

32.28

1.3

1.5

2653.70

6108.42

e6/l

0.31

128

605

Other necrotizing vasculopathies (FG)

136

449

3.14

32.27

1.3

1.4

1178.28

824.54

e6/l

0.15

109

348

Other disorders of nervous system

141

476

3.07

32.14

1.9

1.2

394.42

1412.59

e6/l

0.89

115

367

Disorders of sclera, cornea, iris and ciliary body

971

6482

1.51

32.10

1.4

1.5

5939.66

1800.39

e6/l

0.54

777

5102

Pneumonitis due to solids and liquids

167

618

2.78

32.05

1.6

1.5

815.59

1046.31

e6/l

0.22

138

494

Arthropathies

1599

5794

1.40

32.01

1.4

1.5

1435.01

2146.62

e6/l

0.35

1257

4506

Other viral diseases, not elsewhere classified

382

1993

1.95

31.90

2.0

1.7

677.03

3116.57

e6/l

0.67

301

1558

Cardiac arrhythmias

1004

4265

1.52

31.86

1.3

1.4

1155.88

589.42

e6/l

1.44

811

3260

Sleep apnoea, including avohilmo

1707

7532

1.38

31.86

1.4

1.5

1779.65

2102.34

e6/l

0.17

1382

5883

Asthma, hospital admissions , main diagnosis only

1427

8880

1.41

31.82

1.5

914.80

2124.45

e6/l

1.43

1160

6940

Parkinson's disease, including avohilmo

272

1260

2.20

31.76

1.4

324.08

1086.26

e6/l

2.94

232

986

Brain glioblastoma, helper endpoint

111

5.94

31.72

1.8

1.3

4049.54

1794.90

e6/l

0.33

Other and unspecified nerve root and plexus disorders, also in other diseases

386

2033

1.93

31.60

1.4

2145.01

3144.72

e6/l

0.17

328

1565

Obesity related asthma

627

3804

1.67

31.51

1.4

1.5

1092.50

3125.09

e6/l

0.97

517

3000

Bacterial pneumonia, not elsewhere classified

634

3367

1.67

31.47

1.7

1.5

961.81

3132.10

e6/l

0.96

503

2650

Other and unspecified drugs and medicaments

196

797

2.54

31.20

1.4

1.5

452.82

1079.18

e6/l

0.84

156

618

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

466

2264

1.83

31.17

1.7

8574.16

1008.03

e6/l

0.44

359

1755

Other symptoms and signs involving the urinary system

214

908

2.42

30.92

1.7

1.6

1193.58

1174.03

e6/l

0.01

177

719

Use of glatiramer acetate

144

5.16

30.87

1.3

1.7

542.67

150.99

e6/l

0.49

112

Disorders of psychological development

282

1239

2.16

30.77

1.9

856.33

4095.89

e6/l

0.51

220

943

Other and unspecified types of non-Hodgkin lymphoma, hilmo

107

317

3.54

30.48

1.8

1.3

557.80

540.30

e6/l

0.01

250

Diffuse brain injury

6.49

30.43

2.1

1.3

867.32

112.64

e6/l

1.18

Acute bronchitis

696

4281

1.61

30.39

1.6

1.5

992.19

2538.55

e6/l

0.83

556

3363

Optic atrophy

138

5.19

30.36

2.0

1.9

1226.19

967.16

e6/l

0.09

107

Other systemic involvement of connective tissue

468

2651

1.79

30.27

1.4

1286.77

2851.76

e6/l

0.49

367

2095

Other and unspecified anaemias

671

3922

1.62

29.97

1.9

1.5

2175.48

2898.64

e6/l

0.22

519

3136

Injury, poisoning and certain other consequences of external causes

887

2879

1.56

29.76

1.6

1.5

5662.12

1552.23

e6/l

0.46

679

2219

Bacterial pneumoniae

663

3616

1.63

29.61

1.7

1.5

930.76

3034.41

e6/l

1.01

526

2839

Optic atrophy, wide definition

141

5.06

29.57

2.0

1.9

1226.19

924.21

e6/l

0.11

112

Dementia due to Parkinsons disease, excluding more controls

11.40

29.45

1.6

1.2

226.84

19.14

e6/l

0.57

Other anaemias

674

3950

1.61

29.41

1.9

1.5

2162.99

2881.82

e6/l

0.22

522

3157

Trigeminal neuralgia

140

497

2.92

29.25

1.4

1.5

383.38

1208.55

e6/l

0.73

106

380

Cluster headache, strict, including avohilmo

132

455

3.03

29.18

1.4

219.68

1570.56

e6/l

1.15

102

355

Chronic sinusitis

750

4831

1.57

29.16

1.5

1.4

4314.79

2135.72

e6/l

0.30

577

3765

Azathioprine

298

1482

2.05

28.95

1.6

1.5

463.37

3508.54

e6/l

0.62

241

1147

Persons with potential health hazards related to communicable diseases

715

4530

1.58

28.92

1.6

1.5

1352.44

1960.47

e6/l

0.21

589

3510

Other infectious diseases, including avohilmo

188

777

2.49

28.86

1.7

1.5

227.40

1229.84

e6/l

1.57

151

612

Coagulation defects, purpura and other haemorrhagic conditions

363

1934

1.91

28.77

2.1

1.6

837.21

3374.68

e6/l

0.67

294

1508

Any event in cancer register

1589

6802

1.37

28.76

2.1

1.4

1297.14

1981.15

e6/l

0.54

1195

5422

Polyarthropathies

1128

5025

1.45

28.59

1.4

1.5

843.21

2360.80

e6/l

0.99

903

3916

Other and unspecified myopathies

176

709

2.55

28.54

1.9

1.5

1627.10

973.18

e6/l

0.31

150

564

Vocal cord dysfunction

231

911

2.27

28.50

1.5

804.28

1009.34

e6/l

0.20

184

714

Benign paroxysmal vertigo

490

2867

1.73

28.31

1.4

1523.86

2652.29

e6/l

0.37

400

2259

Type 2 diabetes, wide definition

1304

5863

1.41

28.28

1.5

1.4

1439.44

2381.00

e6/l

0.62

1048

4609

Volume depletion

169

670

2.58

28.22

1.6

483.18

838.91

e6/l

0.56

146

539

Other bacterial intestinal infections, including avohilmo

404

2240

1.83

28.12

1.7

1.5

602.11

3229.67

e6/l

0.89

305

1767

Transport accidents

801

4369

1.54

28.12

1.3

1.5

869.81

1583.43

e6/l

1.18

636

3474

Neuralgia and neuritis, unspecified

124

421

3.06

28.10

1.7

1.4

612.42

386.06

e6/l

0.20

334

Viral pneumonia

251

1184

2.17

28.09

1.6

547.90

1099.08

e6/l

0.96

210

918

Aplastic and other anaemias

716

4204

1.57

28.07

1.8

1.5

2131.46

2740.82

e6/l

0.19

557

3354

Dermatitis

1079

7376

1.44

28.05

1.6

1.5

1174.68

2133.40

e6/l

0.68

869

5783

Benign neoplasm: Brain, supratentorial

128

5.18

27.99

2.3

1.7

2488.14

134.36

e6/l

0.80

100

Zoster [herpes zoster], including avohilmo

848

5472

1.51

27.71

1.6

1.4

3373.94

2408.27

e6/l

0.14

667

4314

Infections of the skin and subcutaneous tissue

1035

7085

1.45

27.65

1.8

1.5

1251.94

2160.15

e6/l

0.59

834

5539

Coxibs

435

1248

1.85

27.64

1.3

1.5

1267.20

1126.36

e6/l

0.07

332

1014

Other and unspecified dermatitis

915

6231

1.48

27.47

1.6

1.5

1278.04

2357.45

e6/l

0.63

730

4882

Bacterial pneumonia (organism specified)

713

4166

1.56

27.25

1.7

1.5

875.77

2819.17

e6/l

1.11

573

3287

Other bacterial intestinal infections

312

1611

1.97

27.17

1.8

1.5

669.22

1130.76

e6/l

0.67

245

1261

Cluster headache, wide,, including avohilmo

134

485

2.87

27.10

1.4

217.54

1705.64

e6/l

1.41

103

376

Other/unspecified cytomegaloviral diseases

160

4.57

27.07

2.4

1.4

194.16

853.83

e6/l

0.43

120

Other and unspecified effects of external causes

524

3162

1.68

27.03

1.4

1.6

2013.49

2124.57

e6/l

0.02

404

2476

Hypothyreosis and Thyroxine purchase for inclusion criteria

1534

7422

1.36

27.00

1.4

1.5

1258.68

2211.97

e6/l

0.68

1230

5822

Other metabolic disorders

257

1245

2.11

26.85

1.6

1.4

397.95

1265.75

e6/l

1.90

202

999

Rheumatism, unspecified

242

1146

2.16

26.83

1.3

1.4

1242.50

1053.66

e6/l

0.09

193

895

Specific development disorders of speech and language

159

606

2.62

26.78

1.9

2.4

1323.25

7226.95

e6/l

0.42

121

447

Other necrotizing vasculopathies

152

590

2.66

26.73

1.3

1.4

1071.36

901.11

e6/l

0.08

121

457

Other infectious diseases

158

625

2.60

26.69

1.7

1.5

143.42

717.35

e6/l

1.67

127

494

Other problems related to primary support group, including family circumstances

253

1189

2.12

26.58

4.0

1.5

15035.49

1146.36

e6/l

0.45

199

912

Cramp and spasm

125

441

2.96

26.57

1.6

1.5

396.94

1585.98

e6/l

0.87

103

338

Irregular menses

881

4471

1.50

26.43

1.5

1.4

5902.98

1355.12

e6/l

0.54

700

3471

Hyperlipidaemia, other/unspecified

575

3195

1.63

26.37

1.4

1.5

2003.46

2124.59

e6/l

0.04

460

2581

Secondary and unspecified malignant neoplasm of lymph nodes

175

731

2.46

26.31

1.8

1.4

512.70

774.90

e6/l

0.22

136

580

Cough

680

4094

1.57

26.16

1.7

1.6

903.22

2627.21

e6/l

1.05

538

3177

Chronic apical periodontitis

1888

8069

1.32

26.13

1.4

2042.32

1859.87

e6/l

0.08

1462

6391

Hypothyroidism, other/unspecified

1476

7173

1.36

25.91

1.4

1.5

1301.53

2266.14

e6/l

0.65

1183

5615

Other arthritis (FG)

536

3289

1.65

25.86

1.4

506.71

3289.52

e6/l

1.40

427

2589

Fracture of rib(s), sternum and thoracic spine

501

3024

1.68

25.79

1.4

1330.37

3433.28

e6/l

0.77

408

2404

Other specified/unspecified arthritis

474

2823

1.70

25.70

1.4

1.5

537.28

3617.42

e6/l

1.29

381

2212

Functional dyspepsia

473

2816

1.70

25.69

1.4

884.74

2789.39

e6/l

0.76

380

2229

Dislocation, sprain and strain of joints and ligaments at neck level

319

1695

1.92

25.64

1.4

1.5

1155.24

3494.29

e6/l

0.50

261

1333

Intracranial and intraspinal abscess and granuloma

6.22

25.62

2.8

1.3

449.47

1468.03

e6/l

0.34

Cytomegalovirus infection, IBD co-morbidity

180

4.20

25.56

2.4

1.3

188.81

768.14

e6/l

0.42

135

Substance use, excluding alcohol

373

2084

1.82

25.45

1.6

1.4

12185.66

968.71

e6/l

0.52

273

1643

Thrombocytopenia, unspecified

156

630

2.55

25.29

2.7

1.5

335.58

766.19

e6/l

0.83

130

494

Irritable bowel syndrome

495

2995

1.67

25.28

1.3

1.5

317.03

2696.82

e6/l

1.19

392

2368

Drug-induced neutropenia

160

656

2.52

25.18

2.1

1.4

651.81

1146.62

e6/l

0.39

145

501

Injuries to the ankle and foot

1289

8065

1.37

25.02

1.5

967.96

2190.59

e6/l

1.12

1001

6324

Other disorders of ear

1532

7399

1.35

24.97

1.6

1.5

1119.45

2201.25

e6/l

0.98

1247

5781

Other and unspecified paralytic syndromes

105

5.36

24.93

1.3

274.31

188.15

e6/l

0.20

Sequelae with surgical and medical care as external cause

350

1936

1.84

24.70

1.7

1.4

1573.83

1290.26

e6/l

0.14

269

1529

Other shoulder lesions

189

839

2.31

24.69

1.4

1545.58

667.00

e6/l

0.52

149

649

Disorders of the thyroid gland

1564

7619

1.34

24.67

1.4

1.5

1289.68

2154.52

e6/l

0.61

1261

5977

Cytomegaloviral disease

185

4.07

24.60

2.4

1.3

188.81

527.37

e6/l

0.37

140

Temporomandibular joint disorders, including avohilmo

819

5404

1.48

24.53

1.4

2256.23

1873.74

e6/l

0.11

651

4239

Cytomegaloviral disease, including avohilmo

190

4.02

24.51

2.4

1.5

188.20

529.86

e6/l

0.38

143

Dermatitis and eczema

1896

8658

1.30

24.31

1.5

1476.33

2013.25

e6/l

0.35

1502

6803

Diseases of pulp and periapical tissues, including avohilmo

1723

6764

1.32

24.22

1.5

1412.30

2019.05

e6/l

0.35

1336

5376

Diabetes insipidus

6.22

24.15

1.9

1.3

1039.84

148.85

e6/l

0.85

Disorders of speech understanding and production

123

446

2.82

23.91

1.9

2.8

1656.14

9860.40

e6/l

0.42

318

Unspecified/other endometriosis

200

901

2.23

23.91

1.4

324.31

763.63

e6/l

1.09

151

714

Other nutritional deficiencies

1167

7756

1.38

23.90

1.4

1.5

1573.17

2151.61

e6/l

0.30

903

6084

Fracture of skull and facial bones

379

2167

1.78

23.90

1.5

3445.37

856.98

e6/l

0.80

284

1705

Inflammatory diseases of female pelvic organs

1064

5183

1.42

23.82

1.3

1.4

1029.90

2188.96

e6/l

0.79

836

4048

Monoplegia

126

4.80

23.65

1.4

263.40

104.85

e6/l

0.32

Leukaemia of unspecified cell type

6.49

23.64

7.6

1.4

7.80

526.25

e6/l

0.96

Lesion of lateral popliteal nerve

113

404

2.90

23.42

1.3

1.5

724.40

1719.86

e6/l

0.53

309

Iridocyclitis

391

2271

1.75

23.35

1.4

3317.26

1389.34

e6/l

0.47

310

1775

Disorders of synovium and tendon

862

5071

1.45

23.03

1.5

2604.79

2473.94

e6/l

0.04

690

3950

Osteoporosis

402

2162

1.73

22.97

1.7

1.4

2499.96

1219.04

e6/l

0.36

322

1717

Disturbance of activity and attention

287

1491

1.92

22.89

1.4

1.8

304.24

852.20

e6/l

1.42

218

1159

204

3.78

22.87

1.4

1.5

2121.17

758.48

e6/l

0.36

157

Lung diseases due to external agents

220

1069

2.09

22.82

1.6

1.5

697.50

950.82

e6/l

0.36

181

850

Voice disturbances

446

2701

1.67

22.79

1.3

1.4

666.88

2889.98

e6/l

0.91

343

2120

Allergic asthma (mode), excluding more controls

385

2183

1.74

22.77

1.4

379.57

2905.63

e6/l

0.81

312

1677

Parkinson's disease

241

1213

2.02

22.72

1.5

1.4

288.58

1115.94

e6/l

3.21

208

947

Fall on and from stairs and steps

457

2788

1.66

22.69

1.4

1.5

1226.85

2732.31

e6/l

0.52

342

2212

Allergic asthma (mode)

385

2186

1.74

22.67

1.4

379.57

2918.66

e6/l

0.82

312

1683

Statin medication

1125

4562

1.40

22.67

1.5

1.4

1725.96

1760.86

e6/l

0.01

866

3594

Fracture of lumbar spine and pelvis

347

1959

1.79

22.64

1.5

1.4

1260.43

1193.46

e6/l

0.04

270

1569

Enthesopathies of lower limb, excluding foot

365

2098

1.76

22.58

1.3

1.5

1016.20

1498.52

e6/l

0.48

292

1600

Restless leg syndrome

267

1397

1.95

22.56

1.3

1.4

629.37

1287.06

e6/l

1.21

194

1101

Vascular dementia (subcortical)

155

4.13

22.51

1.5

1.3

195.66

171.73

e6/l

0.06

122

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

102

354

2.98

22.32

1.4

1.3

316.18

607.49

e6/l

0.39

283

Immunodeficiency with predominantly antibody defects

222

3.62

22.32

2.5

1.7

50.68

698.57

e6/l

0.66

167

Exposure to other specified factors

1387

8987

1.33

22.16

1.4

1.5

1382.62

1957.08

e6/l

0.36

1058

7097

Disorders of refraction and accommodation

514

3236

1.60

22.06

1.7

1.6

9032.38

1201.61

e6/l

0.55

411

2502

Injuries to the shoulder and upper arm

1418

8271

1.33

22.04

1.5

731.20

2233.43

e6/l

2.00

1140

6504

Emotional disorders starting during childhood or adolecense, excluding more controls

100

333

3.00

22.04

3.1

2.3

326.92

593.17

e6/l

0.21

254

Hypersomnia

109

4.95

21.94

1.2

33.14

1191.49

e6/l

0.62

Purpura and other haemorrhagic conditions

246

1264

1.98

21.92

2.4

1.5

501.60

4265.95

e6/l

0.68

200

994

Sequelae of injuries, of poisoning and of other consequences of external causes

416

2503

1.69

21.85

1.7

1.4

767.84

2604.30

e6/l

0.63

327

1958

Malignant neoplasm, wide definition

1467

6457

1.33

21.79

2.1

1.4

1311.14

1979.01

e6/l

0.47

1098

5145

Congenital malformations of the nervous system

232

3.53

21.64

2.0

3.3

8755.80

225.75

e6/l

0.49

170

Supplementary factors related to causes of morbidity and mortality classified elsewhere

544

3500

1.57

21.64

1.6

1.5

2259.11

2213.19

e6/l

0.01

465

2740

Injuries to the wrist and hand

1715

8819

1.30

21.58

1.4

1.5

1343.35

1997.98

e6/l

0.47

1335

6961

Covid-19 suspected case

395

2358

1.70

21.39

1.5

296.75

2538.01

e6/l

0.78

318

1850

Deforming dorsopathies

429

2613

1.66

21.36

1.4

1.6

889.47

1355.65

e6/l

0.61

350

2003

Adrenocortical insufficiency

311

3.09

21.21

1.5

1.6

170.79

262.80

e6/l

0.36

236

Postprocedural endocrine and metabolic disorders, not elsewhere classified

226

1141

2.02

21.20

1.6

1.4

450.57

1331.51

e6/l

1.67

176

918

Other and unspecified tonsillitis

606

3316

1.53

21.08

1.5

1.4

501.90

1913.93

e6/l

0.64

482

2574

Exclusions for E4_PCOS_CONSORTIUM

1225

5670

1.36

21.07

1.4

1.5

4064.59

1379.38

e6/l

0.42

970

4431

Benign neoplasms

1641

6879

1.31

21.05

1.5

1614.27

1818.81

e6/l

0.10

1294

5432

Malignant neoplasm, including Hilmo

1459

6455

1.32

21.01

2.1

1.4

1320.01

1978.83

e6/l

0.46

1090

5144

Bacterial intestinal infections, IBD co-morbidities

302

1681

1.82

20.95

1.8

1.5

506.76

1230.61

e6/l

1.52

234

1321

Paracetamol or NSAID medication

257

652

2.01

20.80

1.9

2.1

840.12

687.36

e6/l

0.11

200

521

Dentofacial anomalies [including malocclusion]

1222

7141

1.35

20.80

1.5

1733.96

1866.94

e6/l

0.05

969

5594

Social phobias

171

784

2.23

20.71

1.6

1272.74

1130.34

e6/l

0.05

130

610

Gastro-oesophageal reflux disease

1107

6886

1.36

20.68

1.3

1.5

2690.90

2035.78

e6/l

0.13

893

5424

Heterophoria

173

800

2.22

20.62

1.6

1.9

1201.50

1031.56

e6/l

0.07

146

618

Type of accident

501

3204

1.58

20.50

1.6

1.5

2381.38

2251.44

e6/l

0.03

437

2511

Hyperkinetic disorders

299

1630

1.82

20.45

1.4

1.9

298.77

3232.72

e6/l

0.68

222

1268

Visual impairment including blindness (binocular or monocular)

126

511

2.53

20.28

1.8

1.6

179.19

1180.14

e6/l

1.08

404

Malignant neoplasm

1414

6298

1.32

20.26

2.2

1.4

1194.48

2024.91

e6/l

0.64

1054

5015

Problems related to lifestyle

202

997

2.07

20.23

1.5

713.26

4803.31

e6/l

0.56

163

791

Inflammatory disease of uterus

269

1464

1.87

20.19

1.2

1.4

287.83

4026.90

e6/l

0.82

217

1154

Unspecified acute lower respiratory infection

275

1507

1.86

20.14

1.5

1.6

3031.77

1174.62

e6/l

0.38

223

1195

Urticaria and erythema

634

4283

1.50

20.06

1.6

1.5

938.73

2137.69

e6/l

0.67

513

3341

Malignant neoplasm

1411

6292

1.32

20.05

2.2

1.4

1198.29

2025.57

e6/l

0.64

1051

5012

Early lumbar disc prolapse, operated

180

854

2.15

20.01

1.3

1.4

347.25

1059.91

e6/l

1.47

155

665

Mixed and other personality disorders

167

772

2.22

19.94

1.3

1.5

429.44

6451.60

e6/l

0.64

124

593

Fasciculation

5.16

19.82

1.4

521.08

101.20

e6/l

0.38

Acute alcohol intoxication

410

2522

1.65

19.76

1.3

1.4

868.63

1217.58

e6/l

0.44

325

1986

Other heart diseases, wide

1583

7435

1.30

19.62

1.4

1.5

964.41

2285.51

e6/l

1.35

1276

5772

Diseases of the skin and subcutaneous tissue

1619

6296

1.30

19.57

1.6

1.5

1258.22

2264.36

e6/l

0.63

1300

4934

Malignant immunoproliferative diseases

5.85

19.43

1.5

1.4

117.96

1914.18

e6/l

0.51

Retrobulbar neuritis in diseases classified elsewhere

8.80

19.39

1.1

1.4

14.07

171.40

e6/l

0.51

Appendectomy

1077

7630

1.35

19.32

1.4

3627.31

1899.97

e6/l

0.36

861

5973

Autonomic disorders

151

3.94

19.26

1.5

1.2

986.20

1396.61

e6/l

0.15

113

Monoamine oxidase A inhibitors

180

867

2.11

19.23

1.2

1.4

912.01

867.07

e6/l

0.02

135

689

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

117

4.48

19.20

1.4

1.3

947.21

137.71

e6/l

0.65

Haemorrhage from respiratory passages

514

2957

1.55

19.17

1.6

1.5

1956.81

2814.67

e6/l

0.20

408

2337

Parkinson's disease, strict definition

215

1107

1.98

19.08

1.5

1.4

315.80

1094.25

e6/l

2.60

186

873

Alcohol abuse, main dg

285

1610

1.80

18.94

1.3

1.5

716.01

3419.13

e6/l

0.60

226

1270

Disorders of muscles

181

883

2.09

18.73

1.3

1.4

283.15

639.00

e6/l

0.91

145

694

Hypermobility syndrome

125

526

2.45

18.72

1.4

1.6

1494.36

8630.22

e6/l

0.47

406

Alcohol dependence

419

2627

1.61

18.71

1.3

1.4

997.24

1213.61

e6/l

0.24

341

2079

Secondary uncertain malignant neoplasm

221

1157

1.94

18.70

1.7

1.4

672.30

1038.67

e6/l

0.37

180

932

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

152

696

2.24

18.63

1.9

1.5

27601.54

1163.72

e6/l

0.49

111

543

KRA_PSY_EATING, excluding more controls

147

656

2.26

18.59

1.3

1.5

285.74

2435.62

e6/l

1.06

121

522

Explicit bacterial Sepsis

165

780

2.15

18.51

2.2

1.4

830.85

1551.84

e6/l

0.61

136

621

Mycoses, including avohilmo

1529

9104

1.29

18.51

1.4

1.5

1152.68

2011.22

e6/l

0.79

1178

7200

Superficial injury of lower leg

448

2863

1.58

18.45

1.4

1.5

616.19

2409.50

e6/l

0.74

349

2259

Diaphragmatic hernia

540

3597

1.52

18.36

1.4

746.29

1616.76

e6/l

2.01

415

2874

Somnolence

4.80

18.34

2.1

1.9

80.46

133.73

e6/l

0.30

Acute alcohol intoxication, ICD10

353

2136

1.68

18.26

1.3

1.5

485.47

2958.74

e6/l

0.78

277

1673

Explicit bacterial Sepsis, including avohilmo

168

804

2.13

18.26

2.1

1.4

824.30

1506.41

e6/l

0.58

138

640

Nystagmus and other irregular eye movements

122

4.31

18.21

1.9

2.3

178.18

133.43

e6/l

0.10

Erysipelas, including avohilmo

1085

6013

1.34

18.18

1.4

2007.27

2529.55

e6/l

0.20

860

4732

Erysipelas

805

4972

1.40

18.10

1.5

1.4

1605.08

2606.19

e6/l

0.38

645

3914

Manic episode

217

3.30

17.98

1.2

1.4

243.42

467.75

e6/l

0.23

169

All influenza (not pneumonia)

259

1444

1.82

17.98

1.6

946.15

3813.22

e6/l

0.54

208

1123

Vascular syndromes of brain in cerebrovascular disorders

248

3.11

17.90

1.5

1.4

1873.89

883.42

e6/l

0.38

194

Superficial injury of abdomen, lower back and pelvis

282

1616

1.77

17.84

1.4

1.5

581.66

3362.25

e6/l

0.63

219

1278

Disorders of conjunctiva

1396

8409

1.29

17.80

1.5

539.52

2223.00

e6/l

2.54

1058

6626

Schizoaffective disorder

158

749

2.16

17.77

1.2

1.5

353.74

1363.98

e6/l

1.30

122

581

Non-allergic asthma (mode)

284

1618

1.76

17.64

1.3

1.4

2522.93

3395.19

e6/l

0.13

224

1261

Missing teeth due to accident, extraction or parodontitis

947

6255

1.36

17.64

1.5

1.4

1314.23

2510.12

e6/l

0.87

750

4956

Dental caries, including avohilmo

1095

4182

1.35

17.53

1.6

1.5

1530.94

1846.56

e6/l

0.19

855

3328

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

844

5926

1.38

17.53

1.4

1.5

904.25

2062.97

e6/l

1.00

694

4626

Pain and other conditions associated with female genital organs and menstrual cycle

376

1939

1.64

17.50

1.4

957.64

1397.21

e6/l

0.33

289

1521

L04AD Calcineurin inhibitors

213

1130

1.93

17.45

2.7

1.8

2518.94

1025.41

e6/l

0.30

159

866

Anterior Iridocyclitis

336

2032

1.68

17.45

1.4

1.5

3539.21

2999.62

e6/l

0.07

275

1598

Other disorders of adrenal gland

104

416

2.59

17.43

1.6

1.7

763.23

373.12

e6/l

0.31

316

Non-allergic asthma (mode), excluding more controls

284

1624

1.75

17.42

1.3

1.4

2522.93

3541.95

e6/l

0.16

224

1264

Other disorders of optic disc

122

4.22

17.38

1.3

1.2

33.03

1026.98

e6/l

0.55

Conjunctivitis

1278

7941

1.30

17.36

1.6

1.5

499.70

1960.41

e6/l

2.27

966

6257

Cauda equina syndrome

109

4.43

17.36

1.4

1.3

713.51

1095.97

e6/l

0.13

Mental and behavioural disorders due to opioids

365

2.70

17.30

2.0

1.5

43807.68

1201.46

e6/l

0.49

291

Diseases of male genital organs

766

2720

1.43

17.24

1.4

1.6

2223.63

1018.08

e6/l

0.68

601

2146

Viral infections of central nervous system, not elsewhere classified/unspecified

4.77

17.22

1.5

1.3

1132.53

110.64

e6/l

0.68

Other diseases of upper respiratory tract

1742

7222

1.26

17.21

1.4

1.5

2541.01

1862.00

e6/l

0.20

1387

5646

Speech therapy

400

2533

1.60

17.20

1.7

1.5

812.41

1233.22

e6/l

0.56

325

1997

Disorders of brain, other and unspecified

5.74

17.16

2.1

1.3

831.56

298.50

e6/l

0.38

Special screening examination for other diseases and disorders

178

891

2.02

17.09

1.7

1.4

822.97

951.43

e6/l

0.12

158

674

Candidiasis, including avohilmo

512

3428

1.51

17.07

1.4

1129.16

2293.44

e6/l

0.48

399

2690

Injuries to the knee and lower leg

1949

8508

1.24

17.02

1.4

1.5

1155.20

2017.94

e6/l

0.85

1528

6720

Need for other prophylactic measures

124

543

2.35

17.01

2.5

1.7

57.56

1138.24

e6/l

1.94

416

Atypical facial pain

106

433

2.52

16.96

1.4

163.48

1235.40

e6/l

0.94

337

Carpal tunnel syndrome

913

5851

1.36

16.94

1.4

1446.03

2141.42

e6/l

0.44

758

4536

Diseases of the digestive system

679

4768

1.42

16.83

1.5

1273.20

2626.50

e6/l

0.75

558

3763

Acute and subacute iridocyclitis

316

1900

1.69

16.80

1.4

1.5

3616.32

1130.36

e6/l

0.53

260

1492

Other disorders of bone

335

2045

1.66

16.79

1.5

1.4

723.57

3253.27

e6/l

0.74

265

1611

Acetic acid derivatives and related substances

385

1217

1.65

16.78

1.3

1.5

1095.69

1160.16

e6/l

0.04

291

983

Lesion of ulnar nerve

228

1250

1.85

16.78

1.4

545.87

1162.89

e6/l

0.86

195

973

Spondyloarthritis

280

1629

1.74

16.77

1.4

2606.29

3808.49

e6/l

0.15

235

1271

Use of pramipexole

329

2000

1.67

16.74

1.4

343.76

1410.07

e6/l

4.23

258

1577

Chorioretinal inflammation

249

3.06

16.68

1.4

646.91

946.66

e6/l

0.16

192

Transplanted organ and tissue status

191

994

1.96

16.60

3.4

1.6

2713.26

1322.21

e6/l

0.25

147

765

Tetraplegia

5.99

16.59

3.6

2.9

2312.17

2203.00

e6/l

0.01

Agoraphobia

260

2.99

16.57

1.2

1.5

208.82

1720.84

e6/l

0.72

206

Other and unspecified iron deficiency

519

3502

1.49

16.46

1.5

1841.49

2391.70

e6/l

0.16

409

2778

Other/unspecified disorders of vestibular function

340

2.71

16.39

1.3

1.4

2534.56

850.43

e6/l

0.34

270

Sequelae of injuries of head

112

478

2.41

16.30

1.8

1.5

1315.13

1456.78

e6/l

0.06

367

Other enthesopathies

459

3032

1.53

16.29

1.3

1.5

1746.97

2889.05

e6/l

0.36

376

2376

Congenital malformations, deformations and chromosomal abnormalities

977

6975

1.34

16.29

1.5

2228.18

1806.18

e6/l

0.17

781

5461

Other disorders of peripheral nervous system

6.32

16.28

1.2

4.68

132.85

e6/l

0.59

Other facial nerve disorders

231

3.11

16.27

1.2

1.5

131.40

2203.19

e6/l

0.92

171

Nonpyogenic thrombosis of intracranial venous system

5.19

16.25

1.8

1.3

8142.46

129.55

e6/l

0.48

Protozoal diseases, including avohilmo

253

3.01

16.21

1.7

1.4

141.24

944.26

e6/l

0.82

192

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1616

8146

1.26

16.20

1.9

1.4

1294.50

2121.72

e6/l

0.66

1279

6368

Ptosis of eyelid

187

974

1.96

16.18

1.6

1.5

614.40

1106.10

e6/l

0.76

152

760

Spondylolisthesis/Spondylolysis

265

1535

1.75

16.15

1.3

1.5

1309.65

1014.98

e6/l

0.21

215

1183

Other congenital malformations of circulatory system

222

3.16

16.13

2.6

1.4

554.69

645.93

e6/l

0.06

169

Mental disorders, not otherwise specified

167

840

2.03

16.05

1.3

1.5

611.90

5559.15

e6/l

0.56

126

660

Other disorders of glucose regulation and pancreatic internal secretion

159

786

2.07

16.01

1.7

1.9

315.83

1218.35

e6/l

1.19

135

606

Excessive vomiting in pregnancy

163

814

2.05

15.98

1.3

1.4

931.35

5830.43

e6/l

0.52

122

632

Sleep disorders, other/unspecified

322

2.73

15.93

1.2

1.6

362.21

1828.34

e6/l

0.85

261

Venous thromboembolism

776

5456

1.38

15.91

1.6

1.4

1370.91

2588.61

e6/l

0.73

630

4320

Other specified disorders of muscle

187

3.32

15.89

1.3

1.4

34.43

246.60

e6/l

2.33

145

Enterocolitis due to Clostridium difficile

172

878

1.99

15.77

2.0

1.5

198.14

831.74

e6/l

2.17

133

691

Mental and behavioural disorders due to sedatives or hypnotics

140

665

2.16

15.73

1.3

1.5

823.71

1366.48

e6/l

0.36

105

528

Acute appendicitis, no complications

912

6804

1.34

15.71

1.4

4155.80

1930.12

e6/l

0.41

735

5338

Hernia of abdominal wall, postoperative

267

1550

1.73

15.70

1.4

1.3

9341.95

1792.48

e6/l

0.44

210

1245

Propionic acid derivatives

418

1336

1.59

15.58

1.5

1.8

746.59

1097.30

e6/l

0.41

322

1073

Unspecified haematuria

590

3350

1.44

15.47

1.5

1629.69

1418.57

e6/l

0.10

480

2663

Other disorders of eyelid

627

4190

1.42

15.40

1.4

1.5

1036.96

2328.50

e6/l

1.27

490

3331

Other specified/unspecified necrotizing vasculopathies

4.38

15.39

1.7

1.2

98.53

1300.97

e6/l

0.50

Keratitis

574

4014

1.44

15.33

1.5

1.4

7608.27

1221.76

e6/l

0.50

463

3148

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

664

4701

1.41

15.31

1.4

1.5

1191.03

2040.44

e6/l

0.36

505

3673

Other diseases of hard tissues of teeth

813

3067

1.38

15.30

1.7

1.5

1287.87

2948.33

e6/l

0.59

636

2447

Dystonia

112

492

2.34

15.29

1.4

1.5

393.93

1298.35

e6/l

0.72

381

Diseases of oral cavity, salivary glands and jaws

818

3073

1.38

15.27

1.6

1.5

1468.26

2946.70

e6/l

0.50

630

2451

Abnormal weight loss

165

842

2.00

15.22

1.4

1.6

316.73

1134.61

e6/l

1.29

139

653

Disorders of mineral metabolism

147

720

2.08

15.18

1.4

1.5

1056.43

1363.04

e6/l

0.15

119

578

Attention to artificial openings

301

2.74

15.17

2.6

1.8

1691.94

825.33

e6/l

0.53

227

Contact with and exposure to communicable diseases

536

3693

1.46

15.14

1.4

1.5

1600.51

2186.73

e6/l

0.15

466

2863

Conjunctivitis (acute, non atopic)

484

3272

1.49

15.12

1.6

506.97

2435.16

e6/l

0.98

378

2563

Intestinal stricture

444

2964

1.51

15.06

1.6

1.5

549.06

2041.42

e6/l

1.24

368

2333

Asthma and allergy, excluding more controls

216

1189

1.82

15.02

1.4

406.49

4093.63

e6/l

0.59

185

912

Maternal care for other conditions predominantly related to pregnancy

363

2263

1.58

15.00

1.4

338.63

3109.82

e6/l

0.95

264

1754

Weight loss

178

937

1.94

14.98

1.7

1.6

302.10

1135.01

e6/l

1.50

150

729

Protozoal diseases

248

2.94

14.98

1.7

1.4

147.94

937.82

e6/l

0.79

190

Obesity

1040

7530

1.31

14.95

1.4

1.5

1596.63

2209.76

e6/l

0.29

817

5894

Amenorrhoea

140

678

2.11

14.94

1.4

28200.85

667.47

e6/l

0.49

107

534

Obesity and other hyperalimentation

1045

7561

1.31

14.93

1.4

1.5

1591.65

2202.38

e6/l

0.29

820

5919

Arnold-Chiari syndrome

4.71

14.88

2.3

138.39

135.68

e6/l

0.01

Nonhereditary hypogammaglobulinemia

4.57

14.87

1.4

1.3

47.13

101.40

e6/l

0.31

Thiamine deficiency

6.43

14.84

1.1

1.5

391.44

200.94

e6/l

0.27

Kela reimbursement Agammaglobulinemia (D80-84)

5.18

14.82

3.6

1.6

8.88

172.28

e6/l

0.84

Paralytic ileus and intestinal obstruction

370

2381

1.57

14.81

1.6

1.5

506.17

1303.36

e6/l

2.49

309

1896

Asthma and allergy

215

1188

1.81

14.76

1.4

407.35

4083.84

e6/l

0.59

184

912

Mouth breathing

617

4401

1.41

14.64

1.5

1.6

664.51

2801.24

e6/l

1.40

502

3436

Nutritional anaemias

726

5070

1.37

14.62

1.5

1483.87

2663.77

e6/l

0.56

581

4044

Hypoglycaemia, other or unspecified

132

631

2.14

14.61

1.8

1.9

148.29

1283.16

e6/l

1.44

112

490

Adverse effects, not elsewhere classified

342

2174

1.59

14.60

1.4

1.7

2635.58

2823.49

e6/l

0.03

271

1699

Ovarian cyst

556

2194

1.46

14.60

1.4

2406.86

1354.54

e6/l

0.32

436

1734

Hereditary ataxia

4.27

14.53

1.3

1.9

585.22

1277.51

e6/l

0.24

Caries of dentine, including avohilmo

1167

4620

1.30

14.44

1.6

4881.24

1757.58

e6/l

0.46

915

3656

Heart failure, not strict

1099

5714

1.30

14.42

1.5

4336.94

1574.40

e6/l

0.71

903

4476

Varicella [chickenpox], including avohilmo

113

511

2.27

14.40

2.1

2.2

1002.55

1006.12

e6/l

0.00

392

Other disorders starting during childhood or adolecense, excluding more controls

355

2.50

14.39

3.2

2.6

195.99

961.53

e6/l

0.73

267

Alcohol withdrawal state with delirium

124

584

2.18

14.28

1.4

578.83

1012.54

e6/l

0.47

107

456

GI-bleeding

442

2980

1.50

14.28

1.5

1213.13

3403.05

e6/l

0.82

359

2357

Anti-inflammatory and antirheumatic products, non-steroids

411

1337

1.56

14.25

1.5

1.8

1039.24

1096.28

e6/l

0.04

314

1074

Soft tissue disorders related to use, overuse and pressure

407

2703

1.52

14.19

1.3

1.4

1148.15

2072.22

e6/l

0.50

322

2132

Other viral hepatitis, including avohilmo

134

652

2.11

14.19

1.7

1.5

29853.15

1210.15

e6/l

0.49

102

502

Myasthenia gravis

131

3.70

14.16

1.7

1.3

127.68

1066.09

e6/l

0.52

Other noninfective gastroenteritis and colitis

392

2585

1.53

14.11

1.5

1.6

524.51

2652.09

e6/l

0.80

315

2023

Diseases of pulp and periapical tissues and dental caries

960

3726

1.33

14.08

1.7

1.5

1505.10

1811.61

e6/l

0.16

749

2972

Dental operations

881

3387

1.35

14.07

1.5

1560.43

1621.26

e6/l

0.03

695

2631

Anankastic personality disorder

367

2.50

14.07

1.5

1.4

738.57

744.29

e6/l

0.00

284

Disorders of optic nerve, not elsewhere classified

156

3.43

14.05

1.4

1.3

21.53

856.00

e6/l

0.60

121

Viral hepatitis, including avohilmo

150

763

2.01

14.04

1.7

1.5

26712.81

1244.51

e6/l

0.48

114

595

Post-traumatic hydrocephalus, unspecified

14.00

13.98

2.1

1.3

162.44

295.50

e6/l

0.18

Pulmonary embolism

413

2760

1.51

13.97

1.6

1.4

1091.44

1331.66

e6/l

0.24

331

2174

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1058

7496

1.29

13.94

1.6

1.5

2103.47

2088.09

e6/l

0.01

849

5867

Chronic rhinitis, nasopharyngitis and pharyngitis

525

3678

1.44

13.93

1.4

1.5

757.62

2245.30

e6/l

0.77

399

2860

Pulmonary heart disease

413

2762

1.51

13.92

1.6

1.4

1091.44

1331.75

e6/l

0.24

331

2174

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

128

616

2.12

13.91

1.3

1.5

17176.04

850.61

e6/l

0.49

106

488

Degeneration of the brain due to alcohol

152

3.43

13.88

1.2

1.5

130.51

910.76

e6/l

0.52

117

Acute pharyngitis

272

1639

1.66

13.87

1.7

1.5

924.93

3300.86

e6/l

0.49

222

1255

Other and unspecified injuries of head

133

651

2.09

13.82

1.5

1.6

1352.50

1173.36

e6/l

0.06

100

517

Superficial injury of hip and thigh

231

1349

1.73

13.76

1.3

1.4

832.26

1119.40

e6/l

0.20

187

1055

Paroxysmal tachycardia

325

1707

1.60

13.75

1.4

1.5

1031.14

710.71

e6/l

0.33

267

1320

Immunodeficiencies

102

452

2.33

13.72

2.3

2.0

63.07

1464.98

e6/l

1.37

344

Asthma/COPD (KELA code 203)

1537

8327

1.24

13.56

1.4

1.5

835.61

2139.04

e6/l

1.54

1225

6536

Urticaria

503

3518

1.44

13.51

1.7

1.5

742.82

2291.47

e6/l

0.75

399

2753

Behavioural disorders, excluding more controls

144

3.45

13.51

1.3

2.1

78304.24

622.56

e6/l

0.49

112

Acute renal failure

317

2017

1.59

13.48

1.5

1.4

676.80

1285.95

e6/l

1.36

249

1595

Oxicams

310

1087

1.63

13.44

1.4

1.6

1523.53

1254.91

e6/l

0.12

260

891

Insulin, intermediate and long-acting

809

5893

1.33

13.41

1.6

1.5

1496.67

2356.79

e6/l

0.44

667

4679

Algoneurodystrophy

292

2.66

13.41

1.4

1.5

574.84

2169.69

e6/l

0.80

222

Obsessive-compulsive disorder

126

612

2.10

13.36

1.3

1.6

519.37

1196.67

e6/l

0.48

485

Diseases of arteries, arterioles and capillaries (FINNGEN)

323

1406

1.60

13.35

1.6

1.3

1422.81

809.14

e6/l

0.52

268

1088

Special screening examination for infectious and parasitic diseases

344

1610

1.57

13.34

1.4

286.61

740.28

e6/l

1.80

221

1203

Other diseases of the digestive system

440

3007

1.48

13.33

1.5

1202.38

3428.49

e6/l

0.85

353

2377

Streptococcal septicaemia

141

714

2.01

13.33

2.2

1.4

858.01

1153.02

e6/l

0.21

116

562

Arthrosis

1070

4548

1.30

13.31

1.4

1.5

2290.55

2586.76

e6/l

0.08

859

3549

Pneumonia due to other infectious organisms, not elsewhere classified

247

2.80

13.29

1.8

1.5

994.38

253.32

e6/l

0.48

195

Other and unspecified disorders of binocular movement

5.56

13.27

2.1

2.4

327.76

32.55

e6/l

0.55

Other viral hepatitis

126

615

2.10

13.27

1.7

1.4

31063.85

1253.76

e6/l

0.49

474

Beningn neoplasm: Meninges, unspecified

118

3.75

13.21

1.9

1.3

998.83

173.24

e6/l

0.79

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

240

1434

1.70

13.21

1.7

1.4

635.65

1406.58

e6/l

0.79

195

1150

Other congenital malformations of nervous system

4.25

13.21

2.3

2.6

138.39

208.14

e6/l

0.25

Diseases of appendix

1177

8345

1.27

13.21

1.4

3494.10

1805.39

e6/l

0.39

932

6571

Pulmonary heart disease, diseases of pulmonary circulation

436

2980

1.48

13.20

1.6

1.4

1037.55

2028.65

e6/l

0.62

350

2356

Faecal incontinence

142

724

1.99

13.16

1.9

1.5

426.13

1041.12

e6/l

1.09

110

565

Streptococcal septicaemia, including avohilmo

144

738

1.98

13.16

2.2

1.4

849.90

1277.17

e6/l

0.33

118

580

Acute and transient psychotic disorders

202

1153

1.78

13.15

1.4

333.18

1208.02

e6/l

1.44

151

911

Acute appendicitis

1104

8075

1.28

13.12

1.4

3524.50

1844.18

e6/l

0.36

876

6340

Abnormal blood-pressure reading, without diagnosis

416

2.34

13.12

1.3

1.7

801.93

1206.30

e6/l

0.20

321

Iron deficiency anaemia

622

4446

1.38

13.08

1.5

1560.47

2759.89

e6/l

0.48

490

3545

Temporal arteritis

278

2.68

13.07

1.2

1.3

1982.67

891.03

e6/l

0.26

220

Disorders of skin appendages

812

6131

1.33

13.06

1.5

1212.45

2017.54

e6/l

0.46

666

4789

Disorders of lens

979

4682

1.30

13.06

1.4

1243.71

2176.55

e6/l

0.81

771

3674

Other symptoms and signs involving the circulatory and respiratory systems

120

578

2.12

13.04

1.5

1.6

513.23

1231.62

e6/l

0.74

102

443

DVT of lower extremities and pulmonary embolism

574

4115

1.40

13.02

1.6

1.4

1415.04

2031.32

e6/l

0.37

468

3274

Use of fingolimod

4.51

13.01

1.4

1.7

2.31

122.90

e6/l

0.97

Viral and other specified intestinal infections, including avohilmo

467

3121

1.45

12.97

1.6

1.5

1387.78

2555.80

e6/l

0.35

392

2450

Adhesive capsulitis of shoulder

239

1433

1.69

12.96

1.5

1.4

480.52

1143.42

e6/l

1.51

195

1125

Viral hepatitis

141

723

1.99

12.94

1.7

1.5

27931.13

1277.19

e6/l

0.48

109

566

Abnormal findings on diagnostic imaging of other body structures

230

1367

1.71

12.93

1.5

1.4

998.67

1352.73

e6/l

0.36

174

1078

Appendicitis, broad definition

1166

8312

1.26

12.90

1.4

3526.81

1813.00

e6/l

0.39

923

6543

Fourth [trochlear] nerve palsy

170

3.19

12.87

1.9

1.3

2535.76

800.75

e6/l

0.31

128

Injuries to the hip and thigh

698

4651

1.35

12.78

1.4

1.5

782.15

2658.84

e6/l

1.25

556

3679

Cutaneous abscess, furuncle and carbuncle

424

2904

1.47

12.78

1.5

1.4

435.60

2621.53

e6/l

0.99

340

2280

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

167

909

1.87

12.76

1.8

1.5

831.02

1240.14

e6/l

0.34

133

730

Noninfective enteritis and colitis

728

5453

1.34

12.76

1.5

541.89

1969.35

e6/l

1.30

574

4282

Conductive and sensorineural hearing loss

1161

6101

1.27

12.72

1.5

1298.98

2572.67

e6/l

0.93

956

4768

Giant cell arteritis with polymyalgia rheumatica

282

2.64

12.71

1.2

1.3

1982.67

886.39

e6/l

0.26

221

Lagophthalmos

4.16

12.68

1.7

1.3

600.96

142.90

e6/l

0.53

Disorders of choroid and retina

1181

6568

1.26

12.64

1.5

1217.46

2490.27

e6/l

0.94

917

5211

Use of dimethyl fumarate

4.50

12.56

1.1

1.2

16.85

205.64

e6/l

1.08

Conjunctivitis (acute, non atopic), including avohilmo

1614

7995

1.22

12.55

1.5

993.87

2244.93

e6/l

1.20

1238

6353

Oter anti-inflammatory and antirheumatic agents, non-steroids

287

971

1.64

12.53

1.3

1.5

1206.52

1300.15

e6/l

0.06

224

797

Polycystic ovarian syndrome, consortium definition

1126

5091

1.28

12.51

1.5

1.4

4893.62

1324.06

e6/l

0.54

898

3968

Brain astrocytoma

6.20

12.51

2.0

1.2

975.06

48.34

e6/l

0.48

Brain astrocytoma, including Hilmo

6.20

12.51

2.0

1.2

975.06

48.34

e6/l

0.48

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

130

657

2.02

12.45

1.4

1.6

756.19

1377.43

e6/l

0.49

513

Varicella [chickenpox]

426

2.29

12.45

1.8

1.9

1234.03

1144.97

e6/l

0.03

334

Endometriosis

522

2136

1.43

12.45

1.3

1.4

847.28

1385.59

e6/l

0.51

400

1695

Giant cell arteritis

328

2.48

12.34

1.2

1.3

1818.59

769.36

e6/l

0.28

257

Diseases of liver

515

3681

1.41

12.29

1.5

1.4

1359.55

3114.99

e6/l

0.62

398

2909

Hypothyroidism, strict autoimmune, 3 medication purchases required

1277

6898

1.25

12.26

1.4

1394.34

2299.54

e6/l

0.54

1032

5407

Myeloid leukaemia

202

2.93

12.23

2.9

1.3

44.24

808.99

e6/l

0.78

162

Hypermetropia

142

744

1.95

12.22

1.8

2.1

1309.46

1049.50

e6/l

0.11

109

563

Hyperplasia of prostate

475

1854

1.45

12.22

1.4

1084.60

1053.90

e6/l

0.02

379

1484

Leisure time condition

292

1870

1.58

12.17

1.6

1982.56

3030.12

e6/l

0.20

254

1464

Symptoms and signs involving emotional state

219

2.82

12.15

1.2

2.1

313.37

352.84

e6/l

0.05

171

Viral and other specified intestinal infections

346

2245

1.52

12.06

1.5

1.6

1563.19

2545.09

e6/l

0.20

297

1745

Other disorders of skin and subcutaneous tissue

1092

7326

1.26

12.00

1.6

1.5

2163.32

2140.70

e6/l

0.01

862

5785

Other postsurgical states

125

633

2.02

11.93

2.0

1.6

778.38

1266.23

e6/l

0.36

103

496

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

5.08

11.90

2.3

1.2

1628.16

293.75

e6/l

0.42

Infections with a predominantly sexual mode of transmission, including avohilmo

664

4538

1.35

11.86

1.5

1.4

1946.84

1828.61

e6/l

0.04

499

3574

Assault by bodily force

149

803

1.89

11.80

1.2

1.6

190.75

5895.78

e6/l

0.64

106

628

Chronic gastritis

359

2419

1.50

11.77

1.3

1.4

679.82

1324.06

e6/l

1.51

271

1936

Assault

237

1457

1.65

11.76

1.3

1.5

306.29

3611.10

e6/l

0.69

170

1142

Disorders of gallbladder, biliary tract and pancreas

1508

7703

1.22

11.76

1.5

1.4

2376.51

1932.24

e6/l

0.11

1196

6068

Obesity due to excess calories

769

5887

1.32

11.74

1.4

1.5

2012.08

2448.51

e6/l

0.15

623

4611

6-mercaptopurine

312

2.47

11.68

10.1

1.5

321.92

1064.42

e6/l

0.61

250

Fall on same level involving ice and snow

892

6960

1.29

11.68

1.4

1.5

1139.56

2262.98

e6/l

0.88

699

5491

Chronic diseases of tonsils and adenoids

1254

6378

1.25

11.64

1.4

1.5

1424.44

2014.33

e6/l

0.26

996

4932

Unspecified privation

176

1002

1.79

11.63

1.2

1.5

910.87

1205.94

e6/l

0.20

119

792

Other gastritis (incl. Duodenitis)

313

2056

1.54

11.62

1.5

1.4

659.29

1437.75

e6/l

1.76

259

1626

Other obstetric conditions, not elsewhere classified

548

2493

1.40

11.62

1.3

734.15

2694.90

e6/l

0.64

433

1947

Degeneration of nervous system due to alcohol

170

3.06

11.60

1.2

1.4

130.51

844.44

e6/l

0.53

131

Panniculitis affecting regions of neck and back

271

2.58

11.59

1.5

9439.81

468.85

e6/l

0.50

208

Insulin, combination of fast acting with intermediate-acting or long-acting

894

6327

1.29

11.58

1.6

1.5

1380.63

2283.61

e6/l

0.52

736

5019

Fenamates

206

820

1.73

11.51

1.5

659.65

1367.86

e6/l

1.00

163

656

Gingivitis and periodontal diseases

1525

6469

1.22

11.47

1.5

1364.08

2246.78

e6/l

0.61

1177

5162

Vitamin deficiency, wide

428

2.23

11.46

1.2

1.7

806.98

559.13

e6/l

0.15

334

Vitamin deficiency

428

2.23

11.46

1.2

1.7

806.98

559.13

e6/l

0.15

334

Other diseases of the respiratory system

274

1753

1.58

11.46

1.7

1.5

921.88

1250.49

e6/l

0.24

222

1374

Other respiratory disorders and diseases

274

1753

1.58

11.46

1.7

1.5

921.88

1250.49

e6/l

0.24

222

1374

Diverticular disease of intestine

1014

4976

1.27

11.45

1.4

3057.37

1583.90

e6/l

0.29

790

3954

Other and unspecified immunodeficiencies with predominantly antibody defects

101

3.78

11.41

3.7

1.5

54.18

258.14

e6/l

1.38

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

536

2433

1.40

11.41

1.3

744.49

2740.01

e6/l

0.64

427

1904

Other maternal disorders predominantly related to pregnancy

879

4265

1.30

11.37

1.4

1016.71

2516.28

e6/l

0.85

709

3283

Other drug-induced secondary parkinsonism

4.32

11.37

1.3

1.4

17.23

169.43

e6/l

1.02

Benign neoplasm: Brain, infratentorial

4.94

11.28

2.3

2.2

668.94

239.76

e6/l

0.65

Other specified and unspecified personality disorders

158

880

1.83

11.27

1.4

1.5

133.61

5603.68

e6/l

0.69

123

689

Lack of expected normal physiological development

3.55

11.22

2.6

1.9

240.03

46631.95

e6/l

0.52

SLE (Finngen)

259

2.58

11.11

1.4

1.7

1239.00

1673.76

e6/l

0.12

206

Hyperhidrosis

168

2.98

11.10

1.3

1.6

81.21

1216.60

e6/l

0.62

130

Other arthrosis

767

3932

1.31

11.09

1.4

1.5

1906.62

1968.98

e6/l

0.03

613

3086

Disorders of calcium metabolism

105

513

2.09

11.07

1.5

1.6

383.28

1002.56

e6/l

0.85

404

Transient global amnesia

126

657

1.95

11.03

1.3

1.4

1714.73

1198.25

e6/l

0.22

106

507

Trochanteric bursitis

212

1288

1.67

11.02

1.3

1.4

802.73

1035.92

e6/l

0.24

169

1013

Unspecified visual impairment (binocular)

118

3.46

11.00

1.4

1.7

255.78

1108.82

e6/l

0.43

Internal derangement of knee

560

4092

1.36

10.99

1.3

1.5

1130.82

2734.54

e6/l

0.79

451

3202

Insulin medication

893

5814

1.28

10.97

1.6

1.5

1382.51

2018.09

e6/l

0.35

735

4615

Sensorineural hearing loss

1071

5704

1.26

10.94

1.5

1390.90

2681.41

e6/l

0.86

880

4467

Failure and rejection of transplanted organs and tissues

119

3.46

10.90

3.5

1.4

10478.70

1119.11

e6/l

0.42

Brain astrocytoma, helper endpoint

5.40

10.85

2.0

1.4

975.06

27.31

e6/l

0.49

Maltreatment syndromes

104

511

2.08

10.85

1.2

1.6

175.92

8813.73

e6/l

0.62

402

All chronic kidney diseases

770

4739

1.30

10.71

1.5

4032.14

1254.95

e6/l

0.49

635

3746

Heartburn

174

1012

1.74

10.68

1.4

1.5

479.99

1110.73

e6/l

1.04

133

785

Superficial injury of wrist and hand

349

2389

1.48

10.67

1.5

1.6

936.70

2827.22

e6/l

0.56

276

1880

Reimbursement for rheumatic diseases

844

6583

1.28

10.63

1.4

1.5

1465.53

2434.39

e6/l

0.44

677

5165

Nephropathy related operations

191

1145

1.69

10.53

1.8

1.7

2713.38

1061.96

e6/l

0.31

146

891

Sacroiliitis, not elsewhere classified

378

2.24

10.50

1.4

1.5

304.04

771.42

e6/l

0.43

289

Elevated blood glucose level

141

776

1.85

10.50

1.7

560.26

1334.53

e6/l

0.91

110

606

Generalized epilepsy

379

2.25

10.48

1.5

1.9

834.83

1359.25

e6/l

0.23

292

Pain associated with micturition

189

1131

1.69

10.47

1.6

1010.31

1226.75

e6/l

0.12

147

880

Gonarthrosis

910

4040

1.28

10.43

1.4

1941.92

1923.20

e6/l

0.01

725

3163

Malnutrition

164

2.97

10.43

1.9

2.5

4713.57

912.52

e6/l

0.44

122

Mycoses

426

3038

1.41

10.41

1.6

1.4

606.50

2699.60

e6/l

0.96

347

2387

Drug-induced adrenocortical insufficiency

154

3.05

10.38

1.6

1.3

180.97

154.03

e6/l

0.06

115

Disorders of acoustic nerve

233

2.62

10.35

1.8

1.3

1994.22

650.01

e6/l

0.34

183

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

108

3.53

10.35

1.3

1.2

583.07

136.06

e6/l

0.53

Secondary hypertension

114

578

1.97

10.35

1.5

5976.32

1376.10

e6/l

0.53

442

Disturbances of smell and taste

268

2.48

10.33

1.5

1037.11

1322.44

e6/l

0.11

209

Disorders of vitreous body and globe

725

5296

1.30

10.30

1.5

1.4

2490.71

2095.30

e6/l

0.14

578

4170

Rash and other nonspecific skin eruption

150

846

1.80

10.29

1.9

1.6

584.82

1199.89

e6/l

0.64

120

661

Osteoporosis with pathological fracture (FG)

102

507

2.05

10.27

1.6

1.5

1726.11

1011.63

e6/l

0.19

393

Diabetic neuropathy

159

911

1.76

10.15

1.7

1.5

14344.17

1198.37

e6/l

0.49

131

716

Diseases of salivary glands

491

3603

1.37

10.11

1.3

1.4

731.22

2438.71

e6/l

0.93

378

2851

Other/unspecified synovitis and tenosynovitis

170

1003

1.72

9.94

1.3

1.4

895.26

856.26

e6/l

0.02

129

789

Fracture of foot, except ankle

394

2797

1.42

9.92

1.5

1542.85

2587.40

e6/l

0.25

305

2206

Convergent concomitant strabismus

108

557

1.98

9.87

1.5

1.9

2190.49

1262.18

e6/l

0.23

432

Disorders of vitreous body

703

5178

1.30

9.85

1.5

1.4

2540.84

2125.86

e6/l

0.14

560

4076

Excessive, frequent and irregular menstruation

577

2292

1.35

9.82

1.5

1.4

7118.06

1304.09

e6/l

0.43

459

1812

Insulin, fast-acting

528

3937

1.35

9.76

1.6

1.5

1322.63

2944.95

e6/l

0.61

436

3109

Other or unspecified ileus, impaction or obstruction

253

1652

1.55

9.73

1.6

1.5

666.19

1257.79

e6/l

1.02

212

1320

Spondylopathies (FG)

215

1355

1.61

9.72

1.4

3302.84

3911.08

e6/l

0.06

183

1070

Obesity, other/unspecified

532

3979

1.35

9.69

1.4

1073.38

2327.86

e6/l

0.58

399

3136

Emotional disorders and disorders of social functioning with onset specific to childhood

107

542

1.97

9.66

3.0

2.3

311.32

177.16

e6/l

0.26

402

Anomalies of pupillary function

177

2.81

9.66

1.1

1.5

407.35

110.88

e6/l

0.57

133

Fracture of shoulder and upper arm

513

3813

1.35

9.63

1.6

1.5

1004.75

2133.66

e6/l

0.56

401

2987

Other eating disorders

479

2.04

9.62

1.4

1.8

388.04

8609.26

e6/l

0.53

378

Other specified/unspecified inflammatory spondylopathies

373

2.19

9.59

1.4

1.5

328.17

846.06

e6/l

0.51

292

Decubitus ulcer and pressure area

439

2.09

9.58

2.3

1.4

709.50

794.24

e6/l

0.07

355

Diseases of middle ear and mastoid

909

5940

1.26

9.54

1.6

1.4

856.96

1896.60

e6/l

0.87

738

4648

Scleritis and episcleritis

110

578

1.94

9.53

1.1

1.4

1352.64

1314.76

e6/l

0.01

451

Convergence insufficiency and excess

119

3.26

9.52

1.2

1.4

15.14

91.88

e6/l

1.50

Schizophrenia

248

1623

1.55

9.51

1.3

1.4

520.10

1125.93

e6/l

1.28

194

1285

Misadventures to patients during surgical and medical care

211

1332

1.60

9.48

1.7

1.4

709.58

1305.68

e6/l

0.91

161

1044

Other condition

231

1491

1.57

9.44

1.8

1.5

2669.08

3591.64

e6/l

0.12

204

1168

Chronic viral hepatitis

101

518

1.99

9.42

1.9

1.5

39517.05

910.99

e6/l

0.50

406

Intermittent heterotropia

116

622

1.90

9.41

1.6

2.4

868.91

1100.44

e6/l

0.11

473

Drug-induced polyneuropathy

3.94

9.38

13.3

1.9

154.82

177.93

e6/l

0.05

Mental retardation, excluding more controls

270

2.38

9.38

2.1

3.0

375.33

463.37

e6/l

0.10

199

Senile cataract

854

4112

1.27

9.37

1.4

1377.98

2150.16

e6/l

0.54

672

3246

Solid cancers, including Hilmo

1308

6312

1.21

9.37

1.5

1.4

1432.32

2003.52

e6/l

0.37

983

5021

Examination and encounter for administrative purposes

105

545

1.95

9.37

1.4

2420.58

1271.07

e6/l

0.32

425

Tubulo-interstitial nephritis, not specified as acute or chronic

104

539

1.96

9.35

1.6

1.5

34875.74

1094.80

e6/l

0.50

427

Early lumbar disc prolapse operation

185

1137

1.65

9.32

1.3

1.4

336.47

5077.91

e6/l

0.79

160

891

Cholecystectomy

1017

7025

1.23

9.23

1.4

3160.90

2022.79

e6/l

0.22

821

5532

Use of riluzole

7.69

9.23

1.0

1.3

134.36

231.05

e6/l

0.17

Postzoster neuralgia

116

3.23

9.21

1.3

64.07

1209.60

e6/l

0.57

Persistent delusional disorders

121

663

1.86

9.20

1.3

1.4

334.40

1352.28

e6/l

1.18

519

Benign neoplasm: Cranial nerves

247

2.47

9.19

1.8

1.3

1951.55

602.91

e6/l

0.35

191

Reactive arthropathies

135

765

1.79

9.17

1.3

1.4

228.63

1182.59

e6/l

2.31

114

605

Tinnitus

344

2420

1.43

9.16

1.3

1.4

533.56

2982.02

e6/l

0.89

271

1900

Sequelae of injuries of neck and trunk

242

2.47

9.08

1.8

1.6

1736.37

928.24

e6/l

0.37

182

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

298

2046

1.47

9.07

1.3

1.4

1442.66

3195.53

e6/l

0.40

229

1607

Other arrhythmias

992

6019

1.24

8.96

1.4

1.5

1362.59

2469.80

e6/l

0.75

802

4680

Emotional disorders starting during childhood or adolescence

101

523

1.95

8.91

3.1

2.2

324.28

7719.96

e6/l

0.48

389

Corneal ulcer

284

1939

1.48

8.90

1.4

13639.02

1050.18

e6/l

0.52

242

1524

Other specified and unspecified disorders of eye and adnexa

294

2.30

8.90

1.5

302.85

734.45

e6/l

0.43

228

Lesion of radial nerve

307

2.27

8.89

1.3

1.5

2536.51

1712.96

e6/l

0.17

231

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

440

3243

1.37

8.88

1.5

1.4

432.84

2604.73

e6/l

1.14

353

2535

Other specified/unspecified systemic involvement of connective tissue

503

1.97

8.78

1.5

241.69

1222.80

e6/l

0.97

389

Dialysis, with operation codes

189

1186

1.61

8.77

1.7

1.6

350.61

1167.64

e6/l

1.57

144

917

Insulin, fast-acting or short human

529

4015

1.33

8.72

1.6

1.5

1322.63

2803.42

e6/l

0.56

436

3169

Disorders of tooth development and eruption

249

1344

1.52

8.71

1.7

1.4

721.46

3482.86

e6/l

0.49

178

1059

Haemorrhage, not elsewhere classified

186

2.63

8.71

2.4

1.4

1683.31

878.72

e6/l

0.25

144

Reactive arthropathies, FINNGEN

114

625

1.85

8.68

1.3

1.5

201.67

1440.71

e6/l

1.71

494

Other disorders of the musculoskeletal system and connective tissue

216

1403

1.56

8.63

1.4

689.95

1217.65

e6/l

0.90

166

1113

Complications of genitourinary prosthetic devices, implants and grafts

200

2.58

8.59

1.5

159.95

158.89

e6/l

0.00

160

Specific development disorders of scholastic skills

490

1.96

8.58

2.9

2.5

191.87

8914.99

e6/l

0.54

360

Personal history of risk-factors, not elsewhere classified

116

3.15

8.57

2.1

1.6

1947.21

164.43

e6/l

0.48

Childhood asthma (age<16)

194

954

1.60

8.51

1.5

1.4

670.72

4723.05

e6/l

0.48

153

714

Gonarthrosis [arthrosis of knee](FG)

1064

5018

1.22

8.51

1.5

1.4

1749.98

2026.77

e6/l

0.13

847

3955

Fracture of lower leg, including ankle

815

6430

1.25

8.49

1.4

1.5

1217.32

2447.60

e6/l

0.88

629

5074

Chondrocostal junction syndrome [Tietze]

320

2.21

8.47

1.4

1.6

217.55

435.71

e6/l

0.39

249

Other and unspecified urticaria

306

2142

1.44

8.44

1.7

1.6

1027.52

3142.62

e6/l

0.58

254

1665

Infections with a predominantly sexual mode of transmission

486

3658

1.34

8.43

1.5

1.4

2408.97

1998.74

e6/l

0.10

363

2883

Causalgia

128

3.01

8.42

1.3

1.6

638.06

988.00

e6/l

0.13

Striking against or struck by other objects

524

3990

1.32

8.40

1.4

1.6

761.26

2186.24

e6/l

0.82

400

3123

Other inflammation of eyelid

213

1389

1.55

8.37

1.7

1.5

206.15

1252.84

e6/l

3.31

156

1078

Childhood asthma (age<16), excluding more controls

193

952

1.60

8.36

1.5

1.4

675.09

4729.27

e6/l

0.48

152

713

Fracture at wrist and hand level

526

4003

1.32

8.36

1.4

1.5

963.93

2174.86

e6/l

0.65

414

3153

Other female pelvic inflammatory diseases

235

1566

1.52

8.36

1.4

1032.75

3963.98

e6/l

0.62

190

1229

Disease of hard tissues of teeth, NOS

733

3019

1.28

8.33

1.5

1435.54

2935.60

e6/l

0.51

569

2413

Superficial injury of thorax

220

1447

1.54

8.31

1.3

1.5

1402.45

3566.47

e6/l

0.37

163

1146

Endometriosis of pelvic peritoneum

248

1517

1.50

8.29

1.3

1.4

763.47

1601.00

e6/l

0.61

186

1200

Other/unspecified enthesopathies of lower limb, excluding foot

108

591

1.85

8.28

1.3

1.6

1853.51

1038.80

e6/l

0.32

459

False labour

484

2248

1.35

8.27

1.3

1.4

544.91

2785.96

e6/l

0.71

388

1741

Impotence

417

2.03

8.23

1.5

1.4

2230.23

701.04

e6/l

0.58

332

Use of amantadine

130

2.96

8.20

1.2

68.65

138.06

e6/l

0.52

Other and unspecified mononeuropathies, also in other diseases

223

2.44

8.18

1.4

1.5

2137.13

1042.49

e6/l

0.22

166

Suppurative and unspecified otitis media

573

3925

1.30

8.15

1.9

1.4

749.38

2054.46

e6/l

0.70

465

3056

SLE, ICD10

287

2.25

8.11

1.4

1.5

1283.62

189.79

e6/l

0.55

220

SLE, strict definition

287

2.25

8.11

1.4

1.5

1283.62

189.79

e6/l

0.55

220

Systemic lupus erythematosus

300

2.22

8.10

1.4

1.5

1239.00

419.86

e6/l

0.38

234

Myositis

194

2.55

8.08

1.4

153.76

290.46

e6/l

0.71

155

Diabetic retinopathy, excluding more controls

336

1326

1.43

8.08

1.6

1.4

1905.94

987.01

e6/l

0.32

271

1044

Atrial fibrillation and flutter

380

1774

1.39

8.07

1.4

1.3

993.14

684.67

e6/l

0.42

299

1369

Other coagulation defects

122

699

1.77

8.06

1.7

1.5

1526.61

1244.86

e6/l

0.10

556

Diabetes medication

1596

7969

1.17

8.04

1.5

1320.91

1909.17

e6/l

0.47

1263

6248

Mental and behavioural disorders due to use of other stimulants, including caffeine

282

2.26

8.03

1.5

1.7

73880.15

1111.35

e6/l

0.50

224

Cholelithiasis, broad definition with cholecystitis

1262

7054

1.19

8.02

1.4

2741.03

2073.19

e6/l

0.15

1010

5572

Intentional self-harm by unspecified means

105

3.17

7.99

1.4

1.3

550.64

105.62

e6/l

0.63

Injuries to the elbow and forearm

1081

7703

1.21

7.96

1.4

1.5

1016.38

2291.54

e6/l

1.07

845

6039

Motor disorders, excluding more controls

123

2.93

7.96

2.4

4.8

33.50

271.44

e6/l

0.72

Cellulitis

329

2358

1.41

7.96

1.8

1.5

2917.23

2779.28

e6/l

0.02

265

1839

Metatarsalgia

141

844

1.69

7.93

1.3

1.5

1365.24

884.07

e6/l

0.24

109

657

Lateral epicondylitis

188

1210

1.57

7.86

1.3

1.4

2903.74

1094.58

e6/l

0.63

159

955

Meniscus derangement

771

4100

1.25

7.85

1.4

1.5

885.77

2792.14

e6/l

1.06

612

3214

Episcleritis

502

1.91

7.85

1.2

1.5

1541.51

1334.29

e6/l

0.05

390

Ischemic heart diseases

1204

6000

1.20

7.83

1.4

1.6

2192.65

1889.00

e6/l

0.15

1023

4617

Amblyopia ex anopsia

371

2.07

7.82

1.7

2.4

1962.48

705.65

e6/l

0.57

282

Impingement syndrome of shoulder

311

2215

1.42

7.80

1.6

1.4

2849.74

1624.62

e6/l

0.59

268

1744

Vascular dementia (undefined)

148

2.71

7.79

1.4

1.3

64.13

1360.36

e6/l

0.83

118

Use of biperiden

468

1.94

7.79

1.4

1.5

708.18

1847.37

e6/l

0.77

363

Viral pneumonia (unknown virus, not influenza)

114

648

1.79

7.77

1.6

1.5

834.49

1200.03

e6/l

0.26

503

Renal failure

608

4063

1.28

7.70

1.5

1431.61

1951.15

e6/l

0.24

486

3251

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

845

6606

1.23

7.65

1.5

559.80

2032.62

e6/l

1.72

626

5187

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

453

3438

1.33

7.59

1.4

1.5

2637.06

2394.05

e6/l

0.05

349

2698

Other specified/unspecified dorsopathies

256

2.28

7.59

1.3

1.6

510.91

533.90

e6/l

0.02

198

Tobacco use

508

1.89

7.58

1.4

328.25

1092.45

e6/l

0.89

397

Gout

339

2105

1.39

7.58

1.6

1.4

1000.44

2413.42

e6/l

0.64

258

1692

Procreative management

531

3380

1.30

7.57

1.6

521.23

2420.56

e6/l

0.97

391

2600

Other diseases of oesophagus

129

764

1.71

7.56

1.4

1.5

17820.79

1233.17

e6/l

0.48

103

599

Acute myeloid leukaemia, helper endpoint

3.25

7.53

2.7

1.3

35.37

1440.53

e6/l

0.67

Acute myeloid leukaemia, including Hilmo

3.25

7.53

2.7

1.3

35.38

1440.53

e6/l

0.67

Acute myeloid leukaemia

3.25

7.53

2.7

1.3

35.37

1440.53

e6/l

0.67

Glomerular diseases

248

1708

1.47

7.52

1.5

11019.33

3404.92

e6/l

0.38

196

1332

Acute myeloid leukaemia and myelodysplastic syndromes

177

2.56

7.51

2.2

1.3

132.23

839.29

e6/l

0.63

152

Necrosis of pulp, including avohilmo

908

7397

1.22

7.49

1.4

1.5

1943.82

2224.37

e6/l

0.11

715

5802

Dermatographic urticaria

115

663

1.76

7.48

1.4

1.5

377.99

1503.05

e6/l

1.39

527

Disorder of lipoprotein metabolism, unspecified

159

996

1.61

7.48

1.3

1.4

687.45

1089.87

e6/l

0.40

113

807

Early onset COPD, excluding more controls

240

1641

1.47

7.48

1.5

1.4

1466.79

1652.03

e6/l

0.10

196

1291

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

115

2.99

7.46

1.3

1.5

191.79

126.77

e6/l

0.19

Thyroiditis, ILD-related definition

168

1068

1.59

7.45

1.4

1.5

1091.93

4944.78

e6/l

0.52

139

822

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

304

2.15

7.45

1.4

1.7

91.50

876.22

e6/l

1.02

236

Other symptoms and signs involving the digestive system and abdomen

224

1515

1.49

7.44

1.6

1.5

3183.48

1495.02

e6/l

0.26

186

1165

Acute mastoiditis

3.78

7.43

1.2

1.6

6220.86

119.67

e6/l

0.47

Otalgia

140

853

1.67

7.41

2.1

1.8

801.10

1185.99

e6/l

0.38

112

659

Sequelae of other external causes

526

1.86

7.41

1.7

1.5

934.93

1138.66

e6/l

0.12

416

Poisoning by narcotics and psychodysleptics [hallucinogens]

132

2.83

7.40

2.8

1.4

119147.20

1335.51

e6/l

0.48

100

Behavioural disorders

203

2.44

7.39

1.3

1.9

78304.24

510.83

e6/l

0.49

160

Diabetes mellitus

1564

7770

1.17

7.31

1.5

1325.32

1944.54

e6/l

0.49

1241

6092

Noninfectious colitis NAS

206

1376

1.51

7.31

1.5

1.7

122.15

3823.06

e6/l

0.74

164

1073

Glaucoma

725

4964

1.25

7.29

1.5

1.4

1362.88

2119.80

e6/l

0.57

593

3931

Fitting and adjustment of other devices

445

2976

1.32

7.28

1.8

1.4

2646.18

1999.94

e6/l

0.17

404

2343

Infection of intervertebral disc (pyogenic)

3.17

7.27

1.6

1.3

41.75

263.32

e6/l

0.69

Anogenital herpesviral [herpes simplex] infection, including avohilmo

186

1218

1.55

7.26

1.4

2083.19

4727.40

e6/l

0.35

141

952

Cholecystitis

181

1177

1.55

7.25

1.4

827.51

1221.35

e6/l

0.25

146

932

Cholelithiasis

1203

6937

1.19

7.23

1.4

2859.41

2093.74

e6/l

0.16

966

5480

Congenital iodine-deficiency syndrome/hypothyroidism

205

2.40

7.20

1.7

1.9

253.38

1621.15

e6/l

0.53

157

360

2.02

7.19

1.4

1.3

662.64

1084.28

e6/l

0.20

297

Viral pneumonia (known virus, not influenza)

237

2.30

7.18

1.8

2.1

100.68

166.83

e6/l

0.46

183

Hyperfunction of pituitary gland

446

1.92

7.17

1.4

1.6

943.27

1288.04

e6/l

0.12

345

Superficial injury of shoulder and upper arm

185

1214

1.54

7.15

1.4

1.5

532.20

4051.78

e6/l

0.58

145

952

Tonsillectomy and adenotomy

907

5207

1.22

7.13

1.4

1.5

746.57

2008.71

e6/l

0.94

715

4038

Solid cancers

1240

6155

1.18

7.11

1.5

1.4

1435.57

2042.97

e6/l

0.39

929

4901

Other neurotic disorders

343

2.05

7.11

1.4

1.5

55.38

971.85

e6/l

1.49

267

Other/unspecified soft tissue disorders related to use, overuse and pressure

219

2.34

7.09

1.3

1.4

1476.38

335.91

e6/l

0.39

176

Orchitis and epididymitis

123

733

1.70

7.08

1.7

1.6

5861.34

846.29

e6/l

0.51

105

587

Abnormal serum enzyme levels

388

2810

1.34

7.02

1.4

1.5

419.21

1479.35

e6/l

3.47

293

2263

Other hearing loss

343

2448

1.37

7.00

1.4

1156.82

2326.07

e6/l

0.55

284

1948

Haemorrhage in early pregnancy

407

2992

1.33

6.97

1.3

1.4

668.99

2588.96

e6/l

0.83

340

2318

Allergic conjunctivitis

879

7000

1.21

6.97

1.5

542.33

1929.87

e6/l

1.72

653

5499

Carrier of infectious disease

196

2.41

6.97

1.4

1.6

1130.05

112.84

e6/l

0.73

155

Urolithiasis

420

3195

1.32

6.96

1.5

1.4

2124.35

3115.94

e6/l

0.28

341

2535

Acute suppurative otitis media

425

3015

1.32

6.95

2.1

1.5

801.99

2371.27

e6/l

0.63

342

2350

Other retinal disorders

860

5382

1.22

6.95

1.6

1.5

1203.06

2587.30

e6/l

0.80

668

4302

Unspecified misadventure during surgical and medical care

502

1.85

6.91

1.8

1.5

204.97

1477.23

e6/l

1.41

394

Other and unspecified erythematous conditions

267

2.19

6.90

1.4

1.8

1051.40

632.37

e6/l

0.15

205

Disorder of the sleep-wake schedule

161

2.57

6.87

1.4

2.4

407.48

1273.17

e6/l

0.50

127

Other fall from one level to another

337

2487

1.36

6.86

1.9

1.6

1138.42

2557.43

e6/l

0.42

279

1931

Conduct disorder

204

2.37

6.85

1.3

2.0

80392.46

503.56

e6/l

0.49

158

Diabetes, varying definitions

1551

7774

1.16

6.84

1.5

1337.74

1942.11

e6/l

0.47

1230

6095

Diseases of peritoneum

142

887

1.62

6.83

1.5

238.46

1194.40

e6/l

1.86

111

700

Benign neoplasm of colon, rectum, anus and anal canal

841

5865

1.22

6.81

1.4

4025.38

1689.52

e6/l

0.41

657

4669

Malignant neoplasm of digestive organs

288

3033

0.72

6.80

1.4

2046.10

1557.12

e6/l

0.17

222

2447

Other erythematous conditions

302

2.10

6.79

1.4

1.8

954.91

556.58

e6/l

0.16

240

Type 1 diabetes

368

2755

1.34

6.77

1.6

1883.65

2708.06

e6/l

0.19

305

2182

Chronic iridocyclitis

456

1.88

6.73

1.4

1.5

899.25

1270.29

e6/l

0.23

357

Event of undetermined intent

109

639

1.73

6.73

1.6

862.04

1308.02

e6/l

0.28

495

Type 2 diabetes

1468

7326

1.16

6.73

1.5

1.4

1352.50

2022.32

e6/l

0.50

1160

5748

Chronic periodontitis, including avohilmo

1474

8119

1.16

6.73

1.4

1824.88

2074.21

e6/l

0.13

1135

6449

Other diseases of pleura

564

3880

1.27

6.72

1.6

1.5

4585.77

1390.88

e6/l

0.39

451

3094

Other enthesopathy of foot (+metatarsalgia)

149

945

1.59

6.72

1.3

1.5

1319.03

1071.26

e6/l

0.11

113

735

Crohn disease

201

1361

1.49

6.72

1.5

1.6

923.22

3878.62

e6/l

0.53

156

1061

Disorders of parathyroid gland

249

1733

1.43

6.71

1.4

743.06

1396.89

e6/l

0.89

188

1368

Other abnormal immunological findings in serum

175

2.47

6.71

1.1

1.9

446.65

199.45

e6/l

0.34

136

Iridocyclitis in diseases classified elsewhere

163

2.54

6.71

1.6

1.7

1719.36

837.56

e6/l

0.22

128

Neovascular glaucoma

310

2.07

6.70

1.8

1.4

174.14

679.73

e6/l

0.74

244

Dipeptidyl peptidase 4 (DPP-4) inhibitors

717

4568

1.24

6.69

1.5

1.4

1186.88

1545.05

e6/l

0.48

581

3629

Other and unspecified syphilis, including avohilmo

6.76

6.68

1.1

1.2

65.11

376.33

e6/l

—

Myocarditis

337

2.02

6.68

1.8

1.4

218.37

1039.36

e6/l

0.85

260

Periodontitis

1475

8124

1.16

6.64

1.4

1820.05

2073.63

e6/l

0.13

1138

6451

Inflammatory diseases of prostate (prostatitis)

160

1035

1.56

6.62

1.5

1.4

762.99

1090.71

e6/l

0.27

129

828

Paralytic ileus

278

2.13

6.62

1.4

1.6

140.41

934.88

e6/l

0.98

221

Candidiasis

210

1440

1.47

6.59

1.6

1.4

399.83

3945.25

e6/l

0.72

172

1104

Other ill-defined and unspecified causes of mortality

112

665

1.70

6.57

1.4

796.90

842.92

e6/l

0.04

107

526

Hernia

1369

7829

1.16

6.56

1.4

1.5

1186.82

1978.12

e6/l

0.75

1073

6189

Molar incisor enamel hypoplasia, with caries

101

3.03

6.56

11.2

2.6

503.05

336.51

e6/l

0.14

Heart failure and antihypertensive medication

305

1435

1.39

6.56

1.5

926.05

1649.21

e6/l

0.71

252

1116

Nonsuppurative otitis media, including avohilmo

494

3340

1.29

6.55

1.6

1.5

736.85

2331.00

e6/l

0.74

385

2589

Other specified/unspecified hearing loss

125

765

1.65

6.55

1.3

1.5

522.33

1261.67

e6/l

1.00

100

603

Drug-induced headache, not elsewhere classified

3.99

6.52

1.3

1.2

336.85

188.80

e6/l

0.21

Ulcer of vagina/vulva

254

2.18

6.51

1.1

1.6

914.20

218.53

e6/l

0.41

199

Vitreous haemorrhage

144

914

1.59

6.51

1.6

1.5

1631.83

907.58

e6/l

0.40

116

726

Injury of eye and orbit

206

1411

1.47

6.50

1.4

1.5

20093.04

825.60

e6/l

0.54

163

1123

Osteonecrosis

549

1.78

6.48

1.9

1.4

774.92

956.43

e6/l

0.15

425

Rheumatoid arthritis

418

2837

1.31

6.47

1.3

1.4

874.59

3668.15

e6/l

1.03

329

2220

Other and unspecified mononeuropathies of upper limb

235

2.22

6.45

1.6

1.4

52.47

947.28

e6/l

0.87

173

Dislocation, sprain and strain of joints and ligaments of thorax

295

2.08

6.43

1.4

1.5

89.33

383.19

e6/l

0.59

232

Toxic effect of other and unspecified substances

108

2.89

6.43

1.5

22.09

134.63

e6/l

1.06

Disorders in reading

173

2.46

6.42

4.7

2.6

196.03

189.11

e6/l

0.02

124

Testicular dysfunction

357

1.97

6.41

1.4

1.5

172.95

1052.45

e6/l

1.01

269

Other keratitis

173

1148

1.52

6.41

1.5

419.28

1190.27

e6/l

1.48

126

892

Calculus of kidney and ureter

390

2975

1.32

6.39

1.5

1.4

2166.30

3202.67

e6/l

0.27

320

2364

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

149

2.57

6.39

4.9

2.7

85.41

871.76

e6/l

0.56

123

Neuralgic amyotrophy

7.87

6.38

1.2

343.44

162.50

e6/l

—

Fentanyl

122

745

1.65

6.37

1.4

1.5

581.94

1168.84

e6/l

0.64

591

Cerebral atherosclerosis

3.18

6.36

1.6

1.2

53.00

1482.68

e6/l

0.54

Scleritis

109

2.86

6.33

1.1

1.2

77.43

139.56

e6/l

0.40

Meralgia paraesthetica

291

2.07

6.28

1.3

1.5

2008.80

1716.50

e6/l

0.06

222

Polyarthrosis

262

1694

1.40

6.28

1.5

1245.60

1354.38

e6/l

0.06

219

1331

Other peripheral vascular diseases

120

736

1.65

6.26

1.2

1.5

2401.80

1357.35

e6/l

0.28

579

Superficial injury of forearm

162

1066

1.54

6.26

1.4

1.7

966.94

4631.03

e6/l

0.51

132

833

Eating disorders

173

1153

1.52

6.24

1.3

1.6

252.36

4269.86

e6/l

0.64

141

894

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

333

2.00

6.24

1.4

1.7

284.25

1167.78

e6/l

0.74

260

Chondropathies

225

1581

1.44

6.23

1.6

1.5

840.75

3453.06

e6/l

0.55

176

1238

Glaucoma secondary to other eye disorders

319

2.01

6.23

1.8

1.4

174.14

677.17

e6/l

0.74

245

Hypercalcemia

375

1.93

6.23

1.3

1.5

138.21

852.10

e6/l

1.21

292

Medical abortion

900

4058

1.21

6.22

1.4

1185.13

1957.79

e6/l

0.35

691

3169

Spasmodic torticollis

272

2.11

6.22

1.3

1.5

98.67

1109.66

e6/l

1.19

205

Redundant prepuce, phimosis and paraphimosis

275

1967

1.39

6.21

1.4

1.6

1443.39

927.19

e6/l

0.40

218

1558

Orthopaedic devices associated with adverse incidents

156

0.00

6.21

0.0

1.2

—

929.58

—

124

Other diseases of intestine

208

1441

1.46

6.20

1.5

1.4

677.24

1430.50

e6/l

0.98

154

1137

Disorders of pituitary gland, other and/or unspecified

3.83

6.19

1.5

1.4

8.69

20.64

e6/l

0.63

Toxic effects of substances chiefly nonmedicinal as to source

177

1191

1.50

6.16

1.3

1.6

20524.06

1032.87

e6/l

0.48

147

924

Other (not insulin) diabetes medications

1433

7291

1.16

6.15

1.4

1054.85

2022.29

e6/l

0.97

1133

5728

Testicular hypofunction

321

2.00

6.14

1.4

1.5

187.40

1119.87

e6/l

0.92

237

Hypogonadotropic hypogonadism

260

2.12

6.14

1.4

1.5

740.36

1718.08

e6/l

0.51

196

Other disorders of patella

245

1752

1.41

6.13

1.2

1.4

1172.20

3473.62

e6/l

0.52

201

1369

Pyogenic arthritis

521

1.77

6.12

1.4

1.5

184.23

760.41

e6/l

1.50

416

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

250

1794

1.41

6.12

1.8

1.6

1404.97

3281.05

e6/l

0.41

189

1402

Care involving dialysis

105

626

1.70

6.11

1.6

1.7

525.54

1022.73

e6/l

0.52

478

Arthropathies in other diseases classified elsewhere

294

2.05

6.11

1.9

1.5

882.40

675.38

e6/l

0.13

241

Vasomotor and allergic rhinitis

562

4409

1.25

6.09

1.4

1.5

541.02

2188.76

e6/l

1.16

463

3415

Benign neoplasm of other and ill-defined parts of digestive system

229

1622

1.42

6.06

1.4

1262.42

1291.59

e6/l

0.01

193

1281

Pregnancy examination and test

251

1106

1.42

6.05

1.3

1512.13

4631.64

e6/l

0.41

202

855

Systemic lupus erythematosus, unspecified

255

2.13

6.05

1.3

1.5

1511.73

195.89

e6/l

0.56

193

Ankylosing spondylitis

115

704

1.65

6.05

1.5

5671.75

888.48

e6/l

0.46

101

545

Excessive attrition of teeth

930

7770

1.19

6.04

1.4

1.5

2102.64

2105.10

e6/l

0.00

714

6090

Collagenous colitis

137

876

1.58

6.04

1.5

795.64

1259.32

e6/l

0.37

116

691

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

226

1598

1.43

6.04

1.8

1.6

1467.66

3477.16

e6/l

0.39

168

1248

Pedestrian injured in transport accident

107

644

1.69

6.03

1.2

1.5

577.89

1358.64

e6/l

0.74

502

Acute lymphadenitis

539

1.75

6.03

2.0

1.6

368.73

1323.34

e6/l

0.83

420

Fibroblastic disorders

273

1994

1.38

6.00

1.4

1204.04

2497.23

e6/l

0.50

215

1589

Other diseases of liver

257

1861

1.39

5.99

1.5

1.4

2304.59

1246.86

e6/l

0.26

197

1469

Diseases of tongue

495

1.78

5.99

1.5

1.4

649.06

8285.89

e6/l

0.51

396

Car occupant injured in other and unspecified transport accidents

279

2051

1.37

5.93

1.4

825.86

3075.59

e6/l

0.62

224

1611

Retinal detachments and breaks

446

3501

1.28

5.90

1.5

1.4

976.36

2093.47

e6/l

0.89

340

2795

Other embolism and thrombosis

171

1154

1.50

5.87

1.4

815.34

1059.78

e6/l

0.16

134

910

Glomerulonephritis

140

906

1.56

5.87

1.6

17102.39

1210.02

e6/l

0.47

105

713

Vestibular neuronitis

126

796

1.60

5.86

1.3

1.4

266.92

1479.48

e6/l

1.99

106

623

Eating disorder

147

960

1.55

5.86

1.3

1.6

285.74

4751.05

e6/l

0.58

121

746

Other cataract

580

3475

1.25

5.86

1.5

1.4

474.31

1875.28

e6/l

1.46

468

2738

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

3.41

5.85

1.5

1.3

32.79

1786.29

e6/l

0.56

Mixed disorders of conduct and emotions, excluding more controls

180

2.33

5.85

1.3

2.1

96936.97

117.25

e6/l

0.50

138

Open wound of wrist and hand

663

5258

1.22

5.84

1.3

1.5

641.93

2418.58

e6/l

1.33

497

4150

Menorrhagia

466

2032

1.29

5.84

1.4

3025.17

1445.48

e6/l

0.46

364

1608

Use of disulfiram, acamprosate or naltrexone

136

876

1.57

5.83

1.4

552.65

1370.39

e6/l

1.02

104

687

Dermatitis due to substances taken internally

493

1.77

5.81

1.7

1.6

2728.51

1256.21

e6/l

0.23

382

Other and unspecified intracranial injuries

206

2.23

5.81

3.3

1.4

489.78

1131.34

e6/l

0.41

159

Injury of nerves and spinal cord at neck level

181

2.33

5.80

1.5

1.3

902.19

746.02

e6/l

0.08

140

Astigmatism

106

643

1.67

5.80

2.5

2.1

6195.36

1052.94

e6/l

0.42

496

Any event in hilmo or specialist outpatient

+∞

5.77

2.3

0.0

74.29

—

e6/l

—

Vertical strabismus

301

2.00

5.76

2.2

1.7

1000.42

791.85

e6/l

0.11

233

Artrosis, including avohilmo

1228

5790

1.16

5.75

1.4

2186.97

2364.68

e6/l

0.06

970

4548

Follicular lymphoma, hilmo

322

1.96

5.74

1.7

1.3

148.40

580.73

e6/l

0.58

245

Ill-defined and unknown causes of mortality

116

722

1.62

5.73

1.4

769.64

913.33

e6/l

0.15

111

569

Sulfasalazine

384

2971

1.30

5.72

1.4

2685.35

2817.23

e6/l

0.02

313

2318

Other and unspecified coagulation defects

481

1.78

5.71

1.5

291.06

1378.78

e6/l

1.06

382

Budesonide

201

1410

1.44

5.66

1.6

1.3

1128.59

3786.07

e6/l

0.48

158

1097

Abnormal findings on diagnostic imaging of lung

595

4590

1.23

5.65

1.4

5099.80

1443.68

e6/l

0.46

470

3665

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1382

7139

1.15

5.63

1.5

1469.75

2055.54

e6/l

0.40

1110

5606

Sicca syndrome [Sjögren]

120

758

1.60

5.61

1.5

1.4

131.39

1410.41

e6/l

2.50

591

Other diseases of anus and rectum

392

3037

1.29

5.60

1.4

1.5

2926.29

2775.24

e6/l

0.02

307

2418

Injury of muscle and tendon at shoulder and upper arm level

471

3749

1.26

5.59

1.3

1.4

688.37

1978.23

e6/l

1.31

389

2971

Gout, FINNGEN

339

2570

1.32

5.58

1.6

1.4

1000.44

2359.07

e6/l

0.74

258

2061

Other and unspecified disorders of adult personality and behaviour

3.55

5.58

1.5

1.4

571.11

25.69

e6/l

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

250

2.09

5.57

8.3

1.6

197.54

1184.02

e6/l

0.69

197

Glaucoma suspect

456

3616

1.27

5.55

1.4

1197.84

1780.04

e6/l

0.31

382

2852

Other disorders involving the immune mechanism, not elsewhere classified

271

2.04

5.54

7.9

1.6

181.97

1379.57

e6/l

0.93

214

Benign neoplasm: Colon

695

5408

1.21

5.52

1.5

1.4

4793.54

1673.21

e6/l

0.47

547

4313

Disorders of synovium and tendon in diseases classified elsewhere

141

2.47

5.52

1.4

1.3

187.67

202.67

e6/l

0.05

109

Nonsuppurative otitis media

350

2330

1.31

5.46

1.8

1.5

748.66

2655.67

e6/l

0.60

284

1810

Effects of other external causes

273

2.02

5.43

1.2

1.6

67.38

1605.01

e6/l

1.28

210

Gastric ulcer

208

1480

1.42

5.40

1.4

1516.16

1503.01

e6/l

0.01

171

1182

Poisoning by medicine, drug-induced

113

2.66

5.40

1.2

1.3

1.74

121.51

e6/l

1.31

Hypoplasia of dental enamel

119

2.66

5.40

10.7

4.4

525.35

537.91

e6/l

0.01

Respiratory insufficiency

524

1.71

5.40

1.7

1.4

832.65

1346.71

e6/l

0.34

405

Other and unspecified iridocyclitis

438

1.79

5.38

1.3

1.6

441.09

1256.99

e6/l

0.87

342

Abnormal results of function studies

130

845

1.56

5.38

1.4

1.6

174.26

1280.31

e6/l

2.05

105

666

Other and unspecified injuries of lower leg

122

783

1.58

5.35

1.3

1.6

1443.82

5684.50

e6/l

0.40

102

611

Vitamin D deficiency

175

2.29

5.35

1.2

1.5

135.73

168.51

e6/l

0.12

133

Fracture of femur

299

2031

1.33

5.33

1.5

871.98

1254.89

e6/l

0.62

244

1614

Otitis media, unspecified

181

1159

1.45

5.32

2.0

1.6

253.23

4396.65

e6/l

0.66

145

885

Ganglion

283

2123

1.34

5.31

1.4

5529.66

3288.56

e6/l

0.30

229

1663

Gastroduodenal ulcer

296

2229

1.33

5.27

1.4

1.5

1213.05

1647.85

e6/l

0.32

238

1779

Arthropod-borne viral fevers and viral haemorrhagic fevers

133

874

1.54

5.25

1.5

1.4

1538.88

1312.17

e6/l

0.11

118

688

Acute laryngitis and tracheitis

180

1237

1.44

5.22

2.2

1.5

175.34

4033.20

e6/l

0.65

143

939

Other local infections of skin and subcutaneous tissue

150

1012

1.50

5.22

2.6

1.6

3261.22

1169.89

e6/l

0.33

121

795

Other and unspecified local infections of skin and subcutaneous tissue

142

948

1.51

5.21

2.6

1.6

3425.87

1150.38

e6/l

0.34

115

748

Nail disorders

128

836

1.55

5.21

1.5

3803.95

1349.93

e6/l

0.34

107

636

Injury of muscle and tendon at wrist and hand level

191

1350

1.43

5.20

1.4

1.5

4203.03

1147.07

e6/l

0.44

154

1071

Overexertion and strenuous or repetitive movements

148

997

1.50

5.20

1.5

1.4

1329.80

1089.20

e6/l

0.15

104

790

Myopia

196

1392

1.42

5.20

1.5

1.6

21600.78

880.65

e6/l

0.58

162

1077

Other disorders of white blood cells

480

1.74

5.20

2.8

1.6

575.69

656.61

e6/l

0.08

373

Biomechanical lesions, not elsewhere classified

443

1.77

5.19

1.4

1.5

690.19

790.02

e6/l

0.08

353

Cerebral palsy

152

2.37

5.19

2.7

2.1

911.20

140.18

e6/l

0.48

108

Familial hypercholesterolemia

163

1119

1.47

5.17

1.4

1253.79

907.58

e6/l

0.19

141

907

Other/unspecified reactive arthropathies

100

618

1.64

5.16

1.3

1.5

179.41

1177.29

e6/l

1.34

488

Vascular dementia (other)

5.40

5.15

1.4

1.2

3.43

98.68

e6/l

—

Other maltreatment syndromes

300

1.94

5.13

1.4

287.97

1454.10

e6/l

0.95

231

Calcific tendinitis of shoulder

489

1.72

5.13

1.6

1.4

638.07

509.09

e6/l

0.10

382

Kidney transplant status

505

1.71

5.12

1.5

1.8

5884.58

1036.23

e6/l

0.43

378

Continuous positive airway pressure

207

1233

1.41

5.12

1.8

1.6

3595.45

1153.23

e6/l

0.38

169

942

Disorders of breast

697

5125

1.20

5.11

1.4

731.90

2286.74

e6/l

1.21

546

4015

Vertigo of central origin

116

2.57

5.11

1.2

285.45

1135.48

e6/l

0.39

Viral haemorrhagic fevers, not elsewhere classified/unspecified

113

721

1.59

5.11

1.5

1.4

1626.42

1341.49

e6/l

0.12

100

569

Perineal laceration during delivery

146

1724

0.68

5.08

1.4

1.3

557.49

3198.63

e6/l

0.61

115

1341

Anogenital herpesviral [herpes simplex] infection

103

645

1.62

5.05

1.4

1.5

2506.81

7101.92

e6/l

0.32

499

Raynaud syndrome

133

883

1.52

5.03

1.4

2391.92

1156.23

e6/l

0.39

103

691

Other congenital malformations of skin

374

1.82

5.02

1.8

2.0

2811.72

1465.61

e6/l

0.23

282

Acute generalized exanthematous pustulosis

396

1.80

5.01

1.7

3407.88

1363.61

e6/l

0.26

309

Thyrotoxicosis, other and/or unspecified

274

2067

1.33

4.98

1.6

1.4

1205.69

2928.84

e6/l

0.42

219

1608

Percutaneous Coronary Intervention

1090

5733

1.16

4.98

1.4

1.6

2131.81

1939.47

e6/l

0.09

943

4409

Anosmia

2.73

4.98

1.8

1.2

308.60

1239.30

e6/l

0.54

Marginal zone B-cell lymphoma, including Hilmo

130

2.46

4.97

1.6

1.3

69857.40

1155.98

e6/l

0.48

103

Other diseases of blood and blood-forming organs

594

1.64

4.94

1.4

657.79

1604.47

e6/l

0.63

459

Ingrowing nail

495

1.70

4.93

1.7

1.6

5408.14

1104.85

e6/l

0.43

379

Dislocation, sprain and strain of joints and ligaments of knee

915

7099

1.17

4.91

1.3

1.5

1560.49

2242.17

e6/l

0.30

713

5573

Extracorporeal dialysis

511

1.69

4.90

1.6

469.35

1055.55

e6/l

0.53

398

Other abnormal findings of blood chemistry

436

1.75

4.90

1.5

1.4

185.07

1388.09

e6/l

1.08

342

Divergent concomitant strabismus

110

705

1.58

4.89

1.7

1.6

1843.94

1189.98

e6/l

0.30

550

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

177

1242

1.43

4.89

1.8

2.0

599.86

4226.91

e6/l

0.61

140

960

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

116

1756

0.66

4.88

1.3

1.4

925.58

1549.77

e6/l

0.58

1416

Postmenopausal osteoporosis with pathological fracture

466

1.72

4.88

1.4

1.3

2188.85

1029.61

e6/l

0.25

367

Coronary revascularization (ANGIO or CABG)

1090

5736

1.16

4.88

1.4

1.6

2135.76

1941.57

e6/l

0.09

941

4412

Amyloidosis

169

2.24

4.87

1.4

2840.64

877.03

e6/l

0.56

137

Other inflammation of eyelid, including avohilmo

661

5533

1.20

4.87

1.5

581.87

2229.78

e6/l

1.53

489

4343

Other congenital malformations

139

938

1.50

4.86

1.6

2.1

1505.36

5273.46

e6/l

0.42

106

716

Discitis, unspecified

119

2.50

4.86

1.3

1.5

87.36

217.21

e6/l

0.41

Dissection of cerebral arteries, nonruptured

3.30

4.85

1.6

1.2

1589.77

186.71

e6/l

0.41

Methotrexate

182

1293

1.42

4.84

1.3

1.4

431.58

4061.12

e6/l

0.67

146

1014

Periapical abscess

666

5583

1.20

4.84

1.5

931.09

2622.14

e6/l

1.27

519

4395

Other specified/unspecified soft tissue disorders

349

1.83

4.83

1.5

1.4

83.69

351.65

e6/l

1.08

273

Car occupant injured in noncollision transport accident

321

1.87

4.81

1.2

1.4

1508.16

1105.33

e6/l

0.11

249

Complications of internal orthopaedic prosthetic devices, implants and grafts

263

1983

1.33

4.81

1.5

1.4

902.88

1256.27

e6/l

0.42

213

1565

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.06

4.80

1.2

1.6

31.43

192.28

e6/l

0.87

Bulimia nervosa (incl. atypical)

307

1.89

4.80

1.2

1.7

680.44

13232.21

e6/l

0.52

243

Fracture of neck

507

1.68

4.78

1.4

1929.28

870.03

e6/l

0.38

403

Acidosis

171

2.22

4.75

1.2

2.0

75.74

904.68

e6/l

0.66

132

Adenomyosis (Endometriosis of uterus)

183

1304

1.41

4.75

1.5

1.4

549.60

1812.20

e6/l

0.94

139

1031

Malignant neoplasm of digestive organs, including Hilmo

347

3243

0.78

4.73

1.4

1700.92

1512.68

e6/l

0.07

271

2615

Previous suicide attempt

103

2.62

4.72

1.3

1.6

19.67

185.41

e6/l

1.33

Biguanides

1373

7312

1.14

4.72

1.4

1088.24

2075.47

e6/l

0.99

1081

5752

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

309

1.88

4.71

1.4

1.5

3198.73

618.40

e6/l

0.60

241

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

353

1.82

4.69

1.8

1.6

974.48

2464.04

e6/l

0.77

274

Erosion of teeth , including avohilmo

402

3216

1.26

4.66

1.6

1.5

809.70

2219.94

e6/l

0.60

294

2533

Major coronary heart disease event

1159

6053

1.15

4.66

1.4

1.6

2059.36

1913.40

e6/l

0.07

996

4665

Hodgkin lymphoma, hilmo

240

2.00

4.65

1.6

1.4

930.35

621.60

e6/l

0.12

186

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1379

7701

1.13

4.65

1.5

1.4

2163.95

2007.21

e6/l

0.07

1103

6055

Open wound of lower leg

203

1481

1.38

4.63

1.5

1.6

931.45

3324.52

e6/l

0.44

160

1160

Mixed conductive and sensorineural hearing loss

151

1047

1.45

4.62

1.4

269.77

1190.81

e6/l

2.32

129

817

Acute peritonitis

520

1.66

4.60

1.6

1.5

339.76

1329.67

e6/l

0.95

403

Type 1 diabetes, wide definition, subgroup 1

296

2283

1.30

4.59

1.5

2063.61

3003.64

e6/l

0.17

242

1794

Patent foramen ovale

221

2.04

4.58

1.3

3.0

123.80

596.65

e6/l

0.69

165

Burns and corrosions

199

1451

1.38

4.58

1.7

1.6

923.04

3613.27

e6/l

0.50

164

1138

Hyperkalaemia

392

1.75

4.57

1.5

1.4

820.58

902.18

e6/l

0.05

314

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

618

1.59

4.54

3.0

2.5

186.65

544.82

e6/l

0.81

464

Atypical virus infections of central nervous system

2.87

4.53

1.6

1.2

2424.25

159.32

e6/l

0.45

Other Crohn's disease

105

679

1.57

4.53

1.6

1.5

122.80

1382.60

e6/l

1.82

525

Other skin changes

241

1812

1.34

4.53

1.6

1.4

265.55

3424.51

e6/l

0.89

197

1438

Recurrent aphthous stomatitis , including avohilmo

203

1488

1.38

4.52

3.0

1.5

1245.09

3819.43

e6/l

0.46

159

1137

Procedures for purposes other than remedying health state

188

2.12

4.51

1.8

1.5

708.40

259.25

e6/l

0.40

136

Amyloidosis, other/unspecified

136

2.34

4.51

1.3

534.04

1055.31

e6/l

0.25

108

Cardiodefibrillation

256

3337

0.76

4.50

1.5

1.4

1396.95

2080.66

e6/l

0.35

197

2672

Mental and behavioural disorders due to cannabinoids

300

1.87

4.49

1.6

1.5

594.19

833.26

e6/l

0.12

232

Explicit fungal Sepsis

4.23

4.48

2.1

1.3

3.10

2961.06

e6/l

—

Vulvovaginal ulceration/inflammation in other diseases

106

689

1.56

4.47

1.2

1.5

2964.02

6515.53

e6/l

0.26

545

Noninflammatory disorders of female genital tract

557

2302

1.22

4.44

1.5

1.4

7761.23

1297.75

e6/l

0.47

438

1821

Medicines for HER+ breast cancer

299

3564

0.78

4.44

1.3

1.5

959.38

2910.70

e6/l

1.02

211

2805

Excessive earwax

872

6815

1.16

4.43

1.5

837.88

2387.00

e6/l

1.51

719

5382

Atypical virus infections of central nervous system, including avohilmo

2.83

4.43

1.6

1.2

2424.25

159.32

e6/l

0.45

Congenital malformations of the circulatory system

214

1541

1.36

4.42

1.8

2.0

454.32

3530.70

e6/l

0.65

168

1180

Localized swelling, mass and lump of skin and subcutaneous tissue

414

3344

1.24

4.42

1.7

1.5

802.09

2492.20

e6/l

0.80

317

2631

Drug-induced cataract

190

2.10

4.41

1.7

1.5

20.25

1153.71

e6/l

0.93

146

Specific developmental disorder of motor function

172

2.16

4.40

2.4

5.0

33.50

536.08

e6/l

1.15

115

Hyperparathyroidism

205

1494

1.37

4.40

1.4

786.05

1231.70

e6/l

0.45

150

1182

Preterm labour and delivery

351

2785

1.27

4.40

1.3

1.4

1099.65

3226.70

e6/l

0.79

282

2161

Achilles tendinitis

128

869

1.49

4.38

1.3

1.5

1864.96

1121.56

e6/l

0.29

101

668

L02BA Anti-estrogens

106

1594

0.66

4.38

1.3

1.4

2272.94

1740.24

e6/l

0.18

1266

Other and unspecified vaccines and biological substances

3.10

4.38

1.1

1.2

2.83

31.51

e6/l

1.39

Congenital malformations and deformations of the musculoskeletal system

145

1004

1.45

4.38

1.9

2.2

592.39

5094.88

e6/l

0.61

112

768

Explicit fungal Sepsis, including avohilmo

4.12

4.37

2.1

1.3

3.10

2871.42

e6/l

—

Other specified and unspecified strabismus

101

2.56

4.37

2.0

2.5

7995.35

307.50

e6/l

0.51

Iron deficiency

310

1.84

4.36

1.3

2.0

1897.90

12408.38

e6/l

0.40

241

Injury of unspecified body region

107

701

1.54

4.36

1.2

1.6

4681.82

1081.00

e6/l

0.38

547

Certain zoonotic bacterial diseases, including avohilmo

253

1.93

4.35

2.9

1.4

797.68

849.70

e6/l

0.03

198

Thyrotoxicosis

333

2630

1.27

4.34

1.6

1.4

1026.99

2767.24

e6/l

0.58

265

2063

Inflammatory bowel disease

440

3586

1.23

4.34

1.5

651.03

2360.45

e6/l

0.92

347

2813

Intentional self-harm by sharp object

233

1.97

4.31

1.4

500.09

1838.25

e6/l

0.77

179

Other and unspecified trigeminal disorders

114

2.43

4.29

1.3

4213.70

105.38

e6/l

0.52

Type 2 diabetes, strict (exclude DM1)

1364

7042

1.13

4.29

1.5

1.4

1041.50

2077.98

e6/l

1.02

1068

5534

Type 2 diabetes, definitions combined

1356

6999

1.13

4.28

1.5

1.4

1044.12

2086.92

e6/l

1.02

1063

5500

Fissure and fistula of anal and rectal regions

313

2459

1.28

4.27

1.5

1.4

4388.00

3105.68

e6/l

0.15

247

1937

Syphilis, including avohilmo

234

1.97

4.26

1.8

1.3

673.94

980.34

e6/l

0.18

176

Syphilis

234

1.97

4.26

1.8

1.3

673.94

980.34

e6/l

0.18

176

Superficial injury of ankle and foot

190

1393

1.38

4.26

1.7

1.6

2981.69

3659.10

e6/l

0.07

147

1092

Diabetes, insulin treatment (Kela reimbursement)

1448

7678

1.12

4.26

1.5

1446.40

1950.24

e6/l

0.36

1166

6016

Other disorders of penis

125

850

1.48

4.24

1.4

1.9

393.58

927.44

e6/l

0.93

671

Additional codes for the location of defect, injury or illness

540

1.61

4.24

1.3

1.6

1055.58

1605.25

e6/l

0.31

420

Hyperprolactinaemia

314

1.81

4.20

1.2

1.5

1326.95

1130.94

e6/l

0.05

246

Rosacea

181

1320

1.38

4.20

1.4

271.45

4669.58

e6/l

0.87

146

1024

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

358

1.75

4.19

1.6

1.4

4353.83

297.71

e6/l

0.52

280

Endometriosis ASRM stages 1,2

253

1941

1.31

4.18

1.4

761.01

3258.21

e6/l

0.67

191

1519

Ovarian dysfunction

120

815

1.49

4.14

1.3

1.4

347.40

5626.31

e6/l

0.59

636

Human immunodeficiency virus [HIV] disease

148

2.22

4.14

1.7

1.4

1002.52

2103.51

e6/l

0.34

111

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

641

4706

1.19

4.14

1.4

2073.14

2199.72

e6/l

0.03

525

3644

Coxarthrosis

634

3448

1.19

4.14

1.5

1978.64

2121.88

e6/l

0.04

510

2721

Ischaemic heart disease, wide definition

1014

5452

1.15

4.13

1.4

1.5

1266.37

2026.71

e6/l

0.76

837

4251

Unspecified event, undetermined intent

209

2.00

4.11

1.6

1.5

578.87

140.86

e6/l

0.35

160

Injuries to unspecified part of trunk, limb or body region

141

989

1.44

4.11

1.2

1.6

8486.64

4946.28

e6/l

0.21

103

767

Alcohol induced polyneuropathy

2.85

4.08

1.3

1.2

47.93

1697.22

e6/l

0.52

Use of interferon beta-1a

203

2.02

4.08

1.5

1.6

440.83

146.73

e6/l

0.54

161

Generalized epilepsy, mode (most common among epilepsy diagnosis)

259

1.89

4.08

1.2

1.9

1401.78

1484.80

e6/l

0.02

203

Malignant neoplasm of pancreas, including Hilmo

686

0.51

4.06

1.4

723.90

1154.73

e6/l

0.37

552

Sequelae of injuries of lower limb

131

909

1.46

4.06

1.4

402.49

1090.10

e6/l

0.97

102

715

Phlebitis and thrombophlebitis (not including DVT)

288

2256

1.28

4.05

1.6

1.4

905.26

1200.89

e6/l

0.29

226

1777

Presbyopia

109

730

1.51

4.04

1.3

1.4

1462.53

1414.52

e6/l

0.01

567

Pregnancy hypertension

582

4381

1.19

4.03

1.4

2102.16

2269.25

e6/l

0.04

477

3401

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

3.31

4.03

1.7

1.3

52.63

2453.17

e6/l

—

Other bursopathies

155

1110

1.41

4.02

1.4

1190.73

1101.67

e6/l

0.04

124

870

Malignant neoplasm of breast, HER2-negative

378

3011

0.81

4.01

1.3

1.4

872.10

1823.56

e6/l

1.18

264

2397

Other specified/unspecified disorders of bone/cartilage

211

1.98

4.01

1.2

1.3

232.16

1107.34

e6/l

0.66

152

Other diseases of arteries and capillaries

115

780

1.49

4.00

1.4

1940.08

1067.26

e6/l

0.30

616

Emergency coronary revascularization (for ACS)

1147

6111

1.14

4.00

1.4

1.6

2128.54

1901.62

e6/l

0.11

992

4715

Rheumatoid arthritis, including avohilmo

475

3936

1.21

4.00

1.3

1.4

2141.75

2413.94

e6/l

0.06

373

3111

Other and unspecified injuries of wrist and hand

379

1.72

3.99

1.2

1.8

2685.81

1163.36

e6/l

0.35

299

Allergic urticaria

120

822

1.48

3.99

1.9

1.7

386.02

5873.74

e6/l

0.61

627

Hydrocele

128

887

1.45

3.98

1.4

1.6

183.97

936.51

e6/l

2.07

709

Atrial fibrillation and flutter with reimbursement

277

1352

1.30

3.97

1.4

1.3

1182.52

840.34

e6/l

0.33

208

1042

Other disorders starting during childhood or adolescence

599

1.56

3.96

3.2

2.6

191.65

6855.28

e6/l

0.50

445

Ulcer of oesophagus

526

1.59

3.95

1.4

436.56

1217.98

e6/l

1.09

414

Autoimmune hyperthyroidism

495

1.61

3.94

1.7

1.5

776.23

1994.49

e6/l

0.88

380

Autoimmune hepatitis, wide definition

365

1.72

3.94

1.3

1.7

477.26

1914.74

e6/l

0.92

286

Deviated nasal septum

424

3478

1.22

3.92

1.4

1247.51

2506.47

e6/l

0.53

340

2709

Abnormal findings on antenatal screening of mother

128

891

1.45

3.92

1.4

967.12

6368.22

e6/l

0.67

118

700

Superficial injuries involving multiple body regions

220

1.94

3.91

1.5

1.4

635.76

943.49

e6/l

0.14

168

Malignant neoplasm of breast

380

3013

0.81

3.88

1.3

1.4

865.80

1822.80

e6/l

1.19

266

2398

Intentional self-harm by other and unspecified firearm discharge

9.67

3.88

2.1

1.3

1065.29

5.88

e6/l

—

Stomatitis and related lesions

277

2173

1.28

3.88

2.7

1.5

1159.53

3132.65

e6/l

0.53

218

1695

Perioral dermatitis

214

1.96

3.87

1.4

1.5

426.69

113.55

e6/l

0.58

164

Polyarthritis, unspecified

315

1.77

3.87

1.3

1.6

369.05

790.95

e6/l

0.55

254

Exophthalmic conditions

2.68

3.86

1.3

1.2

18.53

147.41

e6/l

0.87

Other and unspecified disorders of vitreous body

533

4378

1.19

3.86

1.4

2936.31

2177.74

e6/l

0.22

420

3452

Generalized skin eruption due to drugs and medicaments

345

1.74

3.86

1.6

1.8

3953.08

1195.26

e6/l

0.31

272

Diabetic maculopathy, excluding more controls

139

985

1.42

3.85

1.5

1.4

3770.17

854.91

e6/l

0.47

115

782

Polymyalgia rheumatica

147

1052

1.41

3.84

1.3

1.4

2763.00

1108.88

e6/l

0.42

109

834

Human immunodeficiency virus [HIV] disease, including avohilmo

153

2.14

3.84

1.7

1.4

1002.52

2013.76

e6/l

0.31

116

Complications following infusion, transfusion and therapeutic injection

114

2.34

3.83

1.4

1.2

755.15

1077.71

e6/l

0.12

Vascular diseases of the intestine

286

1.81

3.83

1.3

7274.44

634.21

e6/l

0.89

227

Infectious mononucleosis, including avohilmo

129

904

1.44

3.82

1.6

1.5

995.97

5111.46

e6/l

0.48

101

700

Infectious mononucleosis

129

904

1.44

3.82

1.6

1.5

995.97

5111.46

e6/l

0.48

101

700

Medial epicondylitis

294

1.79

3.81

1.4

493.52

381.56

e6/l

0.13

226

Other diseases of lip and oral mucosa

579

4909

1.18

3.80

1.5

1023.95

2332.72

e6/l

0.91

430

3873

Melanocytic naevi

431

3559

1.22

3.79

1.5

1.4

681.78

2228.79

e6/l

0.74

337

2799

Thiazolidinediones

133

938

1.43

3.79

1.5

1.3

770.29

1159.83

e6/l

0.41

102

742

Other and unspecified disorders of white blood cells

332

1.74

3.79

3.5

1.6

275.33

500.68

e6/l

0.26

255

Hypertrophic disorders of skin

548

1.57

3.79

1.4

1.6

215.27

849.97

e6/l

1.31

433

Angina pectoris

710

4042

1.17

3.78

1.4

1.5

1289.50

1884.31

e6/l

0.41

583

3125

Hyperkinetic disorders (excl. ADHD)

213

1.94

3.77

1.4

3.4

76.19

1143.39

e6/l

0.71

157

Sub-endpoint used in defining T1D endpoints

370

2960

1.23

3.77

1.6

1875.05

2524.52

e6/l

0.15

308

2325

Other/unspecified enthesopathies, not elsewhere classified

100

668

1.51

3.77

1.3

1.4

671.63

633.61

e6/l

0.04

525

Later onset COPD

175

1888

0.74

3.76

1.3

1.4

1705.46

2559.81

e6/l

0.22

136

1524

Benign neoplasm: Stomach

119

824

1.46

3.76

1.4

1734.56

1322.13

e6/l

0.10

638

142

1016

1.41

3.75

1.2

1.4

454.72

1380.30

e6/l

0.68

814

Special screening examination for neoplasms

439

1.63

3.74

1.4

996.96

1461.18

e6/l

0.21

328

Other articular cartilage disorders

175

2.04

3.73

1.2

1.4

285.89

651.23

e6/l

0.35

133

Biological medication for rheuma

256

2000

1.29

3.73

1.5

1.6

4019.42

3253.85

e6/l

0.09

206

1551

Viral conjunctivitis

189

2.00

3.73

1.4

1.7

158.12

120.07

e6/l

0.12

148

Other epidermal thickening

379

1.68

3.72

1.8

1.7

55.32

1058.12

e6/l

1.76

295

Papulosquamous disorders

520

4378

1.19

3.72

1.3

1.5

737.95

2879.03

e6/l

1.40

407

3445

Dermatophytosis, including avohilmo

941

8112

1.14

3.71

1.4

1.5

1210.80

2174.87

e6/l

0.67

716

6421

Personal history of other diseases and conditions

173

1274

1.36

3.71

1.8

1.6

365.36

4490.56

e6/l

0.75

128

987

Malignant neoplasm of breast, including Hilmo

391

3055

0.82

3.71

1.3

1.4

1542.03

1798.80

e6/l

0.12

276

2431

Malignant neoplasm of breast, HER2-negative, including Hilmo

391

3055

0.82

3.71

1.3

1.4

1542.03

1798.80

e6/l

0.12

276

2431

Other disorders of kidney and ureter

162

1187

1.38

3.70

1.4

1.5

4036.23

1161.51

e6/l

0.50

125

928

Hypertrophic scar

504

1.59

3.69

1.4

1.6

134.90

905.92

e6/l

1.64

397

Toxic effect of ethanol

350

1.71

3.68

1.2

1.7

64811.85

1261.65

e6/l

0.48

267

Ulcer of lower limb, not elsewhere classified

167

1231

1.37

3.67

2.0

1.4

3104.42

1234.40

e6/l

0.30

126

967

Type 1 diabetes, wide definition

301

2400

1.26

3.66

1.5

1.6

2023.75

2932.73

e6/l

0.17

247

1888

Other and unspecified mental retardation

196

1.98

3.66

2.4

4.6

254.67

328.61

e6/l

0.16

134

Crushed, pushed or stepped on by crowd or human stampede

115

796

1.46

3.66

1.3

1.9

1358.15

5944.54

e6/l

0.45

609

Coeliac disease

166

1224

1.37

3.65

1.5

1.6

706.74

4284.31

e6/l

0.58

141

937

Disorders of multiple cranial nerves

11.76

3.64

1.3

206.17

307.67

e6/l

—

Exposure to other and unspecified inanimate mechanical forces

116

805

1.46

3.64

1.4

1.6

112.35

1122.94

e6/l

1.71

626

Other noninflammatory disorders of vulva and perineum

131

929

1.42

3.64

1.6

1.4

363.59

958.48

e6/l

0.98

103

733

Secondary polycythaemia

184

1.99

3.62

1.3

38.31

1181.48

e6/l

0.90

141

Other peripheral vertigo

115

798

1.45

3.61

1.5

1.4

360.76

1229.62

e6/l

1.21

626

Gestational [pregnancy-induced] hypertension

357

2904

1.23

3.60

1.3

1.4

2690.07

2240.92

e6/l

0.07

281

2254

Acute pancreatitis

241

1878

1.29

3.59

2.0

1.4

474.61

1252.81

e6/l

2.07

189

1496

Melanocytic naevi of upper limb, including shoulder

213

1.92

3.59

1.9

1.7

33.60

646.90

e6/l

0.60

164

Plantar fascial fibromatosis

123

865

1.43

3.58

1.3

1.4

1252.08

876.07

e6/l

0.16

683

Cardiac murmurs and other cardiac sounds

130

914

1.42

3.55

1.9

1.8

827.79

5450.17

e6/l

0.54

112

686

Fracture of forearm

763

5962

1.15

3.55

1.4

1.5

1097.60

2146.11

e6/l

0.62

594

4667

Sequelae of injuries of upper limb

135

968

1.41

3.54

1.5

697.66

1004.55

e6/l

0.26

116

756

Personal history of malignant neoplasm

119

836

1.44

3.51

3.5

1.5

242.95

1581.64

e6/l

2.47

657

Benign neoplasm: Adrenal gland

106

729

1.47

3.51

1.3

1.4

2556.67

1148.58

e6/l

0.48

565

Other and unspecified epidermal thickening

222

1.88

3.49

1.8

70.43

822.57

e6/l

0.80

176

Type 2 diabetes, definitions combined, including avohilmo

1354

7036

1.11

3.49

1.5

1.4

1757.97

1941.06

e6/l

0.07

1056

5537

Early syphilis

100

2.37

3.49

1.9

1.5

537.87

990.45

e6/l

0.22

Autoimmune thyroiditis

173

2.01

3.49

1.7

1.5

71.21

142.22

e6/l

0.48

134

Diabetic retinopathy, strict definition

198

1338

1.32

3.48

1.5

1.4

2845.96

2759.35

e6/l

0.01

165

1059

Pruritus

151

1107

1.37

3.47

1.5

1.4

1895.46

4504.62

e6/l

0.30

122

855

Crohn disease (strict definition, all UC cases excluded)

489

1.57

3.45

1.6

1287.10

1506.43

e6/l

0.08

371

Effects of foreign body entering through natural orifice

331

2692

1.24

3.44

1.6

2413.46

2537.22

e6/l

0.02

267

2099

Asthma mixed form (mode)

380

1.65

3.42

1.3

1.4

317.08

10947.30

e6/l

0.54

298

Disorders of globe

174

1.99

3.42

1.7

1.5

18876.29

886.99

e6/l

0.48

136

Open wound of abdomen, lower back and pelvis

275

1.77

3.41

1.9

1.8

363.97

1542.51

e6/l

0.82

211

Abscess of anal and rectal regions

117

824

1.43

3.41

1.5

2102.84

1305.34

e6/l

0.35

643

Effects of heat and light

2.93

3.41

1.6

1.2

1098.70

191.75

e6/l

—

Recurrent dislocation and subluxation of joint

643

1.49

3.41

1.3

1.6

106.63

1069.13

e6/l

2.08

514

Early syphilis, including avohilmo

114

2.25

3.40

1.8

1.4

474.65

855.40

e6/l

0.21

Hypertrophy of breast in women and men

264

2097

1.27

3.39

1.6

1.4

873.03

3551.55

e6/l

0.80

211

1626

Dependent personality disorder

168

2.01

3.39

1.2

1.5

18.07

564.29

e6/l

0.62

125

Residual foreign body in soft tissue

444

1.59

3.38

1.5

1.4

324.28

305.55

e6/l

0.03

346

Caries of enamel

1447

8563

1.11

3.38

1.7

1.5

669.34

2153.38

e6/l

2.10

1051

6820

Recurrent dislocation of patella

484

1.57

3.37

1.2

1.5

2189.41

8975.02

e6/l

0.41

381

Other follicular disorders

108

752

1.45

3.36

1.4

4275.33

6449.24

e6/l

0.14

579

Benign neoplasm of other and unspecified sites

269

1.78

3.36

1.5

1.3

1157.39

862.95

e6/l

0.15

208

Sequelae of infectious and parasitic diseases, including avohilmo

621

1.49

3.35

1.7

1.4

498.74

1452.76

e6/l

0.98

495

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

869

0.61

3.34

1.2

1.4

3690.32

893.07

e6/l

0.36

695

Exposure to other and unspecified man-made environmental factors

162

2.02

3.34

2.0

1.5

339.48

1831.58

e6/l

0.65

126

Infections of genitourinary tract in pregnancy

132

954

1.40

3.33

1.4

1628.06

5335.72

e6/l

0.43

114

730

Asthma mixed form (mode), excluding more controls

383

1.63

3.33

1.3

1.4

317.08

10890.76

e6/l

0.55

300

Diseases of spleen

135

2.12

3.32

1.5

1.3

1878.22

1038.16

e6/l

0.17

105

Other diseases of pancreas

108

754

1.45

3.32

1.4

1.5

354.22

920.96

e6/l

1.40

592

Mental retardation

412

1.61

3.31

2.1

3.3

368.98

681.65

e6/l

0.37

304

Other and unspecified diseases of blood and blood-forming organs

212

1.87

3.30

1.6

1.3

166.47

663.02

e6/l

0.43

160

Female genital prolapse

371

1690

1.23

3.30

1.3

1.4

974.04

1605.23

e6/l

0.43

290

1336

Hepatic failure, not elsewhere classified

308

1.71

3.30

1.5

531.39

543.44

e6/l

0.01

239

Alcoholic liver disease

124

889

1.41

3.28

1.3

1.4

427.29

1171.08

e6/l

1.02

702

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

110

772

1.44

3.28

1.3

1.5

135.94

1053.86

e6/l

2.19

613

Chronic kidney disease

352

2783

1.22

3.28

1.5

2079.10

2139.14

e6/l

0.01

289

2223

Unspecified nephritic syndrome

170

1.98

3.28

1.4

1.3

173.12

799.77

e6/l

0.45

132

Pregnancy with abortive outcome

891

4085

1.14

3.28

1.4

1691.05

1943.99

e6/l

0.08

712

3192

Gonococcal infection

309

1.71

3.27

1.8

1.3

2491.53

1775.99

e6/l

0.11

235

Diabetic nephropathy, excluding more controls

161

977

1.35

3.26

1.8

1.4

3398.86

1098.87

e6/l

0.42

135

767

Hordeolum and other deep inflammation of eyelid

585

1.50

3.25

2.2

1.5

284.89

1302.13

e6/l

1.08

454

Injuries involving multiple body regions

340

1.67

3.25

1.6

510.28

782.31

e6/l

0.19

262

Other disorders of the genitourinary system

149

1103

1.36

3.24

1.5

1.4

329.28

1372.04

e6/l

2.55

113

873

Malignant neoplasm of other connective and soft tissue

199

1.89

3.24

1.1

1.3

53.16

786.29

e6/l

0.73

160

Other and unspecified injuries of ankle and foot

402

1.61

3.24

1.6

1.8

546.64

11111.55

e6/l

0.58

314

Nummular dermatitis

108

758

1.44

3.23

1.7

1.4

169.43

1112.24

e6/l

2.48

592

Colorectal adenocarcinoma

132

1775

0.73

3.23

1.3

1.4

1643.97

1522.20

e6/l

0.03

1444

Impetigo

442

1.58

3.22

2.8

1.9

107.42

1753.24

e6/l

1.43

334

Motor disorders

199

1.90

3.21

2.4

5.0

33.50

298.72

e6/l

1.34

131

Adenocarcinoma and papilloma adenocarcinoma of rectum

834

0.61

3.20

1.2

1.4

3897.11

923.32

e6/l

0.36

667

Anorexia (incl.atypical)

554

1.51

3.20

1.3

1.6

52.42

8028.39

e6/l

0.61

435

Other inflammatory liver diseases

587

1.50

3.20

1.3

1.5

349.00

1564.15

e6/l

1.22

464

Chronic hepatitis, not elsewhere classified

281

1.73

3.19

1.5

1.4

10222.95

818.06

e6/l

0.49

221

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

114

797

1.42

3.17

2.0

2.3

279.56

6115.54

e6/l

0.63

604

Other and unspecified rosacea

122

879

1.40

3.16

1.4

277.02

1372.04

e6/l

2.08

686

Open wound of ankle and foot

142

1049

1.36

3.15

1.5

1.7

977.15

4614.79

e6/l

0.50

111

827

Crohn disease (strict definition, require KELA)

639

1.47

3.13

1.8

1.6

1267.58

1321.25

e6/l

0.02

492

Wide developmental disorders, excluding more controls

261

1.74

3.12

1.5

2.8

318.54

835.34

e6/l

0.36

199

Atopic dermatitis

883

6232

1.13

3.11

1.4

1.5

1269.13

1956.24

e6/l

0.31

680

4854

Dialysis

360

1.63

3.11

1.5

1.8

276.18

1269.84

e6/l

0.91

279

Benign neoplasm: Skin of lower limb, including hip

224

1.82

3.10

1.2

1.6

333.77

658.85

e6/l

0.26

170

Radial styloid tenosynovitis [de Quervain]

478

1.54

3.10

1.5

1.4

620.73

513.29

e6/l

0.12

370

Ehlers-Danlos syndrome, including avohilmo

119

2.16

3.09

1.3

1.6

1.67

83.01

e6/l

1.05

Other noninflammatory disorders of vagina

102

715

1.44

3.09

1.6

1.4

2228.53

1151.25

e6/l

0.34

565

Other dialysis

269

1.74

3.09

1.7

400.76

868.76

e6/l

0.35

203

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

297

2420

1.23

3.08

1.4

2329.99

2573.03

e6/l

0.04

228

1908

Diseases of arteries, arterioles and capillaries

821

5313

1.14

3.07

1.5

1.4

1891.87

1714.33

e6/l

0.10

654

4221

Intestinal malabsorption

424

1.58

3.06

1.4

1.6

1297.19

615.69

e6/l

0.38

325

Benign neoplasm: Spinal meninges

2.37

3.06

1.9

1.1

1216.31

153.82

e6/l

0.66

Multiple myeloma, including Hilmo

338

1.65

3.06

1.4

1.3

24.50

598.15

e6/l

1.10

275

Pilonidal cyst

120

868

1.39

3.05

1.6

1.5

4588.23

933.75

e6/l

0.48

680

Dermatophytosis

173

1323

1.32

3.04

1.5

1000.07

1149.34

e6/l

0.08

142

1038

Acute pancreatitis (for exclusion)

241

1922

1.26

3.04

2.0

1.4

474.61

1379.75

e6/l

2.45

189

1518

Campylobacter enteritis

233

1.79

3.04

1.2

1.6

17.03

959.38

e6/l

0.98

182

Endocrine disorders, other/unspecified

147

2.01

3.03

1.3

440.14

103.46

e6/l

0.53

112

Coxarthrosis [arthrosis of hip](FG)

675

4047

1.15

3.03

1.5

1.4

1873.05

2339.53

e6/l

0.16

544

3207

Disorders of oesophagus in diseases classified elsewhere

161

1.96

3.03

1.9

1.3

435.42

878.22

e6/l

0.23

121

Pedestrian injured in collision with pedal cycle

263

1.74

3.03

1.3

1.4

461.40

707.71

e6/l

0.19

203

Adalimumab

139

1031

1.36

3.02

1.6

5291.86

1249.64

e6/l

0.42

111

801

Degenerative macular diseases

129

945

1.37

3.02

1.7

1.4

873.44

1056.80

e6/l

0.12

108

750

Retinal detachment with retinal break

150

1125

1.34

3.02

1.5

1.4

868.19

1235.05

e6/l

0.36

116

888

Mental retardation, wide definition

438

1.56

3.02

2.1

3.2

355.21

643.74

e6/l

0.36

323

Dislocation, sprain and strain of joint and ligaments of hip

301

1.68

3.01

1.6

1.5

253.88

908.85

e6/l

0.77

232

Seronegative rheumatoid arthritis

135

997

1.36

3.01

1.3

1.4

178.07

1368.68

e6/l

3.08

100

784

Insulin, fast-acting (human)

182

1404

1.30

3.00

1.6

1.5

2841.81

3660.35

e6/l

0.09

151

1111

Malignant neoplasm of endocrine gland

653

1.45

3.00

1.4

1.3

880.02

887.66

e6/l

0.00

521

Human immunodeficiency virus [HIV] disease resulting in other conditions

141

2.03

2.99

1.8

1.3

1139.00

1038.51

e6/l

0.03

105

Haemolytic anaemias

302

1.68

2.99

1.4

1.6

767.63

534.14

e6/l

0.16

232

Malignant neoplasm of breast, HER-positive

281

2569

0.81

2.99

1.3

1.4

992.75

1981.46

e6/l

0.96

198

2048

COPD (mode)

321

2055

1.22

2.98

1.4

1956.38

1498.95

e6/l

0.25

254

1633

Trigger finger

173

1327

1.31

2.98

1.4

986.91

1168.19

e6/l

0.15

131

1044

Torticollis

114

2.14

2.97

1.3

1.5

20.74

802.63

e6/l

0.61

Nonalcoholic fatty liver disease

138

1026

1.36

2.97

1.6

1.5

3600.82

1236.03

e6/l

0.32

105

805

Other bullous disorders

220

1.80

2.97

1.3

1.6

23985.06

638.79

e6/l

0.47

169

Acute nasopharyngitis (common cold)

154

1154

1.33

2.96

1.7

1.4

790.36

4445.72

e6/l

0.56

131

896

Salpingitis and oophoritis

217

1716

1.27

2.96

1.4

1178.76

1474.85

e6/l

0.16

166

1344

Status post-ami

178

1744

0.77

2.95

1.4

1476.96

2754.41

e6/l

0.40

157

1342

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

142

2.01

2.94

1.8

1.4

1139.00

1028.73

e6/l

0.04

106

Ménière disease

110

790

1.40

2.93

1.3

1.4

1364.28

1290.52

e6/l

0.03

617

Crohn disease (strict definition, require KELA, min 2 HDR)

633

1.45

2.91

1.8

1.6

1303.79

1290.35

e6/l

0.01

487

Burn and corrosion of hip and lower limb, except ankle and foot

207

1.82

2.90

2.8

1.5

402.29

1027.97

e6/l

0.43

156

Diseases of external ear

462

3945

1.18

2.90

1.5

983.84

2744.42

e6/l

0.86

356

3110

Tumor necrosis factor alpha inhibitors

227

1810

1.26

2.90

1.5

4461.81

3447.22

e6/l

0.11

181

1407

Primary hyperparathyroidism

131

970

1.36

2.90

1.3

1.4

631.03

1183.33

e6/l

0.47

756

Haemorrhoids and perianal venous thrombosis

415

3486

1.19

2.90

1.3

1.4

809.66

2640.62

e6/l

0.95

336

2765

Other abortion

2.36

2.89

1.2

1.5

1019.15

64.69

e6/l

0.52

Superficial injury of neck

171

1.91

2.89

1.3

1.6

119.35

765.69

e6/l

0.49

136

Urethral stricture

398

1.57

2.89

1.4

2244.07

1068.55

e6/l

0.23

318

Gonarthrosis,primary

1165

6340

1.11

2.89

1.4

1736.64

1823.36

e6/l

0.04

935

5017

Fall involving bed

252

1.73

2.87

1.5

1.8

188.21

733.56

e6/l

0.63

199

Hypertensive heart and/or renal disease

266

1570

1.24

2.86

1.4

612.75

1908.86

e6/l

2.04

232

1248

Malignant neoplasm of mesothelium and soft tissue

321

1.64

2.86

1.2

1.3

246.55

986.29

e6/l

0.89

255

Systemic sclerosis (FG)

186

1.86

2.86

1.3

1.6

394.52

677.77

e6/l

0.27

144

Blood alcohol or alcohol intoxication level

208

1.81

2.86

1.3

1.7

1003.04

1870.70

e6/l

0.31

158

Artificial opening status

496

1.51

2.86

1.8

1.6

1635.73

1030.33

e6/l

0.30

377

Unspecified abortion

456

1.53

2.85

1.3

3513.74

1534.73

e6/l

0.25

353

Malignant neoplasm of breast, ER-positive, including Hilmo

284

2576

0.82

2.85

1.3

1.4

983.17

1975.78

e6/l

0.98

200

2055

Vascular disorders of the intestines

496

1.50

2.84

1.3

1.4

5278.57

976.81

e6/l

0.82

396

Congenital malformations of the respiratory system

187

1.86

2.83

1.7

3.4

1970.96

1644.76

e6/l

0.07

136

Intercostal neuropathy

2.72

2.83

1.1

1.4

354.14

2394.95

e6/l

—

L04AC Interleukin inhibitors

670

1.43

2.83

1.3

1.5

3165.44

1361.88

e6/l

0.33

512

Viral conjunctivitis, including avohilmo

370

1.59

2.81

1.4

1.6

176.97

1083.51

e6/l

0.66

286

Presbycusis

123

895

1.36

2.79

1.3

1.4

1767.82

1095.40

e6/l

0.22

107

720

Seropositive rheumatoid arthritis

284

2317

1.22

2.78

1.3

1.4

1182.04

3189.18

e6/l

0.57

228

1840

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

483

1.51

2.78

1.6

1.4

645.53

1675.20

e6/l

0.77

380

Crohn's disease of small intestine

681

1.42

2.77

1.8

1.5

1166.29

6870.54

e6/l

0.51

533

Malignant neoplasm of endocrine gland, including Hilmo

104

748

1.40

2.77

1.4

793.16

972.81

e6/l

0.14

592

Benign neoplasm of eye and adnexa

128

952

1.35

2.77

1.5

1.4

284.20

1103.85

e6/l

1.67

743

Bullous disorders

467

1.51

2.77

1.3

1.5

13067.77

749.17

e6/l

0.46

366

Other specified and unspecified retinal disorders

278

1.68

2.76

2.3

1.5

253.78

669.29

e6/l

0.43

214

Volvulus

203

1.80

2.75

1.1

1.6

50.57

780.39

e6/l

0.73

161

Psoriatic and enteropathic arthropathies

146

1108

1.33

2.75

1.4

847.07

1385.54

e6/l

0.54

120

872

Bacterial, viral and other infectious agents, including avohilmo

124

919

1.36

2.75

1.4

1.6

200.09

5291.96

e6/l

0.66

100

714

Use of rotigotine

2.30

2.75

1.6

1.3

59.00

1473.03

e6/l

0.54

Presence of other functional implants

745

4508

1.13

2.74

1.5

1.4

1051.22

2173.04

e6/l

1.11

625

3568

Hypertrophy of breast

228

1832

1.25

2.74

1.5

1.4

736.85

3816.68

e6/l

0.81

181

1420

Other diseases of pericardium

388

1.56

2.74

1.5

1.6

1440.98

640.51

e6/l

0.33

313

Bitten or struck by other mammals

160

1231

1.31

2.74

1.2

1.5

245.44

4240.32

e6/l

0.71

124

963

Osteomyelitis

525

1.48

2.74

1.4

587.22

748.23

e6/l

0.13

418

Melanocytic naevi of trunk

161

1240

1.31

2.73

1.3

1.5

712.96

4144.84

e6/l

0.58

115

983

Malignant neoplasm, without specification of site, including Hilmo

325

1.61

2.72

1.4

1165.82

976.14

e6/l

0.07

269

Colorectal cancer

174

2131

0.78

2.72

1.3

1.4

1591.78

1526.15

e6/l

0.02

134

1722

Coronary artery bypass grafting

176

1668

0.78

2.72

1.3

1.4

1000.75

2703.48

e6/l

0.57

143

1285

Entropion and trichiasis of eyelid

608

1.44

2.72

1.3

1.4

1603.40

599.59

e6/l

0.42

485

Injury of other and unspecified intrathoracic organs

559

1.46

2.72

1.4

1.5

1286.23

766.54

e6/l

0.26

446

L02BG Aromatase inhibitors

247

2992

0.81

2.71

1.3

1.5

492.39

2987.89

e6/l

1.23

176

2357

Mixed specific developmental disorders

244

1.70

2.71

2.2

4.2

131.31

372.22

e6/l

0.64

166

Other specified/unspecified bacterial intestinal infections

576

1.45

2.70

1.7

1.5

867.11

1360.77

e6/l

0.31

450

Early complications of trauma

398

1.55

2.69

1.5

1.4

7805.46

1107.10

e6/l

0.45

310

!Aliquae complicationes praecoces traumatis

398

1.55

2.69

1.5

1.4

7805.46

1107.10

e6/l

0.45

310

Other disorders of male genital organs

327

1.61

2.68

1.4

1.5

788.07

1139.58

e6/l

0.15

246

Endocarditis

296

1.64

2.68

1.6

1920.76

723.47

e6/l

0.44

234

Systemic sclerosis

191

1.81

2.65

1.3

1.5

394.52

548.09

e6/l

0.14

147

Evidence of alcohol involvement determined by level of intoxication

2.21

2.65

1.4

1.8

1861.00

197.32

e6/l

0.58

Diabetic retinopathy

395

2073

1.19

2.64

1.6

1.5

1677.11

2017.53

e6/l

0.08

320

1660

Endometriosis of rectovaginal septum and vagina

696

1.41

2.64

1.3

1.4

564.75

1059.30

e6/l

0.70

549

Sexual dysfunction

148

1.93

2.64

1.8

1.4

340.24

2476.07

e6/l

0.85

114

Charcot foot

141

1.95

2.64

1.9

1.4

1925.57

181.83

e6/l

0.72

103

Arteriovenous malformation of cerebral vessels

100

2.16

2.63

2.0

1.2

623.14

142.90

e6/l

0.54

Inflammatory disorders of breast

655

1.42

2.62

1.2

1.4

332.82

6908.39

e6/l

0.59

510

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

689

1.41

2.62

1.8

1.6

1250.22

7008.46

e6/l

0.51

530

Other diseases of peritoneum

361

1.57

2.61

1.3

1.5

67.13

1652.40

e6/l

1.26

282

Other contact dermatitis

103

748

1.39

2.61

1.4

827.28

6080.11

e6/l

0.52

586

Muscle strain

252

1.69

2.60

1.3

1.4

55.71

124.88

e6/l

0.95

201

Hypoparathyroidism

283

1.65

2.60

1.3

1.6

535.82

230.92

e6/l

0.30

220

Hereditary retinal dystrophy

114

2.06

2.60

1.3

1.8

65.47

1170.31

e6/l

0.56

Gonococcal infection, including avohilmo

346

1.58

2.59

1.9

1.3

2428.77

1750.70

e6/l

0.11

262

Crohn's disease NAS

623

1.43

2.59

1.5

1.6

1129.41

1242.04

e6/l

0.05

490

Perforation of tympanic membrane

128

963

1.34

2.59

1.5

773.10

1186.34

e6/l

0.27

106

758

Erythema nodosum

245

1.70

2.59

1.3

1.5

2380.26

187.37

e6/l

0.65

187

Achalasia of cardia

121

2.02

2.58

1.2

1.3

113.12

1036.11

e6/l

0.51

Peroneal tendinitis

135

1.96

2.58

1.2

1.9

26.70

140.16

e6/l

1.47

102

Pyoderma gangrenosum

2.49

2.58

1.3

1.2

17.00

208.09

e6/l

—

Hydronephrosis

133

1007

1.33

2.57

1.5

1.4

680.00

1085.16

e6/l

0.32

107

793

Otitis externa, unspecified

158

1226

1.30

2.56

1.4

1.6

1086.60

4208.71

e6/l

0.48

123

950

Congenital malformations of the respiratory system, including avohilmo

201

1.78

2.56

1.7

3.2

1900.57

1538.07

e6/l

0.08

147

Atopic dermatitis, strict definition with reimbursement

431

3555

1.17

2.56

1.4

1.5

347.76

1864.64

e6/l

0.79

347

2757

Hypertensive Heart Disease

238

1463

1.24

2.56

1.4

616.01

1664.97

e6/l

1.53

204

1160

Vitamin B12 deficiency anaemia

110

811

1.36

2.54

1.4

1015.41

1193.69

e6/l

0.11

647

Disorders of phosphorus metabolism and phosphatases

3.09

2.53

1.2

2.8

8266.82

88.87

e6/l

0.58

Helminthiases, including avohilmo

396

1.53

2.53

1.8

2.1

258.70

10736.42

e6/l

0.56

310

Tuberculosis, wide, including avohilmo

493

1.47

2.53

1.5

1.4

77.81

634.17

e6/l

1.32

393

Dementia due to Parkinson's disease

172

1.83

2.52

1.6

1.3

226.84

995.94

e6/l

0.60

138

Foreign body in alimentary tract

494

1.47

2.52

1.3

1.7

824.26

890.46

e6/l

0.04

380

Postprocedural musculoskeletal disorders, not elsewhere classified

627

1.42

2.51

1.5

1.4

455.96

953.72

e6/l

0.76

489

Malignant melanoma

177

1397

1.27

2.51

1.3

1.4

340.24

1485.34

e6/l

1.94

137

1130

Dislocation, sprain and strain of joints and ligaments of head

381

1.54

2.50

2.0

2.1

283.14

1672.30

e6/l

0.95

292

Spondylopathies in diseases classified elsewhere

2.24

2.50

1.2

1.4

79.33

64.62

e6/l

0.10

Chronic pancreatitis

147

1134

1.30

2.50

1.3

1.4

208.09

1261.51

e6/l

2.73

114

884

Tuberculosis, wide

486

1.47

2.50

1.5

1.4

79.14

642.29

e6/l

1.32

388

Gluteal tendinitis

349

1.56

2.50

1.4

1.5

77.61

656.71

e6/l

1.76

274

Systemic sclerosis, icd10

195

1.77

2.50

1.3

1.5

394.52

551.79

e6/l

0.14

149

Acute gastritis

611

1.42

2.49

1.5

103.20

998.69

e6/l

2.70

484

Acute bronchiolitis

581

1.41

2.48

2.3

2.7

130.08

7377.06

e6/l

0.53

428

Malignant neoplasm of rectum

841

0.66

2.48

1.3

1.4

4515.36

913.75

e6/l

0.54

676

Thyrotoxicosis with diffuse goitre

176

1392

1.27

2.46

1.8

1.4

522.95

3957.11

e6/l

0.67

143

1080

Malignant neoplasm of bronchus and lung, including Hilmo

148

1587

0.77

2.46

1.3

1.4

17177.75

1645.78

e6/l

0.45

105

1282

Malignant melanoma, including Hilmo

196

1570

1.25

2.46

1.3

1.4

361.42

1493.99

e6/l

2.22

153

1263

Chronic ulcer of skin, not elsewhere classified

546

1.44

2.45

1.4

652.54

937.31

e6/l

0.26

428

Tuberculosis, IBD comorbidity

472

1.47

2.44

1.5

1.3

79.14

659.65

e6/l

1.34

379

Congenital deformities of feet

242

1.68

2.44

1.6

1.9

100.94

161.02

e6/l

0.30

182

Atrophic disorders of skin

200

1608

1.25

2.44

1.5

1.4

3251.35

3588.77

e6/l

0.04

148

1261

Otitis externa

300

2513

1.20

2.43

1.4

1.5

1186.76

2853.22

e6/l

0.51

234

1970

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

328

1.58

2.43

1.4

1.9

315.50

704.51

e6/l

0.41

254

Burns and corrosions of external body surface, specified by site

149

1157

1.30

2.43

1.7

1016.80

4196.53

e6/l

0.46

124

897

Other or ill-defined heart diseases

473

1.47

2.43

2.2

1.5

2715.16

940.49

e6/l

0.65

370

Peripheral arterial reconstruction

1293

0.73

2.41

1.3

1.4

633.22

1065.08

e6/l

0.56

1030

Outcome of delivery

227

1129

1.24

2.41

1.2

1.3

4185.19

4648.65

e6/l

0.03

151

878

Polycystic ovarian syndrome

582

1.42

2.41

1.2

1.4

380.28

7303.94

e6/l

0.56

466

Hypertensive encephalopathy

3.79

2.40

1.4

114.63

25.38

e6/l

—

Alcohol-induced chronic pancreatitis

566

1.43

2.39

1.2

1.4

95.44

986.25

e6/l

1.66

439

Personal history of certain other diseases

183

1.78

2.39

1.6

1.4

30.71

117.64

e6/l

1.05

144

Anaemia in chronic diseases classified elsewhere

183

1.77

2.38

1.5

1.4

14267.73

821.03

e6/l

0.49

146

Ankylosing spondylitis, ICD10

113

849

1.34

2.35

1.5

5786.20

1180.96

e6/l

0.43

661

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

171

1357

1.27

2.35

1.4

714.03

1366.05

e6/l

0.93

133

1060

Disorders of orbit

379

1.52

2.35

1.5

1118.87

1388.33

e6/l

0.09

294

Chronic myeloproliferative disease

2.08

2.35

1.3

71.27

1247.36

e6/l

0.52

Malignant neoplasm of other connective and soft tissue, including Hilmo

347

1.54

2.34

1.1

1.4

731.43

958.02

e6/l

0.13

273

Abnormal findings in nipple discharge synovial fluid wound secretions

126

1.94

2.34

1.3

172.00

131.54

e6/l

0.10

Mixed disorders of conduct and emotions

253

1.65

2.33

1.3

2.3

96936.97

125.87

e6/l

0.50

189

Tongue abnormality

544

1.43

2.33

1.5

662.77

904.49

e6/l

0.15

426

Conotruncal defects

154

0.32

2.32

1.0

4.1

405.60

348.26

e6/l

—

111

Tibial collateral bursitis [Pellegrini-Stieda]

2.16

2.32

1.8

5.15

93.61

e6/l

1.59

Convalescence

429

1.48

2.31

1.5

1.4

4482.65

1462.61

e6/l

0.37

328

Other infective (teno)synovitis

3.60

2.30

1.4

1.3

417.38

37.59

e6/l

—

Oligomenorrhoea

325

1.56

2.29

2.0

1.4

216.13

481.74

e6/l

0.51

253

Injury of nerves at forearm level

2.06

2.29

1.2

1.5

10.73

1608.94

e6/l

0.76

Prepatellar bursitis

357

1.53

2.29

1.3

1.4

215.28

467.56

e6/l

0.75

285

Scoliosis

715

1.37

2.28

1.7

1.8

1024.00

728.95

e6/l

0.14

555

Malignant neoplasm of rectum, including Hilmo

1036

0.71

2.27

1.3

1.4

3484.31

975.60

e6/l

0.48

832

Other abnormal products of conception

439

2494

1.16

2.27

1.3

1.4

2654.17

2490.45

e6/l

0.03

340

1943

Other obstructive and reflux uropathy

374

1.51

2.27

1.3

1.6

905.53

462.85

e6/l

0.29

285

DVT of lower extremities

210

1713

1.23

2.26

1.4

2496.72

1387.99

e6/l

0.42

177

1351

Generalized epilepsy, strict definition

194

1.73

2.25

1.7

2.1

69.84

249.34

e6/l

0.89

149

Blepharochalasis

326

2772

1.18

2.25

1.3

1.4

1100.57

1329.68

e6/l

0.21

252

2201

Other congenital malformations, including avohilmo

178

1427

1.25

2.25

1.5

1.9

1296.14

3667.88

e6/l

0.39

139

1093

Congenital deformities of feet, including avohilmo

367

1.52

2.24

1.5

1.9

103.67

1520.18

e6/l

1.04

276

Glucosamine medication

507

3551

1.14

2.22

1.4

1942.71

1819.65

e6/l

0.05

404

2802

Other orthopaedic follow-up care

466

1.45

2.22

1.2

1.5

74.14

1801.25

e6/l

1.68

354

Viral warts, including avohilmo

292

2464

1.19

2.22

1.4

1.6

978.99

2768.69

e6/l

0.56

244

1917

Diabetes mellitus in pregnancy

450

2485

1.15

2.21

1.3

1.4

394.29

2882.59

e6/l

0.94

361

1929

Malignant melanoma of skin, including Hilmo

162

1288

1.26

2.21

1.3

1.4

415.77

1375.42

e6/l

1.33

124

1036

Polypectomy (DHB20)

584

1.40

2.20

1.5

1.4

109.30

1116.44

e6/l

2.03

463

Drug-induced osteoporosis with pathological fracture

129

1.90

2.20

2.3

1.4

3.67

121.25

e6/l

1.09

Other leukaemias of specified cell type

3.89

2.19

8.4

1.2

64.29

374.54

e6/l

—

Suggestive for eosinophilic asthma

112

850

1.33

2.19

1.4

271.15

1039.23

e6/l

1.76

674

Acne, including avohilmo

327

2252

1.18

2.19

1.4

1.5

1194.78

2782.41

e6/l

0.42

251

1756

Multiple myeloma and malignant plasma cell neoplasms

353

1.52

2.18

1.5

1.4

25.76

549.39

e6/l

0.97

275

Other (seronegative) rheumatoid arthritis, wide

213

1748

1.22

2.18

1.3

1.4

267.88

1422.53

e6/l

4.54

162

1393

Nasal polyp

223

1839

1.22

2.17

1.3

1.4

229.87

3389.97

e6/l

0.89

182

1439

Other acquired deformities of musculoskeletal system and connective tissue

386

1.49

2.17

1.4

1023.74

800.84

e6/l

0.13

295

Retinal vascular disorders

120

921

1.31

2.16

1.5

1.4

1506.92

980.64

e6/l

0.23

727

Contusion of toe(s) without damage to nail

235

1.64

2.16

1.9

1.5

297.69

634.12

e6/l

0.27

183

Sequelae of intentional self-harm, assault and events of undetermined intent

2.28

2.15

1.7

2.0

8.50

254.45

e6/l

—

Late syphilis, including avohilmo

130

1.88

2.15

1.7

1.3

805.18

948.61

e6/l

0.05

106

Diabetic maculopathy

138

1019

1.29

2.15

1.5

1.4

3770.17

3289.87

e6/l

0.05

115

796

Retinal vascular occlusion

119

914

1.31

2.14

1.5

1.4

1522.14

985.93

e6/l

0.23

723

Other superficial mycoses, including avohilmo

147

1161

1.27

2.14

1.4

1.5

405.70

4354.35

e6/l

0.64

106

908

Disorder of external ear, unspecified

291

1.56

2.13

1.3

1.4

155.18

411.39

e6/l

0.46

228

Spontaneous abortion

601

3576

1.13

2.13

1.3

1.4

1913.65

2109.99

e6/l

0.05

473

2787

Pneumonia derived septicemia

291

1.56

2.13

1.5

1.9

1485.12

474.48

e6/l

0.46

231

Allergic rhinitis

437

3769

1.15

2.13

1.4

1.6

512.77

2096.87

e6/l

0.90

352

2936

Follicular cysts of skin and subcutaneous tissue

228

1890

1.21

2.12

1.6

1.4

713.87

1166.95

e6/l

0.74

193

1488

Burns and corrosions of multiple and unspecified body regions

175

1.74

2.12

2.8

1.4

18.88

1448.75

e6/l

0.79

134

Glomerular disorders in diseases classified elsewhere

135

1057

1.28

2.11

1.6

1.5

3579.61

1097.47

e6/l

0.36

110

834

Postpartum haemorrhage due to anatomy

1182

0.74

2.11

1.3

1.4

316.27

1385.43

e6/l

1.09

951

Other and unspecified injuries of thorax

131

1.86

2.10

1.2

1.3

57.72

110.97

e6/l

0.39

103

Hyperaldosteronism

237

1.63

2.10

1.9

1.5

4496.32

185.73

e6/l

0.63

181

Injury of nerves at lower leg level

2.12

2.10

1.0

1.3

113.00

169.26

e6/l

—

Nontoxic multinodular goitre

212

1748

1.22

2.09

1.4

1.5

654.05

1195.75

e6/l

0.72

167

1369

Other diseases of stomach and duodenum

548

1.40

2.08

1.7

1.5

138.78

1456.80

e6/l

1.70

430

Other endocrine disorders

525

1.40

2.08

2.7

2.9

453.64

8245.50

e6/l

0.49

376

Primary angle-closure glaucoma

317

1.53

2.07

1.5

1.3

221.83

627.98

e6/l

0.52

247

Disorders of continuity of bone

126

981

1.29

2.07

1.9

1.4

2024.91

1243.38

e6/l

0.23

765

Female infertility, associated with anovulation

102

772

1.33

2.06

1.5

1.3

380.99

826.34

e6/l

0.90

613

Malignant melanoma of skin

135

1061

1.28

2.05

1.3

1.4

412.10

993.32

e6/l

1.17

104

848

Sequelae of infectious and parasitic diseases

609

1.37

2.05

1.6

1.4

525.08

1487.70

e6/l

0.95

484

Heart failure and coronary heart disease

358

2901

0.86

2.05

1.4

1.5

672.37

2197.84

e6/l

1.16

306

2255

Lichen simplex chronicus

286

1.56

2.05

1.5

1.4

6891.53

829.55

e6/l

0.53

224

Caught, crushed, jammed or pinched in or between objects

517

1.41

2.04

1.4

1.6

3524.42

636.37

e6/l

0.39

396

Superficial injury of ankle and foot, unspecified

2.89

2.02

1.0

1.5

1191.89

199.71

e6/l

—

Acne

151

1199

1.26

2.02

1.5

1.6

1567.40

4072.27

e6/l

0.34

124

922

Assault by unspecified means

193

1.68

2.02

1.3

1.5

325.18

2122.19

e6/l

0.93

150

ILD, hospital admissions 3, with pneumonia sepsis

620

1.36

2.00

1.3

1.5

111.24

709.52

e6/l

2.42

488

Atopic dermatitis, strict definition

422

3614

1.15

2.00

1.4

1.6

276.17

2259.12

e6/l

1.16

339

2807

Chronic conjunctivitis

264

1.57

2.00

2.0

1.9

460.85

906.08

e6/l

0.34

207

Pre-eclampsia or eclampsia

276

2343

1.18

2.00

1.4

568.64

2627.58

e6/l

0.67

231

1826

Other disorders of breast

172

1396

1.24

2.00

1.4

157.10

4442.23

e6/l

0.91

126

1084

Benign neoplasm: Other and unspecified parts of mouth

272

1.56

1.99

1.3

1616.79

937.39

e6/l

0.20

212

Encephalocele

4.95

1.99

1.4

1.3

101428.60

29.73

e6/l

—

Ehlers-Danlos syndrome

1.99

1.98

1.3

1.7

2.00

97.42

e6/l

0.99

Spontaneous rupture of synovium and tendon

690

1.34

1.98

1.5

1.4

513.87

718.34

e6/l

0.24

543

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

545

1.39

1.98

1.2

1.4

581.77

883.66

e6/l

0.28

435

Chronic periodontitis, complicated

726

6400

1.11

1.98

1.4

1870.43

2380.32

e6/l

0.26

548

5080

Helminthiases

134

1.82

1.97

1.3

1.7

39.11

952.06

e6/l

0.57

106

Separation of retinal layers (serosa)

370

1.47

1.97

1.1

1.3

1390.15

1486.74

e6/l

0.02

281

Colonic or urogenital fistula

329

2835

1.16

1.97

1.5

1.4

4259.37

2755.83

e6/l

0.19

255

2224

Other and unspecified injuries of shoulder and upper arm

289

1.54

1.97

1.5

1.4

87.92

131.40

e6/l

0.35

224

Bacterial, viral and other infectious agents

111

857

1.30

1.96

1.4

1.6

225.78

1220.35

e6/l

1.72

669

Hernia of abdominal wall

565

5048

1.12

1.96

1.4

4995.76

2082.05

e6/l

0.33

444

4011

Isolated growth hormone deficiency

1.99

1.96

2.2

5.4

1206.07

201.92

e6/l

0.71

Malignant neoplasm of thyroid gland, including Hilmo

666

1.35

1.96

1.4

878.76

886.05

e6/l

0.00

527

Delayed milestone in childhood

217

1.60

1.95

2.7

5.2

221.55

1067.46

e6/l

0.71

144

Other and unspecified abdominal hernia

314

1.51

1.94

1.4

429.12

1126.27

e6/l

0.74

252

Multiple myeloma

203

1.64

1.94

1.1

1.4

14.68

799.39

e6/l

0.86

168

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

203

1.64

1.94

1.1

1.4

14.68

799.39

e6/l

0.86

168

Late syphilis

1.95

1.92

1.8

1.2

938.29

1243.96

e6/l

0.09

Primary open-angle glaucoma, strict

263

2225

1.18

1.92

1.5

1.4

1394.14

1017.96

e6/l

0.23

220

1777

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.36

1.92

1.7

1.4

27.00

149.69

e6/l

—

Pedestrian injured in collision with car, pick-up truck or van

204

1.64

1.91

1.3

151.46

1010.03

e6/l

0.68

158

Dysplasia of cervi uteri

304

1830

1.17

1.91

1.3

1.4

13807.64

1448.75

e6/l

0.47

229

1438

ILD, hospital admission 2, with pulmonary infections

721

1.32

1.90

1.3

1.4

102.04

853.82

e6/l

3.34

572

Malignant neoplasm of bronchus and lung

130

1368

0.79

1.90

1.2

1.4

19780.45

1652.41

e6/l

0.46

1103

Ulcerative colitis

311

2678

1.17

1.90

1.4

1.5

594.70

2753.62

e6/l

0.85

246

2095

Other puerperal infections

110

853

1.30

1.90

1.3

1.4

40.55

6084.93

e6/l

0.75

673

Malignant neoplasm of thyroid gland

610

1.35

1.89

1.4

1.3

945.43

930.87

e6/l

0.01

486

Benign mammary dysplasia

157

1271

1.24

1.88

1.5

1.4

1801.41

4548.31

e6/l

0.41

127

990

Contusion of ankle

399

1.44

1.88

1.9

1.8

724.51

1307.95

e6/l

0.36

309

Other benign neoplasms of connective and other soft tissue

115

898

1.29

1.88

1.4

1.5

776.14

1134.74

e6/l

0.34

702

Torsion of ovary, ovarian pedicle and fallopian tube

213

1.62

1.87

1.3

1.4

824.10

594.13

e6/l

0.13

171

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

190

1.66

1.86

1.5

1.4

28.86

221.32

e6/l

1.01

155

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

375

1.46

1.86

2.7

2.5

512.23

1005.84

e6/l

0.32

285

Presence of cardiac and vascular implants and grafts

389

3263

0.87

1.86

1.4

1112.04

2072.66

e6/l

0.60

323

2602

Other and unspecified vascular occlusions

698

1.33

1.85

1.5

1.4

688.55

867.39

e6/l

0.14

555

Prolonged pregnancy

150

1579

0.81

1.85

1.5

1.4

257.10

3362.72

e6/l

0.70

123

1232

Etanercept

639

1.34

1.84

1.3

1.6

3004.58

1494.95

e6/l

0.23

494

Thyroiditis

665

1.33

1.84

1.5

1.4

1888.74

1525.07

e6/l

0.08

523

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

108

1.88

1.84

1.3

1.4

60.79

854.61

e6/l

0.56

Hip and thigh

3.20

1.83

2.4

1.1

1252.14

279.12

e6/l

—

Burns and corrosions confined to eye and internal organs

238

1.57

1.83

1.7

1.6

868.72

1317.69

e6/l

0.18

181

COPD, hospital admissions 1, only main diagnosis

271

2720

0.85

1.83

1.4

2007.19

2232.05

e6/l

0.07

223

2157

Other factor of the environment

101

1.92

1.83

1.5

1.3

486.50

153.63

e6/l

0.64

Disorders of porphyrin and bilirubin metabolism

1.95

1.82

2.0

1.4

457.62

1246.20

e6/l

0.30

Other and unspecified follicular disorders

385

1.44

1.82

1.4

1.5

7763.96

1857.10

e6/l

0.39

298

Myocardial infarction, strict

419

3361

0.88

1.82

1.4

1.5

771.78

2021.86

e6/l

1.00

347

2616

Intestinal adhesions without obstruction

718

1.32

1.82

1.5

434.31

1263.13

e6/l

1.08

570

Flat foot [pes planus] (acquired)

111

867

1.29

1.82

1.3

1.5

374.55

1124.32

e6/l

1.65

678

Embolic stroke

278

1.52

1.81

1.7

1.4

2529.30

582.38

e6/l

0.70

219

Benign neoplasm: Sigmoid colon

207

1731

1.20

1.81

1.5

1.4

12756.66

1416.98

e6/l

0.51

156

1368

Deep endometriosis

116

912

1.28

1.81

1.3

1.4

516.79

5849.17

e6/l

0.67

703

Sequelae of other and unspecified infectious and parasitic diseases

478

1.39

1.81

1.7

1.4

671.16

1681.63

e6/l

0.73

377

Benign neoplasm: Rectum, anus and anal canal

219

1841

1.19

1.81

1.4

337.26

1441.13

e6/l

4.17

159

1455

Combinations of oral blood glucose lowering drugs

324

2811

1.16

1.80

1.5

1.4

1521.82

1490.27

e6/l

0.02

260

2230

Psoriasis

349

3045

1.15

1.80

1.3

1.4

567.16

2678.89

e6/l

1.00

265

2381

Umbilical hernia

333

2897

1.15

1.79

1.4

7244.78

2908.54

e6/l

0.28

257

2278

Follow-up care involving plastic surgery

312

0.54

1.79

1.4

1.5

30.90

1767.14

e6/l

—

227

Carcinoma in situ of breast, intraductal

783

0.71

1.79

1.4

1357.93

1441.03

e6/l

0.03

606

Pneumococcal septicemia

280

1.52

1.78

1.5

1.9

1574.19

562.96

e6/l

0.41

218

Dependence on enabling machines and devices, not elsewhere classified

109

1.87

1.78

3.8

2.1

1089.85

1542.21

e6/l

0.12

Glaucoma secondary to eye inflammation

2.08

1.78

1.2

1.5

15.60

125.00

e6/l

—

Sulfonylureas

247

2303

0.85

1.77

1.5

1.4

9808.46

1313.41

e6/l

0.47

196

1844

Acquired haemolytic anaemia

185

1.64

1.77

1.4

1.3

1037.48

124.73

e6/l

0.63

152

Inflammatory disorders of male genital organs, not elsewhere classified

1.96

1.76

1.2

1.6

4.08

2928.42

e6/l

0.79

Glucagon-like peptide-1 (GLP-1) analogues

396

3492

1.14

1.75

1.4

841.00

1643.81

e6/l

1.31

317

2746

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

396

3492

1.14

1.75

1.4

841.00

1643.81

e6/l

1.31

317

2746

Conductive hearing loss, unspecified

100

775

1.30

1.75

2.2

1.6

199.78

1226.50

e6/l

1.74

600

Other and unspecified vasculitis limited to skin

170

1.67

1.75

1.1

1.7

4.45

796.57

e6/l

0.65

135

Melanoma in situ

355

1.45

1.75

1.2

1.4

14.26

612.05

e6/l

1.17

278

Postprocedural disorders of digestive system, not elsewhere classified

273

1.52

1.75

1.7

1.6

7587.65

587.39

e6/l

0.76

213

Post-traumatic wound infection, not elsewhere classified

241

1.55

1.75

1.3

1.4

12851.45

877.62

e6/l

0.49

185

Other specified disorders of kidney and ureter

257

1.53

1.75

1.5

2527.03

610.71

e6/l

0.55

194

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

225

1.57

1.75

1.3

1.4

173.89

798.79

e6/l

0.68

186

Chronic lymphocytic leukaemia

225

1.57

1.75

1.3

1.4

173.89

798.79

e6/l

0.68

186

Chronic lymphocytic leukaemia, helper endpoint

225

1.57

1.75

1.3

1.4

173.89

798.79

e6/l

0.68

186

Postpartum haemorrhage due to retained placenta

110

1392

0.79

1.74

1.5

1.4

7489.77

1155.61

e6/l

0.57

1112

Chromosomal abnormalities, not elsewhere classified

233

1.57

1.74

1.6

3.5

2416.29

289.70

e6/l

0.60

165

Other pleural conditions

767

1.30

1.74

1.5

20939.52

910.37

e6/l

0.47

602

5-aminosalicylic acid

262

2245

1.17

1.74

1.5

1.4

728.12

2970.95

e6/l

0.70

204

1751

Other bursitis of hip

140

1.73

1.6

1.4

1605.64

244.77

e6/l

0.84

108

Vasculitis limited to skin, not elsewhere classified

194

1.62

1.73

1.2

1.6

4.24

739.51

e6/l

0.72

157

Hidradenitis suppurativa

365

1.44

1.72

1.3

1.4

404.17

11675.36

e6/l

0.56

286

Colorectal cancer, including Hilmo

212

2338

0.84

1.72

1.3

1.4

1304.57

1557.41

e6/l

0.11

166

1892

Open wound of forearm

116

919

1.27

1.71

1.3

1.6

847.64

5260.56

e6/l

0.54

720

Other predominantly sexually transmitted diseases, not elsewhere classified

230

1953

1.18

1.71

1.4

3051.11

3165.09

e6/l

0.01

173

1535

Acute nephritic syndrome

156

1.69

1.71

1.5

1.4

274.42

1326.77

e6/l

0.62

120

Oesophagitis

441

1.39

1.70

1.4

1.5

148.69

990.84

e6/l

1.51

337

Psoriatic arthropathies

116

920

1.27

1.70

1.4

1004.08

1316.63

e6/l

0.23

726

Anxious personality disorder

164

1.67

1.70

1.3

1126.15

556.28

e6/l

0.19

127

Complications predominantly related to the puerperium

336

2939

1.15

1.70

1.3

1.4

407.75

2759.61

e6/l

1.11

257

2304

Pediculosis, acariasis and other infestations, including avohilmo

238

2029

1.18

1.69

1.3

1.6

581.48

3073.96

e6/l

0.71

188

1586

Lactose intolerance, other/unspecified

227

1.56

1.69

1.3

1.8

978.21

618.64

e6/l

0.18

178

Persons encountering health services in circumstances related to reproduction

814

4998

1.09

1.69

1.6

1353.39

2295.25

e6/l

0.52

635

3855

Pyoderma

149

1.70

1.68

1.4

1.6

40.72

116.37

e6/l

0.78

115

Contact with heat and hot substances

519

1.36

1.68

1.4

1.7

146.02

922.20

e6/l

1.16

395

Septal defects

678

1.31

1.68

1.5

2.7

218.27

817.06

e6/l

1.38

512

Bursitis of shoulder

188

1.61

1.67

2.1

1.3

61.20

447.40

e6/l

0.81

144

Other lesions of median nerve

188

1.61

1.67

1.1

1.3

194.60

778.28

e6/l

0.45

145

Hypoplasia of dental enamel, prenatal

2.43

1.67

5.7

5.3

2.83

840.36

e6/l

—

Female infertility, cervical, vaginal, other or unspecified origin

339

1892

1.15

1.67

1.5

1.4

1112.45

1520.31

e6/l

0.21

252

1487

Cardiomyopathy in other diseases

2.51

1.66

1.3

1.4

65.20

238.39

e6/l

—

Certain conditions originating in the perinatal period

120

850

1.26

1.66

2.9

2.1

250.84

5023.03

e6/l

0.52

636

Other sexually transmitted chlamydial diseases

678

1.31

1.64

1.6

1.5

131.76

6701.40

e6/l

0.62

534

Hereditary corneal dystrophies

289

0.55

1.62

3.4

1.5

166.64

865.83

e6/l

0.83

223

Lactose intolerance

262

1.50

1.62

1.5

1.7

1217.61

812.28

e6/l

0.21

209

Foreign body in genitourinary tract

1.94

1.62

1.3

48.18

243.09

e6/l

1.15

Unstable angina pectoris

397

2761

1.13

1.62

1.4

1.5

1198.93

2293.11

e6/l

0.60

327

2152

Contact with lifting and transmission devices, not elsewhere classified

151

1.68

1.62

1.5

1.4

672.17

1371.59

e6/l

0.30

116

Other disorders of conjunctiva

157

1296

1.22

1.61

1.3

1.5

720.20

1177.53

e6/l

0.53

126

1031

Endometriosis of ovary

205

1632

1.19

1.61

1.4

2099.71

1619.84

e6/l

0.16

162

1295

Uterine polyps

343

1754

1.15

1.61

1.4

2965.31

1565.58

e6/l

0.31

264

1390

Malignant neoplasm of accessory sinuses

3.14

1.61

1.5

1.3

6172.00

334.07

e6/l

—

Postpartum haemorrhage

271

2580

0.86

1.61

1.4

3182.00

2761.66

e6/l

0.06

219

2007

Pre-eclampsia

255

2197

1.17

1.61

1.4

606.34

2589.13

e6/l

0.59

215

1718

Sacrococcygeal disorders, not elsewhere classified

230

1.54

1.61

1.3

1.6

5.07

153.89

e6/l

3.51

182

Bronchitis, not specified as acute or chronic

750

1.29

1.60

1.3

1.4

528.64

845.58

e6/l

0.37

591

Disorders resulting from impaired renal tubular function

321

1.45

1.59

1.5

1.7

10589.61

641.20

e6/l

0.46

246

Chronic nephritic syndrome

313

1.45

1.58

1.7

1.4

538.68

892.06

e6/l

0.22

239

Lichen planus

148

1218

1.22

1.58

1.4

1.5

753.17

1206.20

e6/l

0.43

121

946

Maternal care for known or suspected abnormality of pelvic organs

342

2027

1.14

1.57

1.4

2302.48

3032.44

e6/l

0.11

270

1572

Defect, injury or illness of neck

2.09

1.57

1.2

1.6

38.38

160.24

e6/l

—

Pre-eclampsia or poor fetal growth

396

3505

1.13

1.57

1.3

1.4

554.48

2404.05

e6/l

0.99

332

2724

Molar incisor enamel hypoplasia

445

1.37

1.56

6.2

2.6

380.13

283.78

e6/l

0.15

320

Myocardial infarction, with ST-elevation

109

1360

0.80

1.56

1.3

1.4

1812.78

961.69

e6/l

0.37

1078

Retinal haemorrhage

192

1.58

1.55

2.6

1.3

223.38

819.06

e6/l

0.49

151

Female infertility

366

1935

1.14

1.55

1.5

1.4

989.17

1498.99

e6/l

0.30

281

1521

Pneumonia due to Streptococcus pneumoniae

323

1.44

1.54

1.5

1.4

158.36

661.44

e6/l

0.50

253

Use of antiglaucoma preparations and miotics

562

1.32

1.54

1.3

1.4

164.53

599.86

e6/l

1.19

445

Gout, idiopatic and unspecified

259

2243

1.16

1.53

1.4

989.03

2359.87

e6/l

0.62

195

1804

Carbimazole or st.post thyroidectomy, condition for graves disease

254

2197

1.16

1.53

1.5

1.4

921.92

3235.99

e6/l

0.72

191

1721

Benign neoplasm: Ascending colon

150

1241

1.21

1.52

1.3

1.4

1666.91

943.95

e6/l

0.27

117

970

Complications following myocardial infarction

0.00

1.52

0.0

1.4

—

364.50

—

Primary open-angle glaucoma

314

2652

1.14

1.52

1.5

1.4

1277.61

2070.44

e6/l

0.36

261

2123

Palmar fascial fibromatosis [Dupuytren]

141

1160

1.22

1.51

1.5

1.4

1242.54

2822.28

e6/l

0.36

117

928

Other abnormal auditory perceptions

101

1.81

1.51

1.3

1.6

852.08

1362.24

e6/l

0.14

Viral agents as the cause of diseases classified to other chapters, including avohilmo

226

1.52

1.50

1.2

1.7

447.48

660.47

e6/l

0.13

177

Habitual aborter

202

1.55

1.50

1.3

1.4

5.56

471.40

e6/l

1.70

162

Ulcerative colitis, NAS

171

1436

1.20

1.49

1.4

1.5

745.55

3682.68

e6/l

0.57

139

1131

Infective dermatitis

129

1054

1.23

1.49

1.4

1947.90

1104.13

e6/l

0.31

115

821

Benign neoplasm: Rectum

193

1638

1.18

1.49

1.4

294.74

1330.39

e6/l

3.62

139

1289

Nonspecific lymphadenitis

557

1.32

1.48

1.9

1.5

467.31

1081.58

e6/l

0.71

433

LSIL lesion of the cervix uteri, vagina or vulva

187

1584

1.19

1.48

1.5

1.4

21853.41

1308.58

e6/l

0.48

141

1250

Foreign body in respiratory tract

462

1.35

1.48

2.4

1.8

10493.32

850.20

e6/l

0.46

356

Myeloproliferative diseases

698

1.28

1.47

1.5

1.4

779.01

1212.75

e6/l

0.25

543

Nontoxic goitre/thyroid nodule

325

2869

1.14

1.47

1.4

911.09

1329.46

e6/l

0.47

257

2255

Other and unspecified nail disorders

195

1.56

1.47

1.3

1.4

712.21

773.77

e6/l

0.02

152

Vasomotor rhinitis (mode)

672

1.29

1.47

1.5

1.4

343.53

1375.90

e6/l

1.27

523

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

795

5697

1.09

1.46

1.4

5715.21

1481.79

e6/l

0.43

623

4475

Malignant neoplasm of corpus uteri, including Hilmo

752

0.74

1.44

1.4

500.57

1332.77

e6/l

1.49

603

Myocardial infarction, unclassifiable

137

1478

0.83

1.44

1.3

1.4

1033.33

1039.04

e6/l

0.00

115

1185

Corns and callosities

586

1.31

1.44

1.8

1.4

570.19

1105.66

e6/l

0.54

458

Lichen ruber planus, wide definition including periferal and oral lichen planus

261

2275

1.15

1.44

1.3

1.4

737.09

1248.80

e6/l

0.85

204

1787

Congenital deformities of hip

188

1.56

1.43

2.9

2.8

2151.75

307.05

e6/l

0.56

143

Benign neoplasm: Liver/bile ducts

237

1.49

1.43

1.5

526.33

612.34

e6/l

0.05

189

IBD patients in KELA-register

295

2594

1.14

1.43

1.6

1.5

880.34

2722.38

e6/l

0.65

238

2036

Melanocytic naevi of lower limb, including hip

422

1.36

1.43

1.4

1.6

179.07

1370.70

e6/l

0.99

330

Labour and delivery complicated by fetal stress [distress]

267

1989

0.87

1.43

1.2

1.4

338.94

3105.81

e6/l

0.81

218

1552

Benign thyroid growths and nodules

373

3091

1.12

1.42

1.4

814.44

1672.08

e6/l

1.16

293

2418

Pedal cyclist injured in transport accident

281

2465

1.14

1.42

1.4

1.5

633.37

2556.64

e6/l

0.67

219

1944

Congenital deformities of hip, including avohilmo

205

1.53

1.41

2.7

2084.32

283.82

e6/l

0.61

156

Gout, unspecified

208

1787

1.17

1.40

1.4

1181.86

2633.99

e6/l

0.49

159

1419

Intentional self-harm by smoke, fire and flames

2.74

1.39

1.3

1.7

1.67

37.94

e6/l

—

Toxic liver disease

119

1.70

1.39

1.8

1.4

213.29

136.10

e6/l

0.17

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

174

1.57

1.39

1.3

2.2

11.37

133.30

e6/l

1.84

135

L02BX Other hormone antagonists and related agents

409

0.66

1.38

1.3

1.4

20.52

1088.53

e6/l

2.05

333

Sudden idiopathic hearing loss

110

893

1.24

1.38

1.5

1.4

2616.73

1266.49

e6/l

0.36

705

Endometriosis ASRM stages 3,4

275

2415

1.14

1.38

1.4

1625.95

2793.78

e6/l

0.30

221

1902

Other aneurysm

425

1.35

1.37

2.1

1.4

3121.02

832.54

e6/l

0.53

336

Lifestyle-related condition

1.78

1.37

1.5

1.3

530.45

132.96

e6/l

0.72

Single delivery by forceps and vacuum extractor

151

1075

0.83

1.36

1.3

1.4

586.72

4792.58

e6/l

0.59

120

810

Atrioventricular septal defect

0.00

1.36

0.0

4.2

—

495.56

—

Benign neoplasm: Transverse colon

119

976

1.23

1.36

1.6

1.4

765.97

846.97

e6/l

0.05

771

Malignant neoplasm of small intestine

183

1.55

1.36

1.6

1.3

759.86

843.30

e6/l

0.03

148

Neuroendocrine tumor and carcinoma of stomach

0.00

1.35

0.0

1.4

—

212.78

—

Congenital malformations of spine and bony thorax

2.09

1.35

1.4

3.6

198.09

343.74

e6/l

0.29

Contact with sharp glass

375

1.37

1.35

1.5

317.77

1232.32

e6/l

0.92

292

Exposure to other and unspecified forces of nature

2.02

1.35

1.1

1.2

20.20

277.06

e6/l

—

Alopecia areata

249

1.46

1.34

1.2

1.7

54.33

178.29

e6/l

1.26

187

Valvular operations

105

1289

0.81

1.34

1.3

1.6

1405.05

3041.86

e6/l

0.40

996

Unspecified jaundice

341

1.39

1.34

1.2

1.6

991.21

1550.34

e6/l

0.24

265

Adjustment and management of implanted device

166

1406

1.18

1.34

1.3

1.5

1284.48

2726.40

e6/l

0.39

126

1101

Fall on and from ladder

655

1.27

1.34

1.3

1.4

903.31

755.97

e6/l

0.10

519

Benign neoplasm of mouth and pharynx

120

987

1.22

1.34

1.3

1.5

6843.33

1280.53

e6/l

0.48

778

Premature rupture of membranes

224

1836

0.87

1.34

1.3

1.4

3482.85

3060.31

e6/l

0.05

193

1422

Benign neoplasm: Choroid

585

1.29

1.33

1.6

1.5

351.40

818.98

e6/l

0.82

465

Viral warts

120

988

1.22

1.33

1.6

488.09

4913.05

e6/l

0.60

103

770

Dissocial personality disorder

121

1.67

1.32

2.6

1.3

3300.85

2458.25

e6/l

0.09

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

692

1.26

1.32

1.8

1.4

1048.76

1158.75

e6/l

0.06

545

Granulomatous disorders of skin and subcutaneous tissue

217

1.49

1.32

1.5

1.3

8530.96

889.41

e6/l

0.42

167

Postpartum hemorraghe, parous women as controls

271

2570

0.88

1.31

1.4

3182.00

967.92

e6/l

0.46

219

2030

Female infertility, tubal origin

438

1.33

1.30

1.4

106.57

825.55

e6/l

1.93

343

Bicipital tendinitis

395

1.35

1.30

1.6

1.4

1001.13

352.48

e6/l

0.52

311

Psoas tendinitis

2.13

1.30

1.1

1.5

121.00

82.00

e6/l

—

Pituitary-dependent Cushing's disease

2.38

1.30

1.3

1.2

89.75

196.38

e6/l

—

Family history of certain disabilities and chronic diseases leading to disablement

482

1.32

1.29

1.4

214.20

9746.02

e6/l

0.64

375

Acne vulgaris

114

935

1.22

1.29

1.4

1.5

1883.33

4997.53

e6/l

0.33

726

Diabetic nephropathy

163

1367

1.18

1.29

1.8

1.4

3349.80

2703.77

e6/l

0.08

137

1080

Peritonsillar abscess

261

2297

1.14

1.28

1.4

1388.45

2662.38

e6/l

0.31

211

1792

Follow-up examination after treatment for malignant neoplasms

650

1.27

1.28

1.7

1.4

1532.74

1310.55

e6/l

0.08

497

Tuberculosis of other organs

130

1.63

1.27

1.3

1.4

184.81

174.26

e6/l

0.02

105

Disorders of puberty, all

170

1.55

1.27

2.2

3.2

1803.52

138.19

e6/l

0.67

129

Other mycoses, not elsewhere classified/unspecified, including avohilmo

146

1.59

1.27

1.6

1.4

2200.50

1400.00

e6/l

0.15

114

Non-small cell lung cancer

816

0.77

1.27

1.3

1.4

794.36

1041.60

e6/l

0.18

658

Malignant neoplasm of accessory sinuses, including Hilmo

2.28

1.26

1.6

1.3

4649.13

3438.86

e6/l

—

Hypoplasia of dental enamel , including avohilmo

424

1.33

1.25

6.7

2.6

403.61

282.75

e6/l

0.18

307

Abnormal findings on examination of urine, without diagnosis

372

1.35

1.25

1.6

49207.76

464.31

e6/l

0.51

288

Torsion of testis

163

1.55

1.24

1.4

2.3

4574.95

1233.37

e6/l

0.47

119

Other disorders of pigmentation

381

1.35

1.24

1.2

1.4

360.17

1092.85

e6/l

0.91

297

Haemangioma, any site

102

833

1.23

1.24

1.4

1.6

1440.76

1129.34

e6/l

0.11

654

Ectropion of eyelid

245

1.44

1.24

1.3

1.4

141.76

384.74

e6/l

0.96

197

Pediculosis, acariasis and other infestations

565

1.28

1.23

1.5

1.6

737.95

1017.28

e6/l

0.20

433

Exposure to smoke, fire and flames

204

1.49

1.23

1.2

1.5

80.33

1033.65

e6/l

0.80

157

Inflammatory bowel disease, strict (require KELA)

295

2625

1.13

1.23

1.6

1.5

880.34

2695.38

e6/l

0.65

238

2059

Crohn's disease of large intestine

495

1.30

1.23

1.3

1.6

440.96

1686.90

e6/l

0.97

385

Unspecified threat to breathing

1.75

1.23

1.3

1.6

2.00

98.88

e6/l

0.80

Papillary adenocarcinoma of thyroid gland

469

1.31

1.22

1.4

1167.53

961.61

e6/l

0.09

369

Pedal cyclist injured in other and unspecified transport accidents

136

1144

1.19

1.22

1.5

766.69

4312.91

e6/l

0.54

110

894

Hirsutism in women

180

1.52

1.22

1.2

1.4

16.05

120.86

e6/l

1.61

145

Benign neoplasm: Peripheral nerves and autonomic nervous system

124

1.63

1.22

1.4

1.3

466.64

1030.44

e6/l

0.26

Other/unspecified rheumatoid arthritis

124

1035

1.20

1.21

1.3

1.4

476.58

1276.18

e6/l

1.59

813

Carcinoma in situ of skin of other and unspecified parts of face

602

1.27

1.21

1.4

1666.39

748.06

e6/l

0.64

481

Congenital malformations of cardiac septa

714

1.24

1.20

1.5

2.6

212.97

612.10

e6/l

1.08

534

Benign lipomatous neoplasm

338

3037

1.12

1.20

1.4

1054.84

2710.08

e6/l

0.68

276

2402

Toxic effect of other noxious substances eaten as food

2.36

1.20

1.2

56.33

378.11

e6/l

—

Lichen sclerosus et atrophicus

129

1083

1.20

1.19

1.5

1.4

4838.83

1321.22

e6/l

0.62

854

Certolizumab pegol

173

1.52

1.19

1.3

1270.80

102.73

e6/l

0.76

129

Retinal breaks without detachment

181

1563

1.16

1.19

1.4

543.57

1636.63

e6/l

2.48

129

1231

Other congenital malformations of skin, including avohilmo

101

829

1.22

1.18

1.7

1885.33

5886.90

e6/l

0.38

637

Mental and behavioural disorders due to hallucinogens

2.05

1.18

1.2

1.3

295690.20

246.89

e6/l

—

Malignant neoplasm of other and unspecified major salivary glands

0.00

1.18

0.0

1.3

—

281.64

—

Colon adenocarcinoma, helper endpoint

1016

0.80

1.18

1.4

372.03

977.86

e6/l

1.52

804

Ectopic pregnancy

209

1826

1.15

1.18

1.4

1512.69

3011.49

e6/l

0.30

157

1427

Hypertrichosis

215

1.46

1.17

1.2

1.4

15.96

1306.28

e6/l

0.56

172

Lichen simplex chronicus and prurigo

561

1.27

1.17

1.5

1.3

4783.13

1268.63

e6/l

0.42

437

Idiopathic gout

749

1.23

1.16

1.3

1.4

2233.54

785.75

e6/l

0.42

605

Postpartum hemorraghe, all women as controls

271

2968

0.89

1.16

1.4

1.3

3182.00

2349.30

e6/l

0.12

219

2316

Open wound of shoulder and upper arm

166

1.52

1.16

1.1

1.4

22.44

1021.91

e6/l

0.55

134

LSIL lesion of the cervix uteri

149

1271

1.18

1.16

1.3

28146.64

1438.71

e6/l

0.49

109

1008

Gestational diabetes (for exclusion)

500

3150

1.09

1.16

1.4

1.3

317.38

2494.12

e6/l

1.10

395

2460

Other menopausal disorders

329

1642

1.12

1.16

1.4

2125.90

1627.10

e6/l

0.18

261

1296

Other infestations, including avohilmo

150

1.55

1.16

1.2

1.8

261.60

919.03

e6/l

0.40

116

Dilated cardiomyopathy

979

0.80

1.14

1.5

382.07

894.33

e6/l

0.96

777

Lichen planus, including avohilmo

216

1896

1.14

1.4

865.56

1367.28

e6/l

0.67

173

1498

Contusion of toe(s) with damage to nail

103

1.67

1.14

2.2

1.5

28803.00

243.34

e6/l

0.47

Lupus nephritis

2.40

1.14

2.4

2.3

0.57

239.59

e6/l

—

All dysplastic lesions of the vulva

396

1.32

1.14

1.9

1.4

302.74

1397.99

e6/l

0.86

307

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

267

1.40

1.13

1.5

115.37

456.71

e6/l

1.01

208

Disorders of purine and pyrimidine metabolism

2.04

1.13

3.5

2.2

218.00

216.72

e6/l

—

Early onset COPD

240

2123

1.13

1.5

1.4

1466.79

1563.25

e6/l

0.06

196

1659

Iron deficiency anaemia secondary to blood loss (chronic)

162

1394

1.17

1.13

1.5

919.30

1302.35

e6/l

0.22

130

1110

Other and unspecified glaucoma

537

1.27

1.13

1.6

1.4

1254.30

719.51

e6/l

0.24

423

Spermatocele

537

1.27

1.13

1.6

1.4

392.58

1084.57

e6/l

0.91

428

Open wound of hip and thigh

293

1.38

1.12

1.4

1.6

585.00

1520.20

e6/l

0.56

224

Hallux valgus (acquired)

376

2434

1.11

1.12

1.5

1.4

1383.15

2912.77

e6/l

0.44

302

1895

Other surgical follow-up care

276

1.39

1.12

1.2

1.7

1510.25

981.85

e6/l

0.14

207

Macular pucker

162

1396

1.16

1.11

1.3

1.4

1296.22

2765.21

e6/l

0.41

116

1100

Degeneration of macula and posterior pole

507

3595

1.09

1.11

1.4

1.5

726.26

2052.11

e6/l

1.31

382

2881

Other osteochondropathies

664

1.24

1.11

1.6

1.5

1412.04

1262.53

e6/l

0.06

518

Congenital malformations of spine and bony thorax, including avohilmo

1.86

1.11

1.4

3.2

181.83

279.39

e6/l

0.22

Abscess of Bartholin gland

260

1.40

1.10

1.1

1.5

313.23

1406.39

e6/l

0.53

203

Amiodarone users

808

0.79

1.10

1.4

1771.38

635.09

e6/l

0.50

644

Seropositive rheumatoid arthritis, wide

283

2533

1.12

1.10

1.3

1.4

1185.44

1220.66

e6/l

0.01

227

2003

Benign neoplasm of ovary

182

1584

1.15

1.10

1.4

511.80

3720.42

e6/l

0.74

140

1244

Other protozoal intestinal diseases

120

1.60

1.10

1.3

1.9

142.67

192.31

e6/l

0.14

Synovial cyst of popliteal space [Baker]

593

1.25

1.10

1.3

1.4

1888.93

618.89

e6/l

0.36

467

Ventral hernia

263

2345

1.12

1.09

1.5

1.4

1756.52

1442.78

e6/l

0.16

219

1851

Disorders of eyelid in diseases classified elsewhere

269

1.39

1.09

1.5

87.27

465.02

e6/l

0.75

213

L02BB Anti-androgens

627

0.76

1.08

1.3

1.4

562.62

1203.02

e6/l

0.62

501

Single delivery by caesarean section

195

1272

0.87

1.08

1.7

1.4

3689.43

4159.20

e6/l

0.04

156

957

Colon adenocarcinoma

1004

0.81

1.08

1.4

372.03

1138.03

e6/l

1.79

807

All dysplastic lesions of the cervix uteri, vagina or vulva

383

3402

1.10

1.07

1.4

10815.62

1346.51

e6/l

0.46

292

2668

conjunctival haemorrhage

676

1.23

1.07

1.3

1.5

196.63

1057.49

e6/l

2.39

530

Other and/or unspecified nontoxic goitre

694

1.23

1.07

1.5

1.4

1411.32

1361.72

e6/l

0.02

540

Cardiomyopathy (excluding other)

1145

0.83

1.07

1.5

507.28

2818.75

e6/l

0.62

893

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

2.16

1.07

3.9

2.2

246.86

266.38

e6/l

—

Burn and corrosion confined to eye and adnexa

203

1.44

1.06

1.3

1.6

887.70

2041.61

e6/l

0.41

157

Varicose veins of other sites

587

1.25

1.06

1.3

1.6

1256.08

1127.27

e6/l

0.05

449

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

205

1749

1.14

1.06

1.5

1.9

440.64

3252.70

e6/l

0.69

166

1346

Contusion of other and unspecified parts of foot

534

1.26

1.05

1.5

1.7

971.87

8757.47

e6/l

0.56

418

Obstructed labour due to maternal pelvic abnormality

168

1460

1.15

1.05

1.4

4745.74

1801.78

e6/l

0.32

124

1130

Dislocation, sprain and strain of joints and ligaments of elbow

669

1.23

1.05

1.7

2.0

468.21

7232.38

e6/l

0.61

508

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

360

0.69

1.05

1.2

1.3

14.28

745.53

e6/l

1.39

299

Endometriosis diagnosis and infertility diagnosis occurring together

136

1164

1.17

1.04

1.5

1.3

806.09

4749.67

e6/l

0.63

105

922

Nontoxic diffuse goitre

246

1.39

1.04

1.5

226.11

1715.15

e6/l

0.74

192

Congenital hypothyroidism without goiter

1.96

1.03

1.2

2.1

336.44

322.75

e6/l

—

Aortic aneurysm

179

2004

0.87

1.03

1.5

1.4

774.09

2491.77

e6/l

0.82

148

1596

Acute epiglottitis

114

1.60

1.03

1.3

984.64

747.53

e6/l

0.08

Burn and corrosion of wrist and hand

350

1.32

1.03

1.4

1.6

3118.67

504.48

e6/l

0.52

268

Placenta praevia

485

0.74

1.03

1.5

1.4

205.57

8762.94

e6/l

0.55

375

188

1.45

1.02

1.4

1.8

443.17

131.71

e6/l

0.32

139

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

753

1.21

1.02

1.2

1.4

1035.34

1456.14

e6/l

0.27

580

Haemangioma and lymphangioma, any site

106

890

1.20

1.02

1.4

1.6

1390.81

1259.48

e6/l

0.04

696

Exposure to other and unspecified animate mechanical forces

290

1.36

1.02

1.3

1.7

1722.14

1661.76

e6/l

0.01

227

Other protozoal intestinal diseases, including avohilmo

180

1.46

1.01

1.2

1.9

6206.28

592.87

e6/l

0.43

143

Other and unspecified psoriasis

618

1.24

1.01

1.3

1.5

195.00

703.64

e6/l

1.19

475

Complications associated with artificial fertilization

172

1.47

1.01

1.4

40.60

179.71

e6/l

1.16

139

Unspecified kidney failure

791

1.21

1.00

1.6

1.5

684.26

1222.76

e6/l

0.47

629

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.99

0.0

5.0

—

249.23

—

Carcinoma in situ of breast

0.00

0.99

0.0

1.2

—

125.40

—

AV-block

186

1396

1.14

0.98

1.3

1.5

809.05

2717.46

e6/l

0.61

161

1107

Injury of nerves at wrist and hand level

353

1.31

0.98

1.5

1006.88

1231.43

e6/l

0.11

277

Other inflammation of vagina/vulva

362

1.31

0.98

1.2

1.5

439.07

1126.87

e6/l

0.38

286

Monoarthritis, not elsewhere classified

362

1.31

0.98

1.2

1.4

232.38

1139.59

e6/l

1.02

296

Reiter disease

1.83

0.98

1.3

1.5

572.44

197.84

e6/l

—

Seborrhoeic dermatitis

109

922

1.19

0.98

1.5

348.07

1078.04

e6/l

1.85

716

Supervision of high-risk pregnancy

265

1428

1.12

0.97

1.3

4836.68

3907.37

e6/l

0.09

206

1103

Paget disease

0.00

0.97

0.0

1.3

—

96.48

—

Deficiency of other B group vitamins

157

1.48

0.97

1.3

1.5

2511.06

123.38

e6/l

0.48

125

Urethritis and urethral syndrome

157

1.48

0.96

1.3

1.5

58.67

682.83

e6/l

0.64

114

Benign neoplasm: Anus and anal canal

216

1.40

0.96

1.5

1.3

551.78

728.91

e6/l

0.11

164

Normotensive glaucoma

686

1.21

0.96

1.4

778.56

1189.47

e6/l

0.41

535

Other obstructed labour

769

0.80

0.95

1.4

2954.25

6275.37

e6/l

0.25

593

Other congenital malformations of the digestive system

449

1.27

0.95

2.7

1430.31

863.03

e6/l

0.26

334

Other disorders of Eustachian tube

268

1.35

0.95

1.2

1.5

1162.79

560.93

e6/l

0.20

209

HSIL lesion of the vulva

158

1.47

0.94

1.3

1.5

9.67

129.50

e6/l

2.16

119

Nephrotic syndrome

277

1.35

0.94

1.7

2.0

73603.12

723.73

e6/l

0.49

210

Other sexually transmitted chlamydial diseases, including avohilmo

131

1130

1.16

0.93

1.4

93.26

4248.19

e6/l

0.66

881

Carcinoma in situ of skin of scalp and neck

192

1.42

0.93

1.9

1.3

46.89

958.63

e6/l

0.92

154

Other diseases of gallbladder

339

1.31

0.92

1.4

1.3

144.97

370.47

e6/l

0.70

265

Calculus of lower urinary tract

401

1.28

0.92

1.6

1.4

1016.25

606.00

e6/l

0.22

310

Autism spe, excluding more controls

192

1.41

0.92

1.1

2.6

395.76

1086.94

e6/l

0.33

143

Other chronic obstructive pulmonary disease, including avohilmo

523

4611

0.93

0.91

1.5

1.4

1564.48

1833.83

e6/l

0.16

414

3677

Benign neoplasm of major salivary glands

101

855

1.19

0.91

1.3

1.4

636.11

1170.59

e6/l

0.53

665

Contraceptive management

550

3581

1.07

0.90

1.3

1.4

2219.54

2729.02

e6/l

0.12

456

2768

Malignant neoplasm of colon

113

1317

0.86

0.90

1.3

1.4

265.55

1260.65

e6/l

3.29

1067

Other, unspecified and serous retinal detachments

262

1.35

0.90

1.4

1.5

619.79

912.17

e6/l

0.17

206

Benign neoplasm: Colon, unspecified

260

2350

1.11

0.90

1.4

2308.11

1388.27

e6/l

0.23

208

1859

Other blood glucose lowering drugs, excl. Insulins

156

1368

1.14

0.90

1.6

1.4

1373.47

1280.27

e6/l

0.05

125

1082

Scabies, including avohilmo

195

1735

1.13

0.89

1.3

1.6

612.32

3444.64

e6/l

0.68

156

1343

Bronchiectasis

628

1.22

0.89

1.4

1.5

1091.90

938.18

e6/l

0.08

498

Maternal care for cervical incompetence

350

1.29

0.89

1.6

1.3

711.41

351.23

e6/l

0.23

268

Medical treatment for female infertility

225

2480

0.90

0.89

1.4

1041.87

2788.90

e6/l

0.54

174

1960

Other and unspecified mononeuropathies of lower limb

211

1.38

0.89

1.6

1.5

1382.63

760.47

e6/l

0.17

154

Postpartum care and examination

179

991

1.14

0.89

1.3

5426.85

5119.43

e6/l

0.02

155

760

Benign neoplasm: Descending colon

611

1.22

0.88

1.3

1.4

414.16

953.21

e6/l

0.95

473

Hallux rigidus

138

1202

1.15

0.88

1.3

1.4

766.57

1007.41

e6/l

0.26

117

943

Allergic purpura

246

1.35

0.88

1.5

1.6

115.59

436.95

e6/l

0.48

189

Idiopathic thrombocytopenic purpura

255

1.34

0.87

1.7

1.4

94.85

671.88

e6/l

0.67

196

Atherosclerosis, excluding cerebral and coronary sclerosis

344

2943

0.92

0.87

1.4

1486.54

2095.21

e6/l

0.27

285

2354

Peripheral retinal degeneration

264

1.34

0.86

2.3

1.5

1018.88

622.60

e6/l

0.19

205

Myeloproliferative diseases (CML excluded)

631

1.21

0.86

1.3

1.4

924.47

1337.25

e6/l

0.20

489

Evidence of alcohol involvement determined by blood alcohol level

120

1.52

0.86

1.2

1.3

79.08

1016.28

e6/l

0.50

Viral agents as the cause of diseases classified to other chapters

187

1.40

0.86

1.3

1.8

652.71

785.87

e6/l

0.06

145

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

272

2472

1.10

0.86

1.4

1228.22

1232.58

e6/l

0.00

219

1956

Primary adrenocortical insufficiency

1.58

0.85

1.5

1.3

73.11

115.42

e6/l

—

Other endophthalmitis

1.81

0.85

1.4

1.7

888.88

147.94

e6/l

—

Atopic conjunctivitis

442

1.25

0.85

1.9

1.7

1138.07

1209.63

e6/l

0.02

342

Other misadventures during surgical and medical care

213

1.37

0.85

1.4

613.21

695.94

e6/l

0.04

158

Colectomy operation

167

1478

1.13

0.85

1.5

1.4

681.50

1288.40

e6/l

0.72

130

1163

Other respiratory diseases principally affecting the interstitium

170

1507

1.13

0.84

1.3

1.4

505.05

1038.74

e6/l

0.79

128

1188

Secondary malignant neoplasm of respiratory and digestive organs

139

0.57

0.84

1.3

96.00

1062.03

e6/l

—

116

Contact with sharp object, undetermined intent

231

1.35

0.84

1.6

1.4

2155.71

1064.23

e6/l

0.32

177

Skin changes due to chronic exposure to nonionizing radiation

391

3271

1.08

0.83

1.4

1279.95

1973.15

e6/l

0.38

295

2633

Chalazion

127

1105

1.15

0.83

1.4

1.5

1497.55

4654.57

e6/l

0.42

101

858

Other/unspecified seropositive rheumatoid arthritis

275

2505

1.10

0.83

1.4

1211.96

1225.08

e6/l

0.01

222

1983

Subacute thyroiditis

310

1.30

0.83

1.6

1.5

3851.69

1286.43

e6/l

0.29

237

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

772

1.18

0.83

1.5

1.4

10385.90

6026.44

e6/l

0.20

613

Assault by blunt object

113

1.52

0.83

2.3

1.4

458.83

795.39

e6/l

0.18

Infliximab

197

1.38

0.83

1.4

461.64

1568.34

e6/l

0.56

151

Respiratory tuberculosis

363

1.27

0.83

1.6

1.4

25.81

591.98

e6/l

1.13

287

Respiratory tuberculosis, confirmed and not-confirmed

363

1.27

0.83

1.6

1.4

25.81

591.98

e6/l

1.13

287

Gout due to impairment of renal function

1.66

0.82

1.3

39.83

1662.86

e6/l

0.54

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

337

1.28

0.82

1.4

18048.65

720.05

e6/l

0.53

258

Benign neoplasm: Ill-defined sites within the digestive system

1.73

0.81

1.3

1.2

401.50

148.66

e6/l

—

Acne conglobata

1.73

0.81

1.4

2.2

1008.75

136.92

e6/l

—

Tuberculosis

400

1.25

0.81

1.6

1.4

23.82

564.69

e6/l

1.23

319

Other renal tubulo-interstitial diseases

198

1.37

0.80

1.7

1.6

119.45

700.36

e6/l

0.53

160

Short stature, not elsewhere classified

256

1.32

0.80

4.2

4.4

635.00

16659.32

e6/l

0.50

185

Other conjunctival vascular disorders and cysts

181

1.39

0.80

1.3

701.00

796.26

e6/l

0.04

134

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

197

1804

0.90

0.80

1.4

13336.16

1551.53

e6/l

0.47

141

1459

Thyroid crisis or storm

0.00

0.80

0.0

1.3

—

22.11

—

Seborrhoeic keratosis

269

2454

1.10

0.80

1.5

1.4

4007.97

1321.78

e6/l

0.36

214

1953

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.80

0.0

4.5

—

1055.47

—

Erectile dysfunction, exclusion

0.00

0.80

0.0

1.3

—

348.63

—

Benign neoplasm: Scrotum

0.00

0.80

0.0

1.6

—

4859.05

—

Drug-induced gout

0.00

0.80

0.0

1.3

—

20.35

—

Wet age-related macular degeneration

107

1192

0.86

0.79

1.6

1.4

583.53

1077.31

e6/l

0.82

964

Atrial septal defect

390

1.26

0.79

1.5

3.0

165.55

796.61

e6/l

1.02

297

Malignant neoplasm of small intestine, including Hilmo

242

1.33

0.79

1.6

1.3

666.79

723.92

e6/l

0.03

196

Benign neoplasm: salivary glands, exclude unknown (D119)

785

1.18

0.79

1.3

1.4

642.85

1229.61

e6/l

0.53

609

Malignant neoplasm of skin, including Hilmo

616

3880

1.06

0.79

1.4

4905.67

1769.64

e6/l

0.40

477

3125

Ankylosing spondylitis, strict definition

402

1.25

0.79

1.6

1.4

11508.22

1797.50

e6/l

0.40

307

418

3495

1.08

0.78

1.5

1.4

1219.79

1962.05

e6/l

0.45

313

2805

Cardiomyopathies, Primary/intrinsic

1095

0.86

0.78

1.5

446.50

2960.78

e6/l

0.65

849

ILD, hospital admissions

142

1253

1.14

0.78

1.3

1.4

229.75

1075.86

e6/l

3.55

104

988

Other salmonella infections

278

1.30

0.77

1.9

1.6

215.79

492.29

e6/l

0.44

220

Occupational exposure to risk-factors

287

1.30

0.77

1.2

1.4

451.44

833.83

e6/l

0.30

223

Other salmonella infections, including avohilmo

367

1.26

0.77

1.7

1.6

345.29

595.29

e6/l

0.35

287

COPD, early/later onset

414

3731

0.93

0.77

1.5

1.4

1569.24

2012.62

e6/l

0.22

331

2983

Other obstetric trauma

572

0.80

0.77

1.2

1.3

10.75

7902.78

e6/l

0.62

444

Drowning and submersion while in natural water

1.79

0.77

1.2

1.5

24.50

279.32

e6/l

—

Other superficial mycoses

200

1.36

0.77

1.3

1.6

141.45

1028.25

e6/l

0.69

154

Other disorders of choroid

107

1.51

0.77

1.2

1.6

112.91

1205.37

e6/l

0.54

Foreign body on external eye

172

1538

1.12

0.76

1.4

1.5

392.51

1029.03

e6/l

1.56

140

1205

Malignant neoplasm of heart, mediastinum and pleura

1.53

0.76

2.1

1.4

32.33

1372.21

e6/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

494

0.79

0.76

1.3

1.4

84.62

977.77

e6/l

1.72

402

Graves disease, strict definition

117

1021

1.15

0.76

1.8

1.4

755.25

1355.35

e6/l

0.66

791

Other congenital malformations of upper alimentary tract

1.72

0.76

3.1

1.3

14.11

198.05

e6/l

—

Contact with other hot fluids

288

1.29

0.76

1.4

1.9

157.63

785.75

e6/l

0.68

216

Marasmic kwashiorkor

2.15

0.76

1.8

1.9

34757.20

273.56

e6/l

—

Disorders of iron metabolism

124

1.46

0.75

1.1

1.4

78.00

1073.56

e6/l

0.56

Chronic tubulo-interstitial nephritis

288

1.29

0.75

1.5

76.26

610.54

e6/l

0.75

227

Other/unspecified postprocedural disorders of ear and mastoid process

2.14

0.75

1.4

1.3

764.20

376.68

e6/l

—

Hair colour and hair shaft abnormalities

2.12

0.75

1.6

1.3

18.60

290.25

e6/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

172

1592

0.89

0.75

1.4

15256.63

1669.61

e6/l

0.47

123

1285

LSIL lesion of the vulva

271

1.30

0.75

2.3

1.5

428.70

1408.91

e6/l

0.46

208

Herpesviral keratitis and keratoconjunctivitis

369

1.25

0.75

1.5

1.6

1365.12

670.45

e6/l

0.38

290

Asthma and opportunity respiratory infection

369

1.25

0.75

1.4

1.5

1368.46

484.73

e6/l

0.36

291

Psoriasis vulgaris

212

1921

1.11

0.74

1.3

1.4

388.13

3157.26

e6/l

0.79

160

1514

Other and unspecified disorders of orbit

1.87

0.74

1.7

1.1

792.57

251.27

e6/l

—

Prurigo nodularis

184

1.37

0.74

1.9

1.2

38.41

801.73

e6/l

0.67

143

Congenital malformations of the musculoskeletal system, not elsewhere classified

150

1.41

0.74

1.2

2.2

15.14

130.78

e6/l

1.37

114

Benign neoplasm: Parotid gland

698

1.18

0.74

1.3

1.4

323.77

1194.02

e6/l

1.16

542

Other specified/unspecified spondylopathies

150

1.41

0.73

1.4

1314.36

246.70

e6/l

0.37

116

Gingival hyperplasia

352

1.26

0.73

2.5

2.1

171.58

532.73

e6/l

0.51

267

Chondrosarcoma

2.04

0.73

1.8

1.4

351.80

425.05

e6/l

—

COPD, hospital admissions

410

3701

0.93

0.73

1.5

1.4

1532.27

2018.61

e6/l

0.25

328

2961

Malignant neoplasm of prostate

241

1565

0.91

0.73

1.4

464.30

1572.36

e6/l

2.03

183

1269

Non-small cell lung cancer, including Hilmo

111

1191

0.87

0.73

1.2

1.4

732.91

1556.27

e6/l

0.79

959

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

147

1308

1.13

0.72

1.4

1449.97

1168.02

e6/l

0.12

116

1033

Glaucoma-related operations

425

1.23

0.72

1.3

212.51

721.53

e6/l

0.84

333

Total colectomy operation

362

1.25

0.72

1.4

1.6

1854.89

791.52

e6/l

0.37

275

Total colectomy

362

1.25

0.72

1.4

1.6

1854.89

791.52

e6/l

0.37

275

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

213

1879

1.10

0.72

1.5

1.9

547.76

3020.73

e6/l

0.64

172

1444

Eclampsia

1.97

0.71

1.2

1.1

127.00

123.19

e6/l

—

Other specified/unspecified disorders of ear

1.96

0.71

1.4

1.5

38.00

234.43

e6/l

—

Other and unspecified disorders of psychological development

130

1.43

0.71

2.8

5.0

1097.17

539.05

e6/l

0.31

Epiphora

177

1.37

0.71

1.3

2.63

197.83

e6/l

2.23

138

Melanocytic naevi, other sites/unspecified

822

1.16

0.71

1.3

1.5

1538.02

1195.82

e6/l

0.08

638

Injury of intra-abdominal organs

221

1.32

0.70

1.6

1.4

29.50

1364.28

e6/l

0.87

171

Malignant neoplasm of colon, including Hilmo

144

1607

0.89

0.70

1.3

1.4

247.97

1457.97

e6/l

2.69

112

1307

Coxarthrosis, primary, with hip surgery

437

4322

0.94

0.70

1.5

1.4

1210.89

1927.46

e6/l

0.52

352

3434

Complications following abortion and ectopic and molar pregnancy

292

1.27

0.70

1.4

1.3

215.50

1293.80

e6/l

0.61

223

Benign neoplasm: other/unspecified salivary gland

195

1.34

0.70

1.4

1.3

1599.86

724.81

e6/l

0.30

150

Mental and behavioural disorders due to tobacco

861

1.15

0.69

1.4

3619.95

1322.36

e6/l

0.50

674

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

135

1.42

0.69

1.9

1.4

26.91

1112.00

e6/l

0.74

110

Congenital malformations of lung, including avohilmo

1.89

0.69

3.4

2.8

28.00

7.79

e6/l

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.69

0.69

3.3

2.1

718.29

265.66

e6/l

—

Interstitial lung disease

142

1266

1.12

0.69

1.3

1.4

229.75

1062.17

e6/l

3.51

104

1001

Interstitial lung disease endpoints

142

1266

1.12

0.69

1.3

1.4

229.75

1062.17

e6/l

3.51

104

1001

Cysts of oral region, not elsewhere classified

547

1.19

0.68

1.6

1.4

1128.10

1522.76

e6/l

0.17

429

Abnormal findings in secretions and smears from cervix uteri vagina vulva

654

4562

1.06

0.68

1.4

6577.98

1568.07

e6/l

0.41

505

3579

Gout, strict definition

172

1551

1.11

0.68

1.4

1345.41

2496.20

e6/l

0.31

131

1239

Benign neoplasm: Connective and other soft tissue, unspecified

102

1.49

0.68

1.5

1.4

775.40

155.27

e6/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

465

1.21

0.68

1.7

1.3

3372.59

1366.39

e6/l

0.30

361

Smoking dependency

863

1.15

0.68

1.4

3619.95

1324.43

e6/l

0.50

673

Cyst of kidney

612

1.18

0.68

1.4

1.5

2063.32

980.65

e6/l

0.37

485

Myocardial infarction

482

3579

0.94

0.68

1.4

1.5

735.88

1981.54

e6/l

1.09

398

2774

Struck by thrown, projected or falling objec

511

1.20

0.68

1.6

91.16

933.60

e6/l

1.33

395

Hypothermia

136

1.41

0.67

1.2

1.5

27.93

942.84

e6/l

0.56

105

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo

1.82

0.67

1.0

1.3

17.40

95.64

e6/l

—

Other interstitial pulmonary diseases

142

1269

1.12

0.66

1.3

1.4

229.75

1068.18

e6/l

3.56

104

1001

malignant neoplasm of female genital organs

123

1354

0.89

0.66

1.3

1.4

780.00

1362.81

e6/l

0.66

102

1095

Polycythaemia vera

259

1.28

0.66

1.2

1.4

71.95

677.71

e6/l

0.80

209

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

1.61

0.66

1.9

1.3

74.71

262.66

e6/l

—

Exposure to other specified electric current

215

1.31

0.65

1.3

1.7

109.43

819.77

e6/l

0.66

164

Anisometropia and aniseikonia

286

1.27

0.65

1.8

1.9

1492.62

625.95

e6/l

0.39

214

Benign neoplasm: Small intestine

331

1.25

0.65

1.6

1.3

1499.57

627.04

e6/l

0.36

251

Contact with nonpowered hand tool

395

1.22

0.64

1.1

1.5

8441.95

1185.06

e6/l

0.43

304

Juvenile osteochondrosis

296

1.26

0.64

2.5

1.6

876.32

932.79

e6/l

0.03

227

Scabies

423

1.21

0.64

1.3

1.5

797.13

1058.76

e6/l

0.14

321

Melanocytic naevi of other and unspecified parts of face

561

1.18

0.63

1.5

1.4

202.42

1311.32

e6/l

1.34

442

Foreign body entering into or through eye or natural orifice

794

1.15

0.63

1.8

1.7

1560.15

789.92

e6/l

0.28

613

Polycystic ovarian syndrome, broad definition

141

1266

1.12

0.62

1.3

1.4

336.89

4572.33

e6/l

0.78

116

995

Abnormal spermatozoa

1029

0.87

0.62

1.4

2122.28

1019.79

e6/l

0.35

811

Allergic colitis

270

1.27

0.62

1.9

3.6

39.85

208.56

e6/l

1.23

198

Antenatal screening

246

1494

0.92

0.62

1.3

1230.99

3754.81

e6/l

0.43

188

1153

Henoch-Schönlein purpura nephritis (HSPN)

1.69

0.62

1.4

1.40

263.48

e6/l

—

Benign neoplasm: Caecum

105

927

1.14

0.62

1.3

1.4

693.88

1165.15

e6/l

0.39

723

Anomalies of dental arch relationship, including avohilmo

253

2113

1.08

0.62

2.2

1.6

294.02

3013.74

e6/l

0.84

200

1623

Other congenital malformations of the digestive system, including avohilmo

531

1.18

0.62

2.5

2.6

1554.88

761.73

e6/l

0.43

384

Cyst of Bartholin Gland

352

1.23

0.61

1.3

1.5

67.44

1211.96

e6/l

0.88

282

Whooping cough, including avohilmo

156

1.36

0.61

2.5

1.3

5204.81

130.75

e6/l

0.46

120

Injury of muscle and tendon at lower leg level

164

1487

1.11

0.61

1.3

1.4

1438.28

1130.52

e6/l

0.17

125

1168

Multiple system atrophy (rare forms of Parkinsonism)

0.00

0.61

0.0

1.2

—

150.07

—

Accidental poisoning by and exposure to alcohol

165

1.34

0.61

1.3

184853.12

1272.99

e6/l

0.47

125

Impaction of intestines

1.59

0.61

2.9

1.3

427.00

78.61

e6/l

—

Desensitization to allergens

565

0.83

0.61

1.3

1.9

133.26

7857.39

e6/l

0.60

441

Malignant neoplasm of prostate, including Hilmo

251

1604

0.92

0.61

1.4

381.88

1534.00

e6/l

2.30

188

1301

Maternal care related to the fetus and amniotic cavity and possible delivery problems

572

3180

1.06

0.60

1.4

2328.63

2661.01

e6/l

0.07

450

2458

Abdominal aortic aneurysm (AAA)

603

0.84

0.60

1.5

1.4

142.51

1024.01

e6/l

1.98

483

All dysplastic lesions of the cervix uteri

328

3017

1.07

0.60

1.3

12568.79

1361.55

e6/l

0.46

250

2363

Malignant neoplasm of other and unspecified urinary organs

0.00

0.60

0.0

1.4

—

113.53

—

Gonarthrosis, primary, with knee surgery

591

4834

0.95

0.60

1.4

1266.82

2077.65

e6/l

0.67

466

3825

CR(E)ST syndrome

131

1.39

0.59

1.3

1.2

68.46

168.70

e6/l

0.55

233

2168

0.92

0.59

1.4

616.79

1984.30

e6/l

0.73

184

1730

Hypertrophic cardiomyopathy

344

0.78

0.59

1.2

1.5

419.77

747.97

e6/l

0.31

266

Bus occupant injured in other and unspecified transport accidents

1.58

0.59

1.0

1.3

6.80

174.75

e6/l

—

Type 1 diabetes, strict definition, subgroup 2

0.00

0.59

0.0

4.5

—

95.60

—

Other and unspecified cicatricial alopecia

0.00

0.59

0.0

1.1

—

73.53

—

Motorcycle rider injured in noncollision transport accidents

273

1.25

0.58

1.2

1.6

1265.86

1409.97

e6/l

0.04

210

Intentional self-harm by jumping from a high place

1.50

0.58

1.0

1.4

249.87

174.20

e6/l

—

Vaginal lichen planus

1.50

0.58

1.3

1.2

170.00

78.07

e6/l

—

Squamous cell neoplasms and carcinomas of the skin

716

1.15

0.57

1.5

1.4

578.83

1254.63

e6/l

0.95

597

Essential (haemorrhagic) thrombocythaemia

301

1.24

0.57

1.4

1570.59

1016.86

e6/l

0.16

244

malignant neoplasm of female genital organs, including Hilmo

148

1554

0.91

0.57

1.4

672.80

1358.41

e6/l

0.99

122

1256

Serous carcinoma of ovary, including Hilmo

286

0.77

0.57

1.2

1.4

753.06

764.62

e6/l

0.01

227

Other abnormal uterine and vaginal bleeding

254

1691

1.08

0.57

1.3

1.4

1153.33

1530.63

e6/l

0.17

192

1339

Major coronary heart disease event excluding revascularizations

688

4335

1.05

0.57

1.4

1.5

767.94

1847.55

e6/l

1.14

565

3362

Maternal care for known or suspected fetal abnormality and damage

199

1548

1.09

0.57

1.3

1.4

482.66

3414.71

e6/l

0.62

132

1206

Pleural effusion

139

1256

1.11

0.56

1.5

1.4

328.85

1293.73

e6/l

2.42

114

988

Other otitis externa (chronic)

624

1.16

0.56

1.4

1.6

2346.64

973.36

e6/l

0.38

484

Carcinoma in situ of skin of upper limb, including shoulder

185

1.30

0.56

1.3

1457.47

1033.36

e6/l

0.11

149

Contact with other sharp object(s)

709

1.15

0.56

1.2

1.5

1757.55

1262.83

e6/l

0.12

539

Hypoplasia of dental enamel, prenatal , including avohilmo

1.50

0.56

5.3

5.8

134.57

495.06

e6/l

—

Tooth eruption problems

189

1675

1.09

0.56

2.4

1.7

417.80

3179.06

e6/l

0.63

151

1285

Need for immunization against other single viral diseases

159

1.33

0.56

2.2

1.4

311.06

1369.08

e6/l

0.60

120

Major anomalies of jaw size

239

1.26

0.55

1.3

1.9

132.08

942.67

e6/l

0.77

180

Myelodysplastic syndrome, including Hilmo

221

1.27

0.55

1.1

1.3

3423.71

753.68

e6/l

0.60

185

Complications of the puerperium, not elsewhere classified

412

1.19

0.55

1.2

1.5

46.24

10488.70

e6/l

0.60

325

Coronary atherosclerosis

751

4535

1.04

0.55

1.3

1.5

1233.98

1797.56

e6/l

0.45

628

3513

Postmenopausal bleeding

284

1384

1.08

0.55

1.4

905.97

1811.49

e6/l

0.53

216

1093

Malignant neoplasm of head and neck, including Hilmo

804

1.13

0.54

1.4

848.61

926.37

e6/l

0.06

639

Pemphigoid

195

1.29

0.54

1.2

1.3

30.05

857.59

e6/l

0.82

155

ILD, hospital admissions 1, main diag only

124

1117

1.11

0.54

1.3

1.4

229.05

900.78

e6/l

2.53

876

Male infertility

413

1.19

0.54

1.9

1.5

5662.68

901.28

e6/l

0.53

323

Mild mental retardation

240

1.26

0.54

1.3

2.4

359.00

1013.76

e6/l

0.48

177

Malignant neoplasm of oesophagus, including Hilmo

272

0.77

0.53

1.1

1.4

38.07

942.99

e6/l

1.20

220

Malignant neoplasm of tonsil

134

1.35

0.53

1.3

670.15

999.02

e6/l

0.13

106

Chondrosarcoma, including Hilmo

1.56

0.53

1.7

1.4

293.17

283.97

e6/l

—

Distal bite

411

1.19

0.53

3.1

2.7

115.34

135.21

e6/l

0.10

317

Idiopathic urticaria

205

1.28

0.53

1.2

1.7

93.67

134.36

e6/l

0.19

160

Haemorrhagic and haematological disorders of fetus and newborn

239

1.25

0.52

5.8

4.3

390.57

902.78

e6/l

0.43

168

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

106

939

1.12

0.52

1.5

1.4

515.13

1199.65

e6/l

1.30

771

Selective deficiency of immunoglobulin A [IgA]y

1.52

0.52

1.5

2.2

0.50

167.57

e6/l

—

Actinic keratosis

369

3167

1.06

0.52

1.4

1349.93

2013.09

e6/l

0.34

279

2546

Nosocomial condition (hospital)

1.51

0.52

1.3

1.2

342.67

167.83

e6/l

—

Liveborn infants according to place of birth

1.44

0.51

3.2

4.2

13.13

252.66

e6/l

—

Malignant neoplasm of oral cavity, including Hilmo

360

1.20

0.51

1.3

1.4

1116.32

903.50

e6/l

0.08

283

Traction detachment of retina

1.48

0.51

1.6

1.3

120.64

164.13

e6/l

0.14

Polyp of the female genital tract

341

1816

1.06

0.51

1.4

3464.55

1517.72

e6/l

0.44

265

1441

Endometriosis of fallopian tube

1.40

0.51

3.1

1.6

5928.56

159.29

e6/l

—

Benign neoplasm of urinary organs

379

1.19

0.51

1.2

1.4

143.72

597.47

e6/l

0.79

294

Exclusion endpoint for clefts

206

1.27

0.51

1.5

3.6

565.86

352.19

e6/l

0.20

148

Alcohol-induced acute pancreatitis

306

1.21

0.51

1.3

1.4

800.36

1408.86

e6/l

0.25

242

Thoracic aortic aneurysm

121

1336

0.90

0.50

1.6

1.4

1098.48

2674.26

e6/l

0.43

1050

Chronic laryngitis and laryngotracheitis

119

1315

0.90

0.50

1.5

1.4

2521.19

1301.98

e6/l

0.49

1026

Mucosal proctocolitis

145

1324

1.10

0.50

1.4

1.5

957.11

3931.71

e6/l

0.52

112

1041

Malignant neoplasm of tonsil and base of tongue

171

1.29

0.50

1.3

615.60

787.04

e6/l

0.08

136

Antepartum haemorrhage, not elsewhere classified

102

915

1.12

0.50

1.2

1.4

3481.36

4824.38

e6/l

0.11

713

Congenital malformations of great arteries

252

0.77

0.49

1.3

4.1

7105.71

931.94

e6/l

0.47

179

Crowding of teeth, including avohilmo

119

891

1.11

0.49

2.6

2.0

105.11

4922.51

e6/l

0.57

681

UC patients in KELA-register (code 208), prior to 1994

372

1.19

0.49

1.3

1.4

166.46

1078.73

e6/l

1.34

282

Type1 diabetes, definitions combined, early onset

718

0.87

0.48

1.9

2.3

823.85

5889.97

e6/l

0.46

555

malignant neoplasm of male genital organs

260

1673

0.93

0.48

1.4

441.20

1577.66

e6/l

2.25

199

1353

Other disorders of veins

487

4572

1.05

0.48

1.3

1.4

2688.51

2631.73

e6/l

0.01

357

3591

Congenital malformations of heart and great arteries

153

1363

1.09

0.47

1.5

2.1

399.14

3900.84

e6/l

0.66

125

1041

Cervical polyps

921

0.89

0.47

1.2

1.4

4802.75

2168.09

e6/l

0.29

718

Benign neoplasm of middle ear and respiratory system

682

1.13

0.47

1.5

10449.00

900.46

e6/l

0.60

528

Scar conditions and fibrosis of skin

392

1.18

0.47

1.6

379.15

938.77

e6/l

0.62

304

Other nutritional anaemias

1.48

0.47

2.9

1.4

395.50

177.20

e6/l

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

191

1.26

0.46

1.3

547.00

762.96

e6/l

0.12

149

Unspecified lump in breast

165

1524

1.08

0.46

1.4

419.83

4284.50

e6/l

0.89

126

1188

Coxarthrosis, primary

660

5266

1.04

0.46

1.5

1.4

1901.31

2056.16

e6/l

0.05

528

4178

Retained placenta and membranes, without haemorrhage

115

1264

0.91

0.46

1.4

644.81

4315.26

e6/l

0.63

976

Benign neoplasm of bone and articular cartilage

807

1.12

0.46

1.3

1.5

305.64

1265.02

e6/l

1.30

623

Anoxic brain damage

1.44

0.46

1.5

1.3

13.45

1568.44

e6/l

0.55

L01XE Protein kinase inhibitors

440

1.16

0.45

3.5

1.5

151.75

740.31

e6/l

1.15

337

Duodenal ulcer

807

1.12

0.45

1.3

1.5

988.96

1443.66

e6/l

0.30

641

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

183

1.26

0.45

1.1

2.3

414.61

206.88

e6/l

0.36

137

Injury of muscle and tendon at hip and thigh level

115

1047

1.10

0.44

1.4

1.5

470.35

1162.22

e6/l

1.00

822

Maternal care for known or suspected malpresentation of fetus

208

1589

0.93

0.44

1.4

2168.01

3396.22

e6/l

0.18

158

1236

D07AA Corticosteroids, weak (group I)

183

1698

1.08

0.44

1.7

1.8

661.06

3231.56

e6/l

0.59

151

1313

Psoriatic arthropathies, ICD10

114

1038

1.10

0.44

1.4

1021.97

1163.88

e6/l

0.09

814

Benign neoplasm of other and unspecified female genital organs

382

0.83

0.43

1.1

1.4

6552.00

1271.43

e6/l

0.37

295

Femoral hernia

331

1.18

0.43

1.0

1.4

153.67

902.05

e6/l

1.16

262

Primary biliary cholangitis (PBC)

162

0.74

0.42

1.2

1.6

857.57

805.72

e6/l

—

128

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.42

0.42

1.1

1.2

0.75

230.43

e6/l

—

Wide developmental disorders

395

1.16

0.42

1.5

3.0

318.54

628.82

e6/l

0.28

290

Malignant neoplasm of oropharynx

140

1.29

0.42

1.3

670.15

971.96

e6/l

0.12

109

Impacted maxillary molar

680

0.88

0.42

1.8

1.6

492.21

5853.70

e6/l

0.47

527

Haemolytic disease of fetus and newborn

0.00

0.42

0.0

8.8

—

484.09

—

Use of selegiline

341

1.18

0.42

1.5

1.4

275.39

587.72

e6/l

0.40

267

Obstetric embolism

0.00

0.42

0.0

1.1

—

19.44

—

Oesophageal obstruction

258

1.21

0.42

1.4

70676.64

993.61

e6/l

0.49

200

Moderate mental retardation

1.39

0.42

2.3

3.0

413.50

272.98

e6/l

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

139

1506

0.92

0.42

1.4

1.5

594.63

3530.09

e6/l

0.61

115

1182

Mandibular retrognathia

688

0.88

0.42

2.4

1.8

97.92

1135.01

e6/l

1.63

532

Alport

0.00

0.42

0.0

4.0

—

302.87

—

Changes in corneal membranes

1.53

0.41

1.4

1.2

102.80

206.76

e6/l

—

Injury of blood vessels at abdomen, lower back and pelvis level

1.53

0.41

2.4

1.5

83.20

273.62

e6/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

1.37

0.41

1.5

1.3

2.63

191.55

e6/l

—

Folliculitis decalvans

0.00

0.41

0.0

1.3

—

9.64

—

Other complications of labour and delivery, not elsewhere classified

134

1287

0.92

0.41

1.2

1.4

1317.48

4092.40

e6/l

0.43

111

1015

Otosclerosis

643

1.12

0.41

1.6

1.4

359.50

874.01

e6/l

0.90

494

Other congenital malformations of face and neck

250

1.21

0.40

1.2

1.7

228.73

907.00

e6/l

0.63

196

Intrahepatic Cholestasis of Pregnancy (ICP)

729

1.11

0.40

1.3

1.4

986.23

6433.06

e6/l

0.52

569

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

872

1.10

0.40

1.2

1.4

895.80

5499.95

e6/l

0.52

674

Seropositive rheumatoid arthritis, strict definition

154

1429

1.08

0.40

1.3

1.4

2024.16

1235.19

e6/l

0.22

123

1119

177

1540

1.07

0.40

1.4

702.19

1107.48

e6/l

0.74

141

1236

Benign neoplasm: Skin of ear and external auricular canal

306

1.18

0.40

1.5

1.4

1710.74

609.78

e6/l

0.43

241

Complications of labour and delivery

792

4256

1.03

0.40

1.4

1752.00

2447.66

e6/l

0.23

623

3306

Disorders of sphingolipid metabolism and other lipid storage disorders

1.44

0.39

1.2

1.1

2.20

272.96

e6/l

—

Mumps, including avohilmo

214

1.22

0.39

1.5

1.4

793.00

533.04

e6/l

0.12

162

Inflammation of lacrimal passages (chronic)

105

0.66

0.39

1.4

1.3

58691.86

196.04

e6/l

—

Type 1 diabetes, definitions combined

118

1081

1.09

0.39

1.9

629.09

4378.12

e6/l

0.54

846

Unspecified urinary incontinence

778

1.11

0.39

1.6

1.5

3325.00

1068.76

e6/l

0.69

600

malignant neoplasm of male genital organs, including Hilmo

269

1708

0.94

0.39

1.4

367.61

1554.55

e6/l

2.56

203

1381

Congenital malformations of aortic and mitral valves

410

0.85

0.39

1.5

2.2

754.69

1220.71

e6/l

0.27

307

Extreme obesity with alveolar hypoventilation

367

0.84

0.39

1.4

158.23

234.42

e6/l

0.23

289

Granuloma annulare

124

1.30

0.39

1.3

1.2

4.00

92.51

e6/l

—

101

Pregnancy, childbirth and the puerperium

320

1586

1.05

0.39

1.4

186.74

3527.68

e6/l

0.77

247

1228

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

589

1.12

0.38

1.8

1.4

302.67

858.37

e6/l

1.02

460

Other and unspecified diseases of spleen

1.40

0.38

1.2

1.4

2.60

202.41

e6/l

—

Pacemaker

341

3020

1.05

0.38

1.4

1.5

1044.61

2059.90

e6/l

0.61

296

2412

Multiple delivery

853

0.90

0.38

1.7

1.4

2005.98

5233.51

e6/l

0.29

640

Other disorders of iris and ciliary body

215

1.21

0.38

1.5

1.4

802.90

1391.96

e6/l

0.23

166

Other and unspecified acute skin changes due to ultraviolet radiation

181

0.77

0.38

2.6

1.2

3.88

785.40

e6/l

—

140

Left bundle-branch block

632

0.88

0.38

1.4

199.50

965.01

e6/l

1.73

489

Pedal cyclist injured in collision with motor vehicle

289

1.18

0.38

1.2

1.3

1679.65

766.36

e6/l

0.27

218

Mumps

206

1.22

0.38

1.4

1.5

837.06

553.13

e6/l

0.13

156

Benign neoplasm: Skin of scalp and neck

214

0.79

0.38

1.2

1.5

933.00

647.25

e6/l

0.14

166

Foreign body or object entering through skin

609

1.12

0.38

1.8

1.5

238.64

825.83

e6/l

0.91

468

Atrial septal defect, secundum type

299

0.83

0.37

1.9

3.0

32.10

240.90

e6/l

1.91

222

Type 1 diabetes, strict (exclude DM2)

117

1076

1.09

0.37

1.9

635.79

4409.15

e6/l

0.54

840

Other psoriatic arthropathies

110

1012

1.09

0.37

1.4

1.5

1057.16

1163.13

e6/l

0.06

792

Carcinoma in situ, bladder

289

0.83

0.36

1.8

1.3

658.44

682.21

e6/l

0.01

232

Pedal cyclist injured in noncollision transport accidents

130

1205

1.08

0.36

1.4

1.6

755.03

4168.27

e6/l

0.55

100

941

Embedded and impacted teeth

329

2797

0.95

0.36

1.6

1.5

649.49

2459.23

e6/l

0.66

271

2172

Unspecified contracted kidney

1.48

0.36

1.0

1.4

7.67

227.32

e6/l

—

Benign lipomatous neoplasm of other sites/unspecified

724

0.90

0.36

1.9

1.4

877.57

1152.49

e6/l

0.17

566

Rhinophyma

1.48

0.36

2.2

1.4

1139.33

3148.77

e6/l

—

Barrett oesophagus

422

1.14

0.36

1.3

1.5

110.15

848.26

e6/l

1.40

321

Allergic contact dermatitis

148

1380

1.07

0.36

1.4

1.5

838.34

3851.15

e6/l

0.55

122

1073

Childhood allergy (age < 16)

191

1480

1.07

0.36

1.9

497.33

3439.41

e6/l

0.58

155

1133

Malignant neoplasm of tonsil, including Hilmo

144

1.26

0.35

1.3

670.15

945.92

e6/l

0.11

112

Malignant neoplasm of floor of mouth

1.41

0.35

1.0

1.4

1.00

2781.47

e6/l

—

Family history of other specific disorders

125

0.72

0.35

1.1

1.5

72.22

220.32

e6/l

—

Puerperal sepsis

134

1246

1.08

0.35

1.3

1.4

831.79

1424.73

e6/l

0.60

104

962

Cardiomyopathy, other and unspecified

679

1.11

0.35

1.4

1.5

1178.76

639.98

e6/l

0.22

535

Labour and delivery complicated by umbilical cord complications

469

0.87

0.35

1.3

1.4

136.83

9523.56

e6/l

0.60

361

Primary coxarthrosis, bilateral

278

2647

1.05

0.35

1.5

1.4

3323.11

2009.62

e6/l

0.23

220

2105

Inguinal or femoral hernia, bilateral

910

1.09

0.34

1.3

1.4

1299.37

1038.82

e6/l

0.08

714

Oral lichen planus, including avohilmo , including avohilmo

671

1.11

0.34

1.3

1.4

96.12

1382.51

e6/l

2.09

518

Delivery, wide proxy

374

1900

1.05

0.34

1.4

1020.51

3212.22

e6/l

0.51

296

1473

Malignant neoplasm of stomach, including Hilmo

436

0.87

0.34

1.6

1.4

6290.24

673.71

e6/l

0.43

349

Sequelae of burns, corrosions and frostbite

1.34

0.34

8.5

1.7

45.33

228.03

e6/l

—

Right hemicolectomy

443

1.13

0.34

1.6

1.4

217.39

809.18

e6/l

0.99

349

Melanoma in situ of other and unspecified parts of face

1.33

0.34

1.2

1.3

0.43

1462.72

e6/l

—

Artificial joint operation, meniscal resection

1141

7121

1.02

0.34

1.4

1044.02

2408.55

e6/l

1.31

895

5635

Failed induction of labour

678

0.90

0.34

1.4

27.60

6660.96

e6/l

0.61

521

Benign neoplasm: Long bones of lower limb

286

0.84

0.34

1.5

1.4

858.56

1691.28

e6/l

0.27

220

Obstructed labour due to malposition and malpresentation of fetus

255

2481

0.95

0.33

1.4

3254.20

2868.37

e6/l

0.05

196

1928

COPD-related respiratory insufficiency

903

1.09

0.33

1.4

975.07

1037.54

e6/l

0.03

705

In situ neoplasms

436

4201

1.04

0.33

1.4

1022.00

2743.70

e6/l

0.89

336

3351

Cholangitis (primary sclerosing, PSC), with reimbursement 202

164

1.23

0.33

1.3

2.1

36.79

193.66

e6/l

1.50

121

Other noninfective disorders of lymphatic vessels and lymph nodes

322

1.15

0.32

1.2

1.5

12562.89

1111.87

e6/l

0.69

249

Carcinoma in situ of other and unspecified sites

306

0.85

0.32

1.8

1.3

592.80

665.61

e6/l

0.04

244

Ankylosing hyperostosis [Forestier]

1.31

0.32

1.1

1.4

113.17

931.60

e6/l

0.50

Benign leiomyoma with endometriosis

153

1437

1.07

0.32

1.4

1891.76

1642.60

e6/l

0.07

129

1133

Other disorders of amniotic fluid and membranes

164

1490

1.06

0.32

1.3

1.4

279.56

3542.97

e6/l

0.69

131

1162

Idiopathic pulmonary fibrosis

549

0.89

0.31

1.2

1.4

29.82

652.64

e6/l

2.13

438

Carcinoma in situ of cervix uteri

105

1132

0.93

0.31

1.2

1.4

124.16

4757.65

e6/l

0.77

894

Arthropathic psoriasis

120

1118

1.08

0.31

1.4

1.5

1014.08

1199.98

e6/l

0.13

878

Impacted teeth

237

2135

0.95

0.31

1.6

1.5

860.78

2790.96

e6/l

0.50

194

1664

Unspecified chronic bronchitis

251

0.83

0.31

1.4

2433.00

518.37

e6/l

0.36

205

Benign neoplasm: Bronchus and lung

0.73

0.31

1.1

1.2

5.43

1347.96

e6/l

—

Delivery

464

2359

1.04

0.30

1.3

1.4

1325.70

2708.92

e6/l

0.36

365

1804

Benign neoplasm: Rectosigmoid junction

334

1.14

0.30

1.4

1.3

265.42

580.32

e6/l

0.41

258

Other corneal oedema

1.28

0.30

1.3

1.2

0.86

164.91

e6/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

745

1.09

0.29

1.3

1.4

986.23

2064.40

e6/l

0.40

600

Thyrotoxicosis with toxic multinodular goitre

504

0.89

0.29

1.4

257.63

1493.01

e6/l

1.29

386

Open bite

582

1.10

0.29

1.9

2.3

333.79

7490.67

e6/l

0.55

448

Cholesteatoma of middle ear

420

1.12

0.29

1.3

1.4

508.45

779.97

e6/l

0.34

335

Abnormalities of forces of labour

100

1076

0.93

0.29

1.2

1.4

487.54

5197.46

e6/l

0.71

826

Artificial joint re-operation

573

1.10

0.29

1.4

1812.40

1055.86

e6/l

0.26

444

Presence of other devices

240

2255

1.05

0.29

1.6

1.4

1707.43

2104.03

e6/l

0.11

207

1796

Malignant neoplasm of oropharynx, including Hilmo

167

1.20

0.28

1.4

1.3

581.33

788.89

e6/l

0.10

135

Familial hypercholesterolemia, with ischemic heart disease

689

1.09

0.28

1.5

1.4

1570.34

672.27

e6/l

0.28

522

Guttate psoriasis

112

1.26

0.28

2.0

1.3

738.67

102.84

e6/l

—

Abrasion of teeth

410

4240

0.97

0.28

1.3

1.4

4146.82

2612.79

e6/l

0.28

300

3329

Mandibular hypoplasia

1.26

0.27

1.1

2.0

327.63

162.61

e6/l

—

Osteitis due to dental implant

1.26

0.27

1.6

1.4

1681.25

153.86

e6/l

—

Malignant neoplasm of skin

559

3673

1.03

0.27

1.4

5240.59

1812.70

e6/l

0.40

436

2953

Mixed hyperlipidaemia

299

1.14

0.27

1.6

1.4

1544.32

844.07

e6/l

0.30

240

Erectile dysfunction

574

0.90

0.27

1.4

1.5

1294.47

995.36

e6/l

0.12

452

Pustulosis palmaris et plantaris

385

0.88

0.27

1.3

1.4

593.84

1535.60

e6/l

0.48

295

Hypertension, Pulmonary Arterial

1.22

0.27

1.9

1.2

110.63

169.34

e6/l

—

Deep bite that required surgery

113

1.25

0.27

1.1

1.3

207.29

138.07

e6/l

0.17

Pneumothorax

586

1.09

0.26

1.5

1.4

2384.00

776.20

e6/l

0.64

460

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

202

1927

1.05

0.26

1.5

711.65

3022.60

e6/l

0.61

167

1519

Left ventricular outflow tract obstruction, narrow definition

489

0.90

0.26

1.5

2.3

628.29

1042.89

e6/l

0.29

365

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

241

2238

1.04

0.26

1.4

9933.55

1562.87

e6/l

0.45

192

1809

Left hemicolectomy

169

1.19

0.26

1.3

82.80

863.31

e6/l

0.62

133

All-cause Heart Failure

588

4198

0.97

0.26

1.5

666.64

1994.31

e6/l

1.63

494

3320

Other disorders of skin and subcutaneous tissue, not elsewhere classified

139

1314

1.06

0.26

1.4

617.92

1031.27

e6/l

0.72

113

1039

All dysplastic lesions of the vagina

256

0.86

0.25

1.3

1.5

225.47

454.83

e6/l

0.38

203

Macular hole

463

1.10

0.25

1.5

1.3

859.97

865.97

e6/l

0.00

362

Abscess of lung

123

1.23

0.25

4.1

1.6

2102.60

1071.56

e6/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

897

1.07

0.25

1.2

1.3

895.80

1804.44

e6/l

0.39

712

Inguinal hernia, bilateral

897

1.07

0.25

1.4

1332.69

1040.51

e6/l

0.09

703

Polycystic kidney disease

207

1.16

0.25

1.3

1.8

1401.32

649.66

e6/l

0.23

160

Other and unspecified nonscarring hair loss

1.21

0.25

1.3

1.2

28.00

72.08

e6/l

—

Other deformities of toe(s)

292

1.13

0.25

1.4

522.08

626.52

e6/l

0.07

228

Benign neoplasm: Lip

159

0.81

0.25

1.2

1.3

548.86

851.73

e6/l

—

120

Type 1 diabetes, strict definition

868

0.93

0.24

1.5

2.0

707.28

5405.26

e6/l

0.55

681

Allergic contact dermatitis due to drugs in contact with skin

180

0.83

0.24

1.6

1.5

186.30

767.21

e6/l

—

137

Conduction disorders

320

2475

1.04

0.24

1.4

1.5

605.37

2267.74

e6/l

1.09

268

1939

Mandibular retrognathia AND surgery (BSSO)

233

0.86

0.24

1.2

1.5

136.30

937.46

e6/l

0.77

183

Primary gonarthrosis, bilateral

562

4585

1.03

0.23

1.4

771.38

2160.61

e6/l

1.65

449

3626

Other secondary coxarthrosis

284

1.13

0.23

1.4

1.5

419.15

1139.39

e6/l

0.66

221

Other hammer toe(s) (acquired)

155

1341

1.05

0.23

1.4

1.5

1738.33

960.02

e6/l

0.30

118

1056

Heart failure and bmi 25plus

321

2068

1.04

0.23

1.4

590.24

2639.58

e6/l

1.19

265

1643

Macular cyst

243

0.86

0.23

1.5

1.4

71.07

671.48

e6/l

0.70

190

Congenital malformations of the urinary system

572

1.09

0.23

1.3

2.2

710.88

671.88

e6/l

0.03

432

Other chronic obstructive pulmonary disease

412

3470

0.97

0.23

1.5

1.4

1578.77

2099.57

e6/l

0.26

329

2790

Pustular psoriasis

432

0.90

0.23

1.3

1.5

530.43

1357.11

e6/l

0.47

336

Non-small cell lung cancer, adenocarcinoma, helper endpoint

505

0.91

0.23

1.3

1.4

537.30

827.90

e6/l

0.29

406

Benign neoplasm of breast

106

1124

0.94

0.23

1.6

1.4

1985.82

1253.75

e6/l

0.23

881

Heart failure, strict

599

4261

0.98

0.23

1.5

666.41

1975.88

e6/l

1.63

504

3364

therapeutic use

247

1.14

0.22

1.6

1.3

124.13

664.93

e6/l

0.60

193

Acquired clawhand, clubhand, clawfoot and clubfoot

1.26

0.22

1.2

1.3

1178.20

93.85

e6/l

—

Acquired stenosis of external ear canal

1.27

0.22

1.4

1.5

30.20

119.63

e6/l

—

Other assisted single delivery

172

1.17

0.22

1.1

1.4

634.00

23240.26

e6/l

0.48

128

Use of benzatropine

0.00

0.22

0.0

1.1

—

5.40

—

Malignant neoplasm of bladder, including Hilmo

884

0.94

0.22

1.6

1.4

881.29

1477.50

e6/l

0.36

726

Carcinoma in situ, other/unspecified

0.00

0.21

0.0

1.2

—

768.83

—

Poor fetal growth

146

1392

1.05

0.21

1.2

1.4

740.83

3915.89

e6/l

0.60

124

1098

Ascorbic acid deficiency

0.00

0.21

0.0

2.7

—

548.17

—

Autism

267

1.13

0.21

1.1

2.7

352.38

851.25

e6/l

0.32

198

Nonischemic cardiomyopathy

843

0.94

0.21

1.5

202.03

861.66

e6/l

1.82

647

Ulcerative proctitis

627

0.92

0.21

1.2

1.4

348.53

1421.62

e6/l

1.22

493

Disorders of copper metabolism

0.00

0.21

0.0

4.0

—

392.17

—

Hirsprung

0.00

0.21

0.0

4.8

—

543.50

—

Transepidermal elimination disorders

0.00

0.21

0.0

1.2

—

178.75

—

Other other unspecified disorders of the circulatory system

296

1.12

0.21

1.3

1.7

2300.23

820.93

e6/l

0.28

229

Infections of breast associated with childbirth

363

1.10

0.21

1.2

1.4

198.28

11595.62

e6/l

0.56

284

Gastrointestinal stromal tumor and sarcoma

105

0.76

0.21

1.3

27272.25

1327.56

e6/l

—

L01XX Other antineoplastic agents

469

1.09

0.21

1.2

1.4

1579.82

724.26

e6/l

0.34

362

Carcinoma in situ of oesophagus

0.00

0.21

0.0

1.3

—

805.00

—

Other infective otitis externa

566

1.08

0.21

1.3

1.5

92.18

1013.09

e6/l

1.17

443

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

838

1.06

0.20

1.4

1.3

583.44

925.76

e6/l

0.39

673

Inflammatory disease of cervix uteri

518

1.08

0.20

1.4

772.68

1319.75

e6/l

0.38

404

Iodine-deficiency-related goitre

0.00

0.20

0.0

1.2

—

762.14

—

Endometriosis of intestine

155

1.17

0.20

1.2

1.4

342.45

469.65

e6/l

0.14

123

Toxic effect of contact with venomous animals

384

1.10

0.20

1.3

1.7

672.36

668.18

e6/l

0.00

289

Other appendicitis

791

1.06

0.19

1.4

2549.26

1332.94

e6/l

0.31

626

Chondromalacia

231

1.13

0.19

1.2

1.5

631.29

1819.77

e6/l

0.41

175

Pollen allergy

241

2297

1.04

0.19

1.3

1.8

394.23

2815.99

e6/l

0.81

190

1778

Cystic kidney disease, including avohilmo

302

0.89

0.19

1.3

1.8

1441.86

820.10

e6/l

0.21

229

Stenosis and insufficiency of lacrimal passages

801

1.06

0.19

1.6

1.5

5929.45

1103.64

e6/l

0.42

622

Golimumab

346

1.10

0.19

1.4

1.7

329.82

1262.95

e6/l

0.76

271

Malignant neoplasm of breast, ER-negative, including Hilmo

202

1959

0.96

0.19

1.4

2078.33

1408.81

e6/l

0.20

144

1573

Contact with machinery

109

1036

1.05

0.19

1.2

1.5

445.86

734.27

e6/l

0.32

808

Congenital malformations of eye, ear, face and neck

685

1.07

0.19

1.4

2.2

1074.49

7276.77

e6/l

0.54

511

Pleural plaque without asbestos

241

1.12

0.19

1.5

1.3

55.57

876.85

e6/l

1.06

192

Olecranon bursitis

472

1.08

0.19

1.4

494.17

567.32

e6/l

0.07

376

Clear cell adenocarcinoma of kidney

395

1.09

0.19

1.5

1.3

787.20

975.04

e6/l

0.10

316

Carcinoma in situ of other and unspecified digestive organs

376

1.09

0.18

1.5

1.3

4218.21

951.84

e6/l

0.38

289

Ventricular septal defect, a heart condition

258

0.89

0.18

2.0

3.8

298.39

307.22

e6/l

0.01

180

Other secondary gonarthrosis

473

1.08

0.18

2.1

1.4

1283.30

677.03

e6/l

0.26

359

Oesophageal varices

342

0.90

0.18

1.3

1.7

44.77

758.76

e6/l

1.09

258

Carcinoma in situ of skin

652

0.93

0.18

1.6

1.4

1493.22

815.97

e6/l

0.34

513

Later onset COPD, excluding more controls

167

1224

1.04

0.18

1.3

1.4

1769.86

1351.24

e6/l

0.13

128

984

Aortic valve malfunction, age under 60 years

949

0.95

0.18

1.7

2993.51

1195.77

e6/l

0.55

737

Malignant neoplasm of breast, HER-negative

183

1821

0.96

0.18

1.4

809.87

1285.19

e6/l

0.61

128

1462

Fistulae involving female genital tract

138

1.16

0.17

1.5

1.3

415.56

582.92

e6/l

—

106

Carcinoma in situ of other and unspecified genital organs

176

1.14

0.17

1.1

1.5

21.60

603.04

e6/l

0.78

131

Varicose veins

660

5073

0.98

0.17

1.5

1.4

1815.59

1898.29

e6/l

0.04

549

3999

Preparatory care for dialysis

368

1.09

0.17

1.4

1.6

407.86

723.40

e6/l

0.26

282

Other and unspecified disorders of pigmentation

0.75

0.17

1.4

1.1

100.00

158.40

e6/l

—

Trichomoniasis

0.74

0.17

1.2

21977.80

76.87

e6/l

—

Bicuspidal aortic valve syndrome

340

0.91

0.16

1.6

1.7

841.73

1434.54

e6/l

0.30

256

Peripheral artery disease

397

3206

0.98

0.16

1.6

1.4

1345.20

2072.94

e6/l

0.38

328

2563

Family history of other conditions

141

0.85

0.16

1.2

1.6

276.42

148.40

e6/l

0.18

109

Non-allergic asthma

826

1.05

0.16

1.3

2.0

2671.91

1259.52

e6/l

0.38

650

Postmenopausal atrophic vaginitis

273

1446

1.03

0.16

1.3

1.4

678.47

1775.91

e6/l

0.83

217

1137

Malignant neoplasm of floor of mouth, including Hilmo

1.13

0.16

1.0

1.3

0.88

1661.07

e6/l

—

Benign neoplasm: Conjunctiva

273

1.10

0.16

1.1

1.4

122.35

741.58

e6/l

0.76

213

720

1.06

0.16

1.4

840.52

748.40

e6/l

0.07

570

Respiratory distress of newborn

191

1.12

0.16

6.2

4.9

194.94

251.24

e6/l

0.12

129

Benign neoplasm: Skin of eyelid, including canthus

135

1403

0.96

0.16

1.3

1.4

1352.37

1180.07

e6/l

0.07

103

1103

Pleural plaque with presence of asbestos

473

0.93

0.16

1.2

1.4

516.53

1226.73

e6/l

0.86

380

Other diseases of biliary tract

750

0.95

0.15

1.5

1.6

147.48

1015.68

e6/l

3.57

589

Glaucoma, exfoliation

750

0.95

0.15

1.5

1.4

702.54

970.71

e6/l

0.31

593

Juvenile arthritis (FINNGEN)

452

0.93

0.15

1.5

2.2

1268.06

9505.88

e6/l

0.46

343

Motorcycle rider injured in other and unspecified transport accidents

555

1.06

0.15

1.2

1.6

1275.00

825.98

e6/l

0.21

410

Other noninflammatory disorders of uterus, except cervix

216

1398

1.03

0.15

1.5

1.4

1078.35

1718.89

e6/l

0.36

174

1108

Deep bite

134

1132

1.04

0.15

2.2

1.9

428.83

4413.09

e6/l

0.61

101

866

Congenital malformations of breast, including avohilmo

182

0.88

0.15

1.1

1.6

1.64

1520.87

e6/l

0.53

140

COPD

436

3611

0.98

0.15

1.5

1.4

1894.89

2046.84

e6/l

0.06

345

2903

Other noninflammatory disorders of cervix uteri

420

0.93

0.15

1.3

1.4

2022.16

1315.16

e6/l

0.16

329

conjunctival degenerations and deposits

169

1.13

0.14

1.2

1.3

1518.58

813.11

e6/l

0.17

126

Emphysema

576

1.06

0.14

1.6

1.4

4409.23

678.15

e6/l

0.70

453

Ulcerative rectosigmoiditis

811

1.05

0.14

1.4

1.5

733.47

1253.52

e6/l

0.39

631

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

411

1.07

0.14

1.5

1.4

981.24

1086.27

e6/l

0.06

318

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

851

1.05

0.14

1.4

1204.32

1267.45

e6/l

0.02

651

Malignant neoplasm of kidney, except renal pelvis

734

1.05

0.14

1.4

1.3

678.31

1007.44

e6/l

0.31

588

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

519

1.06

0.13

1.4

1.3

249.04

969.44

e6/l

1.40

394

Other specified disorders of external ear

305

1.08

0.13

1.6

1.4

505.96

505.85

e6/l

0.00

241

Cardiomyopathy

171

1659

1.03

0.13

1.5

771.74

2689.21

e6/l

0.73

125

1286

Other congenital malformations of peripheral vascular system

132

1.14

0.13

1.3

2.2

1.40

254.00

e6/l

—

102

Thyroiditis, unspecified

123

1.14

0.12

1.4

1.8

366.43

274.96

e6/l

0.09

Laparoscopic right hemicolectomy

447

0.94

0.12

1.8

1.3

273.85

597.62

e6/l

0.46

350

Benign neoplasm: Skin of upper limb, including shoulder

162

1.11

0.12

1.5

1.3

161.20

835.56

e6/l

—

122

Single spontaneous delivery

453

2353

1.02

0.11

1.2

1.4

1458.06

2717.71

e6/l

0.32

354

1798

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

326

1.07

0.11

1.0

3.2

116.85

479.46

e6/l

0.75

240

Benign neoplasm: Skin of trunk

374

0.93

0.11

1.3

1.5

181.26

860.19

e6/l

0.98

289

Respiratory tuberculosis, not confirmed

259

1.08

0.11

1.6

1.3

29.48

690.58

e6/l

0.87

202

Congenital malformations of the urinary system, including avohilmo

611

1.05

0.11

1.3

2.1

753.73

1089.78

e6/l

0.20

458

Cardiac arrest

377

1.06

0.11

1.2

1.4

132.42

1021.96

e6/l

1.42

290

Isolated proteinuria

240

0.91

0.11

1.3

1.5

113073.13

593.36

e6/l

0.50

187

Pathological resorption of teeth

347

1.07

0.11

1.5

19595.00

1455.03

e6/l

0.44

267

Malignant neoplasm of oral cavity

279

1.08

0.11

1.1

1.5

1521.05

941.72

e6/l

0.16

223

Inguinal hernia

691

4535

1.01

0.11

1.5

1531.42

2275.18

e6/l

0.34

552

3607

Leiomyoma of uterus

737

4181

0.99

0.11

1.4

1514.25

2405.81

e6/l

0.40

574

3275

Overjet

289

0.93

0.11

4.2

3.0

109.05

147.51

e6/l

0.13

226

Congenital ovarian cysts

434

0.94

0.10

1.3

1.4

6.04

1553.35

e6/l

1.57

345

Crossbite

763

1.04

0.10

3.5

2.3

183.28

684.20

e6/l

1.39

567

Malignant neoplasm of ovary

413

0.94

0.10

1.2

1.4

1827.14

1128.10

e6/l

0.20

329

Tooth agenesis EXCLUDE clefts and syndromes

402

0.94

0.10

2.7

2.4

683.46

662.15

e6/l

0.01

300

Malignant neoplasm of urinary organs, including Hilmo

948

1.03

0.10

1.4

1.3

538.57

1085.36

e6/l

0.77

770

Malignant neoplasm of tongue, including Hilmo

212

1.09

0.10

1.2

1.5

1910.24

1027.49

e6/l

0.20

172

Psoriasis (vulgaris), strict definition

300

0.93

0.10

1.4

1684.52

1499.01

e6/l

0.05

228

Mandibular prognathia AND surgery (LeFortI or BSSO)

1.11

0.10

1.0

1.5

49.80

230.49

e6/l

—

Type 1 diabetes, strict definition, subgroup 1

827

0.96

0.10

1.5

1.9

718.33

5644.85

e6/l

0.55

652

Malignant neoplasm of tongue

164

1.10

0.10

1.1

1.5

2496.38

838.64

e6/l

0.31

135

Other malignant neoplasms of skin (=non-melanoma skin cancer)

474

3258

0.99

0.09

1.4

6063.62

1603.68

e6/l

0.46

371

2627

HSIL lesion of the cervix uteri, vagina or vulva

233

2286

1.02

0.09

1.2

1.3

569.31

2983.08

e6/l

0.80

180

1800

Rubella [German measles], including avohilmo

291

1.07

0.09

1.7

1.3

924.60

1348.49

e6/l

0.16

235

Congenital aortic valve stenosis

1.04

0.09

1.0

4.3

126.00

303.44

e6/l

—

Malignant neoplasm of head and neck

664

1.04

0.09

1.3

1.4

1052.86

943.12

e6/l

0.06

526

Respiratory tuberculosis, not confirmed, including avohilmo

262

1.07

0.09

1.6

1.3

29.48

683.83

e6/l

0.87

204

Left ventricular outflow tract obstruction (LVOTO), broad definition

101

1040

0.97

0.09

1.7

1.9

2677.82

1129.77

e6/l

0.52

799

Venous complications and haemorrhoids in pregnancy

155

1.10

0.09

1.1

1.7

16141.25

1815.59

e6/l

0.40

121

Other acquired deformities of ankle and foot

1.09

0.09

1.5

1.1

34.00

119.51

e6/l

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

826

0.97

0.08

1.3

1.4

912.72

1347.31

e6/l

0.30

642

Pleural plaque

684

0.96

0.08

1.3

1.4

365.24

955.07

e6/l

1.13

549

Congenital malformations of ovaries, fallopian tubes and broad ligaments

548

1.04

0.08

1.4

39.97

8191.76

e6/l

0.62

430

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

181

0.92

0.08

3.2

5.0

137.17

1023.10

e6/l

0.68

128

Exfoliative dermatitis

1.10

0.08

1.4

1.3

10.57

178.67

e6/l

—

Multiple gestation

987

0.97

0.08

1.7

1.4

193.20

4577.53

e6/l

0.60

772

Myocardial infarction, without ST-elevation

362

3307

0.99

0.08

1.4

567.55

2085.57

e6/l

1.47

296

2647

Ethmoidectomy

130

1330

0.98

0.08

1.4

1.5

4687.34

4017.44

e6/l

0.05

113

1043

Malignant neoplasm of ovary, including Hilmo

541

0.96

0.08

1.3

1.4

1333.38

1353.24

e6/l

0.01

429

Congenital malformations of breast

164

0.91

0.08

1.1

1.3

1.80

1662.14

e6/l

—

127

Pericarditis

303

1.06

0.08

1.2

1.7

1099.67

707.37

e6/l

0.20

232

Graves ophthalmopathy

215

0.93

0.07

1.4

1.5

538.50

160.45

e6/l

0.32

166

Twin gestation

955

0.97

0.07

1.7

1.4

201.67

4721.55

e6/l

0.60

748

Other and unspecified disease of Bartholin gland

225

1.07

0.07

1.5

1.4

564.17

471.31

e6/l

0.08

176

Calcific aortic valvular stenosis, operated

239

2335

0.98

0.07

1.4

1.5

1557.99

2223.33

e6/l

0.25

198

1876

Calcific aortic valvular stenosis

239

2335

0.98

0.07

1.4

1.5

1557.99

2223.33

e6/l

0.25

198

1876

Ulcerative colitis (strict definition, require KELA)

182

1788

1.02

0.07

1.3

1.5

764.56

3099.55

e6/l

0.56

151

1407

Amputation of toe

550

0.96

0.07

2.2

1.4

170.77

802.87

e6/l

1.55

431

Other congenital malformations of female genitalia

1.06

0.07

1.3

1.5

694.67

52.52

e6/l

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.04

0.07

1.0

1.3

76.78

1400.81

e6/l

—

Arthropathy in Crohn disease

1.13

0.07

1.2

1.3

3.50

173.72

e6/l

—

HSIL lesion of the cervix uteri

208

2112

0.98

0.07

1.2

1.3

615.64

3156.95

e6/l

0.77

162

1673

Primary biliary cholangitis, wide definition

173

0.92

0.06

1.3

2.0

546.64

778.76

e6/l

0.13

135

Calcific aortic valvular stenosis, including rheumatic fever

240

2339

0.99

0.06

1.4

1568.65

2210.89

e6/l

0.24

199

1879

Primary Sclerosing Cholangitis, IBD and UDCA required

187

1.07

0.06

1.1

2.3

78.00

192.04

e6/l

0.59

139

Retinoschisis and retinal cysts

187

1.07

0.06

1.2

1.5

1367.86

818.63

e6/l

0.15

142

Non-small cell lung cancer, adenocarcinoma

477

0.96

0.06

1.3

537.30

830.34

e6/l

0.29

384

Supervision of normal pregnancy

257

1447

1.01

0.06

1.4

1.3

520.88

3877.06

e6/l

0.67

192

1115

Maternal care for known or suspected disproportion

416

0.96

0.06

1.4

16596.94

729.40

e6/l

0.49

326

Cystic kidney disease

274

0.95

0.06

1.3

1.8

1331.45

844.81

e6/l

0.15

209

Lung cancer and mesothelioma

152

1311

0.98

0.06

1.3

1.4

16700.98

1508.47

e6/l

0.46

108

1050

Family history of malignant neoplasm

116

1183

0.98

0.06

1.3

521.97

5128.84

e6/l

0.80

923

Injury of muscle and tendon at ankle and foot level

217

1.06

0.06

1.3

1.5

813.69

1155.29

e6/l

0.17

168

Cholangitis (primary sclerosing, PSC)

513

1.03

0.06

1.2

1.7

518.40

675.42

e6/l

0.12

403

Congenital malformations of genital organs

104

1012

1.02

0.06

1.5

2.0

208.19

4989.06

e6/l

0.67

770

Respiratory and cardiovascular disorders specific to the perinatal period

282

1.05

0.05

5.5

3.9

150.44

222.66

e6/l

0.24

199

Calcific aortic valvular stenosis, diagnosis (helper)

239

2328

0.99

0.05

1.4

1557.99

2220.09

e6/l

0.25

198

1871

Operations 2 for CAVS

239

2328

0.99

0.05

1.4

1557.99

2220.09

e6/l

0.25

198

1871

Isolated proteinuria with specified morphological lesion

1.11

0.05

1.2

1.4

387.80

1437.44

e6/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

509

3406

1.01

0.05

1.4

5763.01

1872.17

e6/l

0.42

398

2737

COPD related to multimorbidity

368

3137

0.99

0.05

1.5

1.4

1759.62

2208.26

e6/l

0.19

297

2512

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

354

0.96

0.05

1.3

98.00

765.02

e6/l

1.11

289

Benign neoplasm: Oesophagus

100

1.10

0.05

1.1

1.4

6.55

1333.68

e6/l

0.59

Basal cell carcinoma, including Hilmo

490

3291

1.01

0.05

1.4

5888.45

1588.68

e6/l

0.46

386

2652

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

177

1746

1.01

0.05

1.3

1.5

783.24

3161.25

e6/l

0.55

147

1372

Carcinoma in situ of skin of lower limb, including hip

159

1.07

0.05

1.1

1.3

112.70

887.36

e6/l

—

127

Long labour

289

2473

0.99

0.05

1.4

617.95

2824.87

e6/l

0.78

216

1915

Carcinoma in situ of skin of trunk

232

0.95

0.05

1.4

1.3

70.31

835.39

e6/l

0.94

188

Other benign neoplasms of skin

391

3942

0.99

0.05

1.4

1144.47

2854.33

e6/l

0.83

307

3119

Other acute skin changes due to ultraviolet radiation

272

0.96

0.04

2.1

1.5

262.19

847.56

e6/l

0.53

214

Chronic suppurative otitis media

615

0.97

0.04

1.7

1219.20

899.06

e6/l

0.18

482

Chronic suppurative otitis media, including avohilmo

736

0.98

0.04

1.6

1.9

3487.69

1121.48

e6/l

0.45

576

IgA nephropathy (IgA glomerulonephritis)

201

0.94

0.04

1.3

623.00

675.10

e6/l

0.03

157

Impacted cerumen

107

1052

1.02

0.04

1.8

1.6

749.64

932.65

e6/l

0.16

829

Acute appendicitis, with complications

192

1899

1.01

0.04

1.4

233.68

3185.93

e6/l

0.85

141

1486

COPD, hospital admissions 3, with asthma pneumonia sepsis

237

2011

1.01

0.04

1.5

1.4

666.53

2312.99

e6/l

0.84

193

1602

Peripheral artery operations in Hilmo

944

0.98

0.03

1.9

1.4

563.54

859.32

e6/l

0.33

749

Other juvenile arthritis

381

0.97

0.03

1.5

2.3

1337.33

10756.27

e6/l

0.46

296

Other disorders of cornea

916

1.02

0.03

1.6

1.4

1064.61

1095.76

e6/l

0.01

707

Ulcerative enterocolitis

260

0.96

0.03

1.0

1.5

66.16

842.80

e6/l

0.87

203

FESS (DNB20)

127

1285

0.99

0.03

1.4

4771.59

4156.09

e6/l

0.04

111

1006

Heart failure,strict

559

3881

1.00

0.03

1.5

1.4

670.64

1466.50

e6/l

2.48

471

3057

Valvular heart disease excluding rheumatic fever

524

3757

1.00

0.03

1.5

1.6

2201.69

2903.11

e6/l

0.19

446

2933

Prolapse and hernia of ovary and fallopian tube

197

0.95

0.03

1.0

1.3

8.31

656.98

e6/l

2.78

163

Arterial embolism and thrombosis

410

0.97

0.03

1.3

1.4

5442.82

667.73

e6/l

0.64

324

Maternal care for other known or suspected fetal problems

289

1823

0.99

0.02

1.3

1.4

653.10

3044.64

e6/l

0.59

240

1417

Fibrosis and cirrhosis of liver

681

0.98

0.02

1.5

683.15

1178.65

e6/l

0.42

530

Suppurative and necrotic conditions of lower respiratory tract

460

1.02

0.02

2.5

1.5

3171.97

1177.72

e6/l

0.62

356

Rubella [German measles]

291

1.03

0.02

1.7

1.3

924.60

1348.49

e6/l

0.16

235

Noise effects on inner ear

329

0.97

0.02

1.5

1.3

427.96

1423.55

e6/l

0.80

253

Malignant neoplasm of urinary organs

809

1.01

0.02

1.4

1.3

633.21

954.89

e6/l

0.34

653

Other ulcerative colitis

560

1.02

0.02

1.6

1.4

1655.10

1372.92

e6/l

0.09

440

Benign neoplasm: Skin of other and unspecified parts of face

911

0.99

0.02

1.5

1.4

824.04

1160.85

e6/l

0.27

717

Graves ophthalmopathy, strict

192

1.04

0.02

1.4

1.5

538.50

171.36

e6/l

0.31

151

Disorders of lacrimal system and orbit in diseases classified elsewhere

208

0.96

0.02

1.4

1.6

538.50

506.26

e6/l

0.02

160

COPD, hospital admission 2, with asthma infections

295

2526

1.01

0.02

1.5

1.4

912.73

2440.13

e6/l

0.95

237

2011

Oral lichen planus

242

1.03

0.02

1.5

1.4

146.26

949.78

e6/l

0.79

184

Basal cell carcinoma

463

3166

1.00

0.02

1.4

6139.06

1501.59

e6/l

0.47

363

2551

Pyothorax

348

0.98

0.01

1.6

1.4

4451.05

905.63

e6/l

0.89

274

Eustachian salpingitis and obstruction

841

1.01

0.01

1.4

1.5

257.42

2090.14

e6/l

1.39

664

Transitory endocrine and metabolic disorders specific to fetus and newborn

183

0.96

0.01

3.1

5.0

126.69

1007.47

e6/l

0.69

130

Foreign body in ear

173

1.04

0.01

1.8

1.9

2239.23

259.58

e6/l

0.82

129

Non-rheumatic valve diseases

520

3717

1.00

0.01

1.5

2209.55

2882.88

e6/l

0.18

442

2901

Embedded teeth, including avohilmo

101

1018

0.99

0.01

1.8

1.6

174.30

4820.66

e6/l

0.67

792

Malignant neoplasm of bladder

453

1.01

0.01

1.5

1.4

1107.12

1049.46

e6/l

0.02

372

LeFortI or BSSO operation

404

1.02

0.00

1.1

1.4

132.58

1862.46

e6/l

1.42

319

Polyhydramnios

495

0.99

0.00

1.5

1.4

15.64

8366.48

e6/l

0.55

384

Cirrhosis of liver, NAS

461

1.00

0.00

1.6

1.5

354.05

729.35

e6/l

0.58

355

Malignant neoplasm of other and ill-defined sites, including Hilmo

104

0.96

0.00

4.0

1.3

58.10

1262.92

e6/l

—

Carcinoma in situ of cervix uteri, endocervix

114

0.96

0.00

1.1

1.4

136.67

98.00

e6/l

—

Embolic stroke with flimmer

170

1.00

0.00

1.5

1.4

2151.55

995.21

e6/l

0.25

139

Maxillary retrognathism

176

1.02

0.00

1.4

2.6

817.08

839.55

e6/l

0.01

132

Other nonscarring hair loss

107

1.03

0.00

1.3

1.2

23.09

55.73

e6/l

0.63

Dermatitis due to ingested food

398

1.01

0.00

1.8

3.0

281.67

10737.51

e6/l

0.51

287

Premenstrual syndrome

147

1.02

0.00

1.3

1.4

0.44

460.72

e6/l

—

117

Right bundle-branch block

304

0.99

0.00

1.5

1.4

754.14

652.68

e6/l

0.08

241

Lesion of plantar nerve

496

1.01

0.00

1.3

1.4

278.13

1456.74

e6/l

1.11

377

Neonatal jaundice from other and unspecified causes

192

1.01

0.00

7.0

4.9

502.93

937.03

e6/l

0.26

132

308

0.99

0.00

2.3

4.0

497.89

622.64

e6/l

0.09

214

Carcinoma in situ of colon

238

1.01

0.00

1.7

1.3

7116.16

650.28

e6/l

0.44

178

Autism spe

272

0.99

0.00

1.1

2.5

395.76

863.58

e6/l

0.29

205

Non-ischemic cardiomyopathy

308

2438

1.00

0.00

1.6

1.5

465.16

2294.80

e6/l

1.20

256

1882

Ascites

589

1.00

0.00

1.6

1.5

293.07

1206.10

e6/l

1.77

457

Scissor bite

302

0.98

0.00

3.4

2.6

7.44

287.09

e6/l

1.53

230

Ulcerative ileocolitis

359

1.00

0.00

1.1

1.5

46.25

2132.37

e6/l

1.51

274

Amputation

759

1.00

0.00

2.0

1.4

317.87

872.00

e6/l

1.09

607

Burn and corrosion of head and neck

181

0.99

0.00

1.1

1.6

6.69

1400.09

e6/l

1.08

137

Nontoxic single thyroid nodule

637

1.00

0.00

1.4

1.5

980.12

1352.95

e6/l

0.23

494

Benign neoplasm: Tongue

225

1.02

0.00

1.3

1.5

2475.60

679.30

e6/l

0.40

172

Myxoedema coma

0.00

0.0

1.1

—

666.00

—

Use of entacapone

1.00

0.00

1.8

1.3

24.20

175.58

e6/l

—

Carcinoma in situ of bronchus and lung

0.00

0.0

1.3

—

268.57

—

Brucellosis, including avohilmo

0.00

0.0

1.3

—

88.83

—

Acquired keratosis follicularis

0.00

-0.00

0.0

1.1

—

11.29

—

Deficiency of other/unspecified nutrient elements

0.00

-0.00

0.0

1.2

—

6.60

—

Chondrolysis

0.00

-0.00

0.0

1.0

—

793.67

—

Myelofibrosis

0.00

-0.00

0.0

1.4

—

14.00

—

Other pulmonary heart/vessel disease

330

1.00

-0.00

1.5

151.64

603.95

e6/l

0.71

263

Other birth injuries

0.00

-0.00

0.0

1.2

—

983.50

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

-0.00

0.0

1.2

—

8.50

—

Brucellosis

0.00

-0.00

0.0

1.4

—

101.40

—

Pediculosis and phthiriasis, including avohilmo

0.95

-0.00

1.7

1.5

1398.83

121.47

e6/l

—

Other specified/unspecified nutritional deficiencies

0.92

-0.00

1.3

1.2

22.00

186.86

e6/l

—

Choroidal degeneration

0.00

-0.00

0.0

1.2

—

309.17

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

2.3

—

29.56

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Erythrocytes [#/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS